Introduction of pneumococcal conjugate vaccination in Ethiopia

Introduction of pneumococcal conjugate vaccination in Ethiopia: a cross-sectional analysis of predictors of vaccine use in children aged 12-23 months using Demographic and Health Survey data from 2016

Lauren L. Lockwood

____________________________________________ Master Degree Project in International Heath, 30 credits. Spring 2018 International Maternal and Child Health Department of Women’s and Children’s Health Supervisor: Andreas Mårtensson Word count: 10,077

UPPSALA UNIVERSITET Lauren Lockwood 2 (46) Abstract

Introduction

Pneumonia is the leading cause of mortality in children under five years of age globally. Vaccination

against pneumococcus with the pneumococcal conjugate vaccine (PCV-13) can reduce pneumonia

incidence and mortality among children. Despite this, PCV-13 coverage is low in Ethiopia.

Aim

The aim of this study was to identify socioeconomic and sociodemographic predictors of receipt of three

doses of PCV-13 vaccine in Ethiopian children aged 12-23 months.

Methods

Secondary data was obtained from the 2016 EDHS for children aged 12-23 months (n=1894). Variables

at the individual, family, household, and societal levels were tested for associations with the outcome

variable—receipt of three doses of PCV-13 using bivariate and multiple logistic regressions.

Results

Of the children sampled, 51.5% received three doses of PCV-13. Multiple logistic regression analysis

revealed that factors at all levels—individual, familial, household, and societal factors—were statistically

significant predictors of receipt of three doses of PCV-13 vaccination. Statistically significant predictors

observed in the multiple logistic regression model were place of the child’s delivery, maternal level of

education, employment status of the maternal partner/husband, wealth quintile, region, and religion.

Conclusion

There is great potential for improvement of PCV-13 immunization coverage in Ethiopia, as there is a

large gap between current PCV-13 vaccination coverage and the Ethiopian Ministry of Health’s target of

93% coverage by 2016. The predictors observed in this study are congruent with previous studies of

vaccination status predictors, and this knowledge may facilitate targeted immunization efforts to improve

PCV-13 coverage in risk groups.

UPPSALA UNIVERSITET Lauren Lockwood 3 (46) 1. Introduction!..................................................................................................................................................!2!

1.1 Community Acquired Pneumonia in a Global Context!.....................................................................................!2!1.2 Pneumonia Pathogenesis, Risk Factors, Prevention, and Treatment!...............................................................!2!1.3 Pneumonia in Ethiopia: Prevention, Epidemiology, and Health System Challenges!.......................................!5!1.4 Conceptual Framework!....................................................................................................................................!6!1.5 Rationale!..........................................................................................................................................................!7!1.6 Aim!...................................................................................................................................................................!7!

2. Methods!........................................................................................................................................................!8!2.1 Study Design!.....................................................................................................................................................!8!2.2 Study Setting!.....................................................................................................................................................!8!2.3 Study Population!..............................................................................................................................................!8!2.4 Study Population Characteristics!.....................................................................................................................!9!2.5 Data Collection!................................................................................................................................................!9!2.6 Variables!..........................................................................................................................................................!9!

2.6.1 Outcome variable!....................................................................................................................................!10!2.6.2 Predictor variables!...................................................................................................................................!10!

2.7 Study Size!........................................................................................................................................................!12!2.8 Statistical Methods!.........................................................................................................................................!12!

3. Ethical Considerations!................................................................................................................................!13!3.1 Ethical Review!................................................................................................................................................!13!3.2 Informed Consent, Voluntary Participation, and Participant Confidentiality!................................................!13!3.3 Additional Ethical Challenges in Longitudinal Demographic and Health Surveillance!................................!14!

4. Results!.........................................................................................................................................................!16!4.2 Predictors of PCV-13 vaccination in children aged 12-13 months!................................................................!20!

5. Discussion!...................................................................................................................................................!26!5.1 Key findings and analysis!...............................................................................................................................!26!

5.1.1 Predictors of PCV-13 Vaccination within the Social Ecological Framework!.........................................!27!5.2 Strengths and Weaknesses!..............................................................................................................................!30!5.3 Contextualizing findings for Global Health Goals!.........................................................................................!32!

6. Conclusion!..................................................................................................................................................!34!

7. Acknowledgements!.....................................................................................................................................!34!

8. References!...................................................................................................................................................!36!

Appendix!........................................................................................................................................................!43!

UPPSALA UNIVERSITET Lauren Lockwood 4 (46) Abbreviations Millennium Development Goal MDG Bacillus Calmette–Guérin vaccine (tuberculosis vaccine) BCG Demographic and Health Survey DHS Pentavalent vaccine (for diphtheria, pertussis, tetanus, hepatitis B, H. influenzae type b) DPT-HepB-Hib Enumeration Area EA Ethiopian Demographic and Health Survey EDHS Global Alliance for Vaccines and Immunization GAVI Human immunodeficiency virus HIV Nongovernmental organization NGO Pneumococcal conjugate vaccines PCV 7-valent pneumococcal conjugate vaccine PCV-7 10-valent pneumococcal conjugate vaccine PCV-10 13-valent pneumococcal conjugate vaccination PCV-13 Southern Nations, Nationalities, and Peoples' Region SNNP Tuberculosis TB World Health Organization WHO

UPPSALA UNIVERSITET Lauren Lockwood 2 (46) 1. Introduction

1.1 Community Acquired Pneumonia in a Global Context

Pneumonia is the leading cause of death in children under five years of age globally (1). Pneumonia is a

lower respiratory tract infection characterized by inflammation of the parenchymal tissues of the lung

including the bronchioles and alveoli. These infections may be classified as nosocomial (i.e. acquired in a

hospital setting) or community acquired. A community acquired infection is defined as “an infection that

begins outside the hospital or is diagnosed within 48 hours after admission to the hospital in a person

who has not resided in a long-term care facility for 14 days or more before admission,” (2). Community

acquired pneumonia makes up the majority of pneumonia disease burden globally, and

disproportionately affects children in lower and middle-income countries, with a staggering 95% of cases

occurring in these settings (3).

Global pneumonia mortality in children under five years of age improved 46%—from 1.7 million to

920,000—between 2000 and 2015 (4). These improvements have not, however, kept pace with other

leading causes of childhood morbidity and mortality e.g. malaria, human immunodeficiency virus (HIV),

diarrheal diseases, and measles (4).

1.2 Pneumonia Pathogenesis, Risk Factors, Prevention, and Treatment

Multiple pathogens can cause pneumonia. The most common causes are bacterial and viral infections,

though in more unusual cases fungal and parasitic pathogens can also lead to pneumonia (5–7).

Streptococcus pneumoniae and Haemophilus influenzae type b are the leading causes of bacterial

pneumonia in children after the first month of life, and both can be effectively prevented through

vaccination (8).

Pneumonia mortality is associated with myriad factors including the severity of the disease, malnutrition,

non-exclusive breastfeeding during the first six months of life, poverty, indoor and outdoor air pollution,

comorbidities such as HIV or measles infection, crowded living conditions, insufficient immunization

status, inadequate access to quality health care, and barriers to care seeking (4,9). Prevention of

pneumonia mortality via meaningful improvements in the majority of these factors would be incredibly

challenging to accomplish outside of the context of general improvements associated with global

development trends (9). On the other hand, vaccination with the currently available pneumococcal

conjugate vaccines in combination with the conjugate H. influenzae type b vaccine has the capacity to

prevent pneumonia and substantially improve pneumonia mortality in low and middle-income countries

by up to 50%—as S. pneumoniae and H. influenzae type b are the most predominant causes of severe

UPPSALA UNIVERSITET Lauren Lockwood 3 (46) pneumonia in young children (9). These two vaccinations have the added benefit of preventing other

challenging infections including sepsis, meningitis, and otitis media (9). In fact, pneumococcal conjugate

vaccines alone would be able to prevent between 50 and 80% of childhood pneumococcal disease

globally, based on current understandings of the distribution of S. pneumoniae strains (9). This makes

vaccination against the major bacterial pneumonia pathogens, S. pneumoniae and H. influenzae type b,

undoubtedly the most promising pneumonia prevention strategy in terms of short-term outcomes for

global pneumonia disease burden (9).

Vaccination against H. influenzae type b began in the 1970s, with a polysaccharide vaccine, which was

later replaced by an H. influenzae type b conjugate vaccine, which had the advantage of improved

immunogenicity1 in infancy (11). Polysaccharide vaccines are made up of long chains of sugar molecules

found in the surface capsule of some bacteria, and provide protection against the pathogen in question via

direct stimulation of the immune system’s B-cells, without the involvement of T-cells (12). Vaccination

with polysaccharide vaccine thereby creates T-cell independent antigens, which have not shown to be

reliably immunogenic in children under two years of age—likely due to their immature immune systems

(12). Conjugate vaccines, however, found a way to circumvent this problem, by combining these long

sugar-chains, found in the bacterial capsule, with a protein molecule; this change induces a T-cell-

mediated immune response post-vaccination, leading to better immune responses in infants as well as

improvements in antibody responses to booster doses later in life (12). Given that vaccination for H.

influenzae type b has occurred in some contexts for more than four decades now, there is a substantial

body of evidence regarding its efficacy. A recent meta-analysis reported that full vaccination for H.

influenzae type b has a vaccine effectiveness of 97% against invasive H. influenzae type b disease2 (10).

Additionally, H. influenzae type 1 vaccination was shown to have 80% effectiveness against bacteremic

pneumonia, after it was introduced to the routine vaccination program in Chile (16).

In contrast, pneumococcal conjugate vaccines (PCVs) are relatively young, and thus fewer studies have

been published regarding their efficacy. The first PCV developed, the 7-valent pneumococcal vaccine

(PCV-7), provides protection against seven serotypes3 of S. pneumoniae and was licensed in the United

States in 2000 (18). After its introduction, the World Health Organization (WHO) reported rapid and

sizeable reductions in vaccine-serotype invasive pneumococcal disease4, in the contexts reviewed:

1 Immunogenicity is defined as a drug’s ability to induce an immune response (10). 2 Invasive H. influenzae type 1 disease defined as isolation of H. influenzae type 1 from a normally sterile body site (13). 3 Serotype is a sub-species classification of microorganisms based on their cell surface antigens (17). 4 Invasive pneumococcal disease is defined as “isolation of S. pneumoniae from a normally sterile body site”—most commonly the blood or cerebrospinal fluid, in cases of sepsis and bacterial meningitis,

UPPSALA UNIVERSITET Lauren Lockwood 4 (46) Australia, Canada, the United Kingdom, the United States, and South Africa (18). Though the WHO did

not review data on the impact of PCV-7 in any low-income countries, a middle income country—South

Africa—saw an 89% reduction in vaccine serotype disease in children under two years of age, three

years post vaccine introduction (18). This is relevant because the more recent pneumococcal conjugate

vaccines, the 10-valent pneumococcal conjugate vaccine (PCV-10) and the 13-valent pneumococcal

conjugate vaccination (PCV-13), which include additional S. pneumoniae serotypes, were licensed not

based on studies of vaccine effectiveness or clinical outcomes, but rather on immunological studies of

non-inferiority compared to PCV-7 (18). The PCV-13 vaccine was approved for use by the U.S. Food

and Drug Administration in 2010, and provides protection against thirteen pathogenic S. pneumoniae

serotypes (18). The vast majority of post-licensure data regarding the vaccine effectiveness for PCV-13

comes from high-income countries, but one study from The Gambia, three years post-transition from

PCV-7 to PCV-13, reported a 55% decrease in all cause invasive pneumococcal disease in 2-23 month

old children and an 82% decrease in PCV-13-serotype invasive pneumococcal disease, compared to the

pre-PCV baseline period (18).

The PCV-13 vaccine is administered in three doses and the recommended vaccination schedule for

infants is one dose at 6 weeks of age, one at 10 weeks of age, and the final dose at 14 weeks of age (21).

Children who receive the vaccine before they reach five years of age, receive protection against the 13

pneumococcal strains included in the vaccine for between three and five years after vaccination (22).

Given that PCV-13 is a conjugate vaccine, it induces a T-cell response, which in turn causes a more

robust immune response against the antigen and a longer lasting immunologic memory (which can be

easily refreshed with booster doses later in life) when compared to polysaccharide vaccines (22,23).

The impact of these PCVs is due only in part to the direct protection against pathogenic serotypes that

vaccination confers to immunized individuals (24). Decreases in invasive pneumococcal disease have

been shown to occur in vaccinated and unvaccinated children, pointing to the herd immunity5 effects of

PCV-13 (24). Some authors have posited that PCVs induce herd immunity when the proportion of

vaccinated children reaches 65-70%, based on the observation that nasopharyngeal colonization by

vaccine serotypes substantially decreases in unimmunized individuals at these vaccination proportions

respectively, and less commonly pleural, pericardial, or synovial fluid.(18,19) Sepsis is a common complication of bacterial pneumonia, for which children younger than 12 months of age run a higher risk in comparison to the general population (20). 5 Herd immunity also referred to as the “herd effect” is defined as “the indirect protection of unvaccinated persons, whereby an increase in the prevalence of vaccine-immunity prevents circulation of infectious agents in unvaccinated susceptible populations,”(25).

UPPSALA UNIVERSITET Lauren Lockwood 5 (46) (24). In fact, by some estimates, the indirect protection PCV provides unimmunized individuals prevents

twice as many instances of pneumococcal disease compared to the direct protection conferred to

immunized individuals (24).

These vaccines do not, however protect against the leading causes of viral pneumonia: respiratory

syncytial virus, adenovirus, and rhinovirus (26). Respiratory syncytial virus is, in fact, the most common

cause of respiratory infections in children under six months of age (26). Accurately establishing the

etiology of a pneumonia case in the clinical setting, however, proves particularly challenging, especially

considering that co-infections with both viral and bacterial pathogens are common (26,27). This of

course has implications for treatment. Many cases of pneumonia in children under five years of age are

viral in origin, and thus should not be treated with antibiotics (27). Therefore in young children with

signs of non-severe pneumonia, the recommendation is watchful waiting rather than oral antibiotics (27).

In cases of children with fever and more severe pneumonia, the first line therapies are oral amoxicillin (a

five day course for uncomplicated cases) or narrow-spectrum intravenous beta-lactam therapy (such as

benzyl penicillin), with broad-spectrum beta-lactam therapies reserved for cases of very severe disease or

for children who have been pre-treated with antibiotics (27,28). Precise recommended dosages, however,

depend on local penicillin resistance rates in each context (27). Given that currently available etiological

markers are suboptimal, there is an ongoing appraisal of decision rules to reduce the number of

antibiotics prescribed to children with pneumonia of viral etiology (27). Barriers to appropriate treatment

and prevention of pneumonia in children under five are, however, plentiful and complex.

1.3 Pneumonia in Ethiopia: Prevention, Epidemiology, and Health System Challenges !

Since 2007, children in Ethiopia are vaccinated against H. influenzae type b in one of the vaccines in the

routine childhood vaccination series, the pentavalent vaccine (DPT-HepB-Hib), which also protects

against diphtheria, pertussis, tetanus, and hepatitis B (29). In November of 2011 the Ethiopian Ministry

of Health, with support from the Global Alliance for Vaccines and Immunization (GAVI), began

vaccinating children against S. pneumoniae with the 13-valent pneumococcal conjugate vaccine (PCV-

13), which provides protection against 13 strains of pneumococcal bacteria, as part of the Ethiopian

national infant immunization program (30). The PCV-13 vaccine is administered in three doses and the

recommended vaccination schedule for infants is one dose at 6 weeks, one at 10 weeks, and the final

dose at 14 weeks (31). When this vaccination program began, over 100,000 children were dying of

pneumonia every year in Ethiopia, and it was predicted that introduction of the vaccine could prevent

over 50,000 of these deaths (32).

Preventable communicable diseases, vaccine-preventable childhood diseases, and nutritional disorders

make up the bulk of Ethiopia’s disease burden (33). The past twenty years have seen dramatic

UPPSALA UNIVERSITET Lauren Lockwood 6 (46) improvements in the health status of the Ethiopian population, but, morbidity and mortality rates remain

high, and service equity and quality indicators remain low (33).

The health system in Ethiopia is made up of three tiers: a primary health care unit, a general hospital, and

a specialized hospital. The primary health care unit is made up of the district health system including a

primary hospital with a catchment population of 60,000 to 100,000, health centers with catchment

populations of 15,000-20,000, and the health centers’ five satellite health posts each with a catchment

population of 3,000-5,000. The general hospitals and specialized hospitals have catchment populations of

1 to 1.5 million and 3.5 to 5 million, respectively (33). This three-tier organizational model was the result

of a recently adopted business management strategy known as business process re-engineering, and has

been implemented throughout the health system. In addition to public sector actors within the health

system, recent years have seen a rapid expansion of the role of private sector for-profit actors as well as

non-governmental organizations in the Ethiopian health system, a shift that has reportedly played a role

in increased health care delivery, coverage, and utilization (33).

In 1980, the World Health Organization’s Expanded Programme on Immunization was adopted in

Ethiopia, and it is currently implemented at all levels of the previously described three-tier health system.

Most government health facilities are able to provide vaccination services, and in cases where

communities do not have a permanent health facility within a five-kilometer radius, vaccination services

are provided on an outreach basis via mobile health care teams (33). The government and non-

governmental organization health centers that provide these immunization services do so free of charge

to the recipient (33). Children younger than one year of age are a target group to receive vaccination

against tuberculosis, polio, measles, diphtheria, pertussis, tetanus, hepatitis B virus, H. influenzae type b,

rotavirus, S. pneumoniae, and polio through the Expanded Programme on Immunization (33).

Immunization coverage is, however, very low in the pastoralist communities throughout the country—

especially in Afar, Somali, and Gambella (33). These areas are sparsely populated and compared to other

areas of the country the health infrastructure is weak (33).

1.4 Conceptual Framework

The conceptual framework chosen for this study was the Social Ecological Model, adapted from the

Centers for Disease Control and Prevention (34).

UPPSALA UNIVERSITET Lauren Lockwood 7 (46)

This conceptual framework was chosen because it provides room for the complexity and interplay of

multiple and overlapping factors that influence an individual’s health and wellbeing within a specific

context. For the purposes of this secondary analysis the Social Ecological Model was conceptualized for

useful application in this study. The health and wellbeing outcome measured in this study was receipt of

three doses of PCV-13, and the potentially predictive factors explored at different levels of the

conceptual framework were as follows. Societal factors explored in this analysis were religion and

region. Community was defined, for the purposes of this study, as the level of the household, and the

accompanying factors examined were wealth quintile, altitude of the household, number of children

under 5 years of age in the household, and residence type defined as rural or urban. Relationship factors

were defined as familial factors, in this study, and at the level of the family, factors relating to the mother

as well as her husband/partner were explored: mother’s education, mother’s age, whether the mother was

working, whether the mother had health insurance, the mother’s media exposure, the husband/partner’s

education, husband/partner’s age, and whether the husband/partner was working. Finally at the level of

the individual, factors specific to the child were explored: the child’s sex, the child’s birth order, the

child’s place of delivery, and whether the child had a postnatal checkup within two months of birth.

1.5 Rationale

Ethiopia was chosen for this study for several reasons. Firstly, Ethiopia has the fifth highest pneumonia

mortality rate in children under five years of age globally, making childhood pneumonia a relevant public

health problem in the country (2). Additionally, the pneumococcal conjugate vaccine (PCV-13) was

introduced in 2011 as a strategy to address this problem.

1.6 Aim

The aim of this study was to identify predictors of receipt of all three doses of the newly introduced

PCV-13 vaccination in children aged 12-23 months in Ethiopia, as evidenced by maternal report or

Figure 1. The Social Ecological Model (Adapted from the Centers for Disease Control and Prevention, CDC) source: https://www.cdc.gov/violenceprevention/overview/social-ecologicalmodel.html

UPPSALA UNIVERSITET Lauren Lockwood 8 (46) vaccination card observed either in the home or the local health center, using data from the 2016

Ethiopian Demographic and Health Survey (EDHS).

2. Methods

2.1 Study Design

The study was a secondary analysis of cross-sectional data collected in the 2016 Ethiopian Demographic

and Health Surveys (EDHS). Data for these Demographic and Health Surveys were collected across

Ethiopia, between January 18th, 2016 and June 27th, 2016 (29,35).

2.2 Study Setting

Ethiopia is located in the Horn of Africa and shares a border with Eritrea, Djibouti, Somalia, Sudan,

South Sudan, and Kenya. The EDHS collected data across nine geographical regions—Tigray, Afar,

Amhara, Oromiya, Somali, Benishangul-Gumuz, Southern Nations Nationalities and Peoples (SNNP),

Gambela, and Harari—and two administrative cities—Addis Ababa and Dire Dawa (30).

The topography and climate across the 1.1 million square kilometer landscape of Ethiopia ranges from

cool highland peaks stretching up to 4550 meters above sea level to one of the hottest and lowest places

on earth: the sunken, desertic Afar Depression at 110 meters below sea level (36,37). The three main

climates of Ethiopia can be broadly described as tropical rainy, dry, and warm temperate—though there

is a significant amount of temperature and precipitation variation depending on the seasons and

prevailing wind patterns (37).

2.3 Study Population

The 2016 EDHS was designed to provide a nationally representative sample of 16,663 women aged 15-

49 and 14,195 men aged 15-59 (30). This sample was established using the sampling frame from the

Ethiopia Population and Housing Census (PHC) from 2007, made up of 84,915 enumeration areas (EAs).

The sampling frame provided information on the location of each EA, the estimated number of

residential households belonging to each EA, and whether residences were urban or rural. Each EA

covered a geographic area containing an average of 181 households (30).

Once the country was divided into nine geographical regions and two administrative cities, these regions

were stratified into rural and urban areas, yielding 21 sampling strata. A two-stage EA sampling was

performed independently in each stratum. 645 EAs were selected in the first stage, with 202 in urban

areas and 443 in rural areas. In each of the EAs, a household listing operation was executed; this

produced a list of households from which the second stage sampling was conducted. In certain

UPPSALA UNIVERSITET Lauren Lockwood 9 (46) particularly large EAs, household listing and subsequent surveying was limited to a segment of those

EAs—leading to EDHS clusters that were composed of an EA in its entirety or a segment of an EA

selected for survey with a probability proportional to segment size (30).

Stage two of the selection involved selection of 28 households per cluster using an equal probability

systematic selection from the previously described household listing. All women 15-49 and men 15-59

were eligible to be interviewed if they were either 1) “permanent residents of the selected household or

2) visitors who stayed in the household the night before the survey,” (30).

2.4 Study Population Characteristics

As of 2017, the World Bank estimated the population of Ethiopia to be 104,957,000 (38). The population

of Ethiopia is a rich cultural melting pot, comprised of over 80 ethnicities and speaking over 80 different

languages (37).

The population of Ethiopia is among the least urbanized in the world. As of 2010 only 16% of the

population lived in urban areas, with most of the population living in rural highland areas. The main

occupations of the rural populations are farming and nomadic livestock production (37).

The majority of the population are Christians—around half are Orthodox Christians and 18% are

Protestants—one-third are Muslims, and 3% follow traditional religion (37).

2.5 Data Collection

The data analyzed in this study was made available by the Demographic and Health Surveys Program for

the purposes of this project. Data collection for the EDHS was carried out by field teams 33, over 5.5

months, in 2016. The teams were made up of one team supervisor, one driver, one field editor, two

biomarker technicians, three female interviewers, and one male interviewer. Teams received training in

interviewing techniques, field procedures, the content of the questionnaires, as well as how to administer

both paper and electronic questionnaires. Additionally these trainings included mock interviews between

students and practice interviews in the field with respondents outside the survey sample (30).

2.6 Variables

The variables in this study were assessed with the DHS Woman’s Questionnaire, which was

administered by trained DHS teams and may be found in the appendix. The DHS Woman’s

Questionnaire, as well as the other EDHS questionnaires were based on the standard DHS questionnaires

and then adapted after the specific population and health issues of relevance to the Ethiopian population.

UPPSALA UNIVERSITET Lauren Lockwood 10 (46) 2.6.1 Outcome variable

The outcome variable was receipt of three doses of PCV-13 vaccination in children aged 12-23 months,

as evidenced by maternal report or vaccination card observed either in the home or the local health

center. Maternal report was established with questions 519B and 520B of the Woman’s Questionnaire in

the Appendix: “Has (CHILD’S NAME) ever received a pneumococcal vaccination, that is, an injection

usually given on the right upper thigh to prevent pneumonia?” and “How many times did (CHILD’S

NAME) receive the pneumococcal vaccine?”, respectively. In response to the first question, mothers

could answer yes, no, or don’t know. In response to the second question, respondents provided a

numerical answer between zero and three. In cases where a vaccination card or other document with

vaccination information was found in the home, interviewers collected the vaccine and date information

from these documents. Respondents also were asked if the child had received any additional

vaccinations, not listed on the vaccination document, and these responses were documented.

Respondents were asked to provide their consent for interviewers to view and copy dates from the child’s

vaccination records at the appropriate health center. If the respondent consented to collection of

vaccination information at the health center, additional questions were asked regarding the location and

name of the health center as well as the name of the doctor or health officer who vaccinated the child.

The consent request and subsequent questions may be viewed in the Woman’s Questionnaire in the

Appendix, starting at line item 1502. The questionnaires used to collect data at the health facilities may

also be found in the Appendix.

Information from the maternal report was combined with information from vaccination cards observed in

the home and in the health clinics and recoded into one categorical variable—receipt of three doses of

pneumococcal conjugate vaccine by any report—with outcomes of “yes” or “no”.

2.6.2 Predictor variables

The predictor variables included in analyses for the purpose of this project were divided into categories

in keeping with the theoretical framework:

Individual factors related to the child:

• Child’s sex.

• Child’s birth order, categorized as 1 or 2, 3 or 4, and 5 or higher.

• Child’s place of delivery, categorized as home, government hospital/health center, or other

(defined as a private hospital/health center, nongovernmental organization (NGO) hospital/health

center, or other care provider).


• Whether the child had a postnatal checkup within two months of birth.

Familial factors:

• Mother’s education, defined as the highest level of education attended by the mother, categorized

as no education, primary education, secondary education, or higher education.

• Mother’s age in ten-year categories. These categories were 15-24, 25-34, and 35-49.

• Whether the child’s mother was currently working.

• Whether the child’s mother had health insurance.

• Mother’s media exposure, defined as exposure to television, radio, or newspaper one or more

times per week.

• Husband/partner’s education, defined as the highest level of education attended by the mother’s

husband/partner, categorized as no education, primary education, secondary education, and higher

education.

• Husband/partner’s age in ten-year categories. These categories were 15-24, 25-34, 35-44, and 45

and older.

• Whether the husband/partner had worked in the past 12 months.

Household factors:

• Wealth quintile. This variable was measured at the level of the household, and scored based on a

combination of the number and type of consumer goods owned (e.g. television, car, bicycle) as

well as household characteristics (e.g. flooring materials, source of drinking water, toilet

facilities). Based on this information scores were arrived at using principal component analysis.

To compile national wealth quintiles, the wealth score of the household is assigned to each

household member, who is then ranked by his or her score. The distribution is thereafter divided

into five equal categories, corresponding to 20% of the national population (35).

• Number of children under 5 in the household, categorized as 1, 2 or more than 2.

• Residence type defined as rural or urban.

• Altitude of residence. This variable was defined as lowland or highland. It was calculated using

the altitude in meters above sea level of the cluster, and thereafter divided into categories of

lowland, defined as all clusters 1499 meters above sea level or lower, and highland, defined as

1500 meters above sea level or higher. Precise measurements for altitude of individual

households were not taken, rather cluster altitude was considered equivalent to household altitude

for the purposes of this study. The cutoff for the categories of lowland and highland at 1500m


was taken from an established lowland/highland cutoff noted in an Ethiopian pastoral research

publication (39).

Societal factors:

• Religion. This variable reflects the self-reported religion of the respondent. This variable was

defined as Orthodox Christianity, Catholic, Protestant, Muslim, traditional, or other.

• Region. For this variable, the EDHS used previously established divisions, made up of nine

geographical regions—Afar Region, Amhara Region, Benishangul-Gumuz Region, Gambela

Region, Harari Region, Oromia Region, Somali Region, Southern Nations, Nationalities, and

Peoples’ Region (SNNPR), and Tigray Region—and two administrative cities—Addis Ababa and

Dire Dawa.

2.7 Study Size

For this secondary analysis, the Children’s Recode of the EDHS data set was used. Households with

zero children under the age of five years were excluded, as were children outside of the age range 12-23

months. This resulted in a sample of n=1894 children.

2.8 Statistical Methods

All statistical analyses were carried out with IBM SPSS Statistics Version 24. The first statistical

analyses carried out were descriptive statistics for the outcome variable as well as the predictor variables.

This provided an overview of the variables of interest in the established dataset. Several numerical

variables were recoded into categorical variables to allow for analysis with the Pearson’s Chi-square test:

the child’s age in months, the age of the husband/partner, the age of the mother, number of children

under five years of age in the household, and the altitude of the residence. Other categorical variables

were also recoded into broader categories, as many of the categories measured in the EDHS for the

established variables of interest were more detailed than the aim of this study sought to analyze, and were

thus deemed outside of the scope of this study. Those variables were the place of delivery of the child,

the child’s birth order, the mother’s media exposure, and whether the husband/partner had worked in the

past 12 months.

After the recoding the necessary variables, potential associations between the predictor variables and the

outcome variable was assessed using a Pearson’s Chi-square test, with significance set at p<0.05. Results

of these analyses can be observed in Table 2.

UPPSALA UNIVERSITET Lauren Lockwood 13 (46) Bivariate logistic regressions were then carried out for each predictor variable against the outcome

variable to obtain crude odds ratios (OR) with 95% confidence intervals (CI).

Variables for which there were statistically significant associations at p<0.05 in the bivariate logistic

regression were included in a multiple logistic regression model, Model I, which adjusted for all

variables included in the model. The results of both the bivariate logistic regressions and the multiple

logistic regression model, Model I, can be observed in Table 3.

Goodness of fit was assessed for the multiple logistic regression model, Model I, with the Hosmer and

Lemeshow test. The Hosmer and Lemeshow test is a type of chi-square test that is used to indicate to

what extent the estimated model (defined as the model with one or more predictor variables) ‘fits’ the

data better—in other words has a better predictive power—than the null model (defined as a model

without any predictor variables). The test produces a p-value, and if the p-value is greater than 0.05, the

estimated model has adequate fit, and in the case that the p-value is less than 0.05, the estimated model

does not adequately fit the data. The multiple logistic regression model, Model I, was found to have

adequate fit with a p value of 0.079.

The sampling weights calculated by the EDHS were not used in this analysis, as the Guide to DHS

Statistics: Demographic and Health Surveys Methodology published in 2012 considered use of sample

weights to be inappropriate for relational estimates such as regression and correlation coefficients, which

were the outcomes of interest for this study (40).

3. Ethical Considerations

3.1 Ethical Review

Ethical clearance for the EDHS was provided by multiple actors: the Ethiopian Health and Nutrition

Research Institute (later renamed the Ethiopian Public Health Institute) Review Board, the Centers for

Disease Control and Prevention, the Institutional Review Board of ICF International, and the National

Research Ethics Review Committee at the Ministry of Science and Technology (37). Ethical review at

these multiple levels is intended to ensure compliance with both U.S. Department of Health and Human

Services regulations regarding protection of human subjects in research as well as norms and laws of the

country where the survey is taking place (41).

3.2 Informed Consent, Voluntary Participation, and Participant Confidentiality

Before the survey was initiated with a potential participant, an informed consent statement was read to

them. This statement communicated to the potential participant that their involvement in the survey was

UPPSALA UNIVERSITET Lauren Lockwood 14 (46) entirely voluntary and could be terminated at any time. It emphasized that if they chose to participate,

their identity as well as all information collected would remain confidential. The statement also informed

the potential participant of the purpose of the interview, how long the interview was expected to take,

how the interview would be conducted, the potential risks and benefits of their participation, and a

contact person who would provide additional information about the survey (41).

Multiple steps were taken to ensure participant confidentiality. Firstly, the data was number-coded based

on each participant’s enumeration area number, household number, and individual number—more

anonymized than, for example, coupling the collected data to participants’ names—and these codes were

then destroyed after data-processing. Additionally, in households with multiple participants, interviews

were conducted in private (i.e. not conducted in the presence of another participant). Also, all data

collected in the survey was kept strictly confidential, and the DHS research teams working with the data

were only allowed to discuss the data insofar as was deemed essential communication, and this

communication was required to be kept within their teams. Finally, the DHS used a random displacement

strategy for the geographic coordinates of each survey: both distance (up to 10 km) and direction were

randomized for each survey as to protect the identities of both households and individual participants

(41).

3.3 Additional Ethical Challenges in Longitudinal Demographic and Health Surveillance

The DHS is a well-established global project that produces large amounts demographic and health data

from low and middle-income countries that can be used to inform policy and research priorities in these

settings. However, the nature of the DHS presents unique ethical challenges when its roles in research,

treatment, and health monitoring become intertwined and especially in cases when these roles clash with

one another. This complexity may be one reason for the relative lack of attention paid to longitudinal

surveillance systems in the ethics literature (42). Such challenges were seen in cases where health

provision was associated with the DHS—for example in the study of diarrheal diseases by the

International Centre for Diarrhoeal Disease Research, Bangladesh as well as in the study of HIV/AIDS in

the Rakai, Uganda DHS. In these cases, questions of long-term versus short-term beneficence were

highlighted such as 1) which diseases should be treated—only the diseases of interest to the research? 2)

who should be treated—only those who participate in the study? 3) what information is missed when

health outcomes improve locally because of DHS initiatives and how does that affect the integrity of the

DHS monitoring role?

Another area of concern is what happens to DHS participants or residents of a DHS catchment area, that

have been receiving health services or other benefits, in case the DHS shrinks their study area or ends

surveillance. Some ethicists suggest, using the “fair benefits” framework, that the benefits accrued by the

UPPSALA UNIVERSITET Lauren Lockwood 15 (46) participants and/or community during their participation extricates the DHS from any future obligations

toward their care (42). However, even in cases with provision of post-participation health care or

benefits, analyses have concluded that the situation remains ethically problematic given the privileged

position of a specific population over another (42).

Given the scope and complexity of the role the DHS plays in research, care provision, and health

monitoring in low and middle income contexts globally, an argument can be made for additional

exploration of the ethical complexities and implications of such an actor in the ethics literature.

UPPSALA UNIVERSITET Lauren Lockwood 16 (46) 4. Results

Figure 2: Flow chart depicting selection of participants for Ethiopian Demographic and Health Survey interviews in 2016 and selection of data for this secondary analysis

!!!!!

28! households!per!cluster!selected!!!

443!rural!EAs!selected! 202!urban!EAs!selected!

All!women!aged!15<49!and!men!aged!15<59!who!were!permanent!residents!of!selected!household!or!

visitors!the!night!preceding!the!survey!were!selected!

!

84,915!EAs!total!

28!households!per!cluster!selected!

!

18,008!households!selected!!

10,291!children!born!to!women!interviewed!

16650!successful!household!interviews!!

417!households!unable!to!be!successfully!interviewed!

941!unoccupied!households!excluded!

15,683!eligible!women!successfully!interviewed!!

14,795!eligible!men!selected!!16,853!eligible!women!

selected!!

12,688!eligible!men!interviewed!!

Men’s!Survey!data!excluded!for!the!

purposes!of!this!analysis!

479!children!deceased!at!the!time!of!the!interview!!

1894!children!aged!!!!!!12<23!months!for!whom!vaccination!data!was!

collected!

2102!children!younger!than!12!months!of!age!excluded!!

28!households!per!cluster!selected!

!

5816!children!older!than!23!months!of!age!excluded!!!

1170!eligible!women!unable!to!be!successfully!interviewed!!

UPPSALA UNIVERSITET Lauren Lockwood 17 (46) 4.1 Descriptive Statistics

Characteristic Total Received 3 doses of PCV13 p-value Yes No Sex of child 0.598

Male 930 474 (51%) 456 (49%) Female 964 503 (52%) 461 (48%) Child’s Birth Order <0.01

1 or 2 718 433 (60%) 285 (40%)

3 or 4 503 259 (51%) 244 (49%)

5 or higher 673 285 (42%) 388 (58%) Place of Delivery <0.01 Home 1089 403 (37%) 686 (63%)

Government Hospital/Health Center

703 501 (71%) 202 (29%)

Other (includes private hospital/health centers, NGO hospital/ health centers and other care providers)

102 73 (72%) 29 (28%)

Frequency Percent Received 3 doses PCV13 No 897 47.4%

Vaccination date on card 853 45.0%

Reported by mother 110 5.8%

Vaccination marked on card 14 0.7%

Don't know 20 1.1% Total 1894 100.0%

Table 2: Sociodemographic and socioeconomic characteristics of children included in secondary analysis of the 2016 Ethiopian Demographic and Health Survey tested against receipt of three doses PCV-13 including Pearson’s Chi-square test. Absolute frequencies (n) and row percentages (%).

Table 1: Absolute and relative frequencies of receipt of 3 doses of PCV13 vaccine, by source of information, in children included in this secondary analysis of the 2016 Ethiopian Demographic and Health Survey

*“Don’t know” responses were categorized as “No” responses in analyses presented in Tables 2 and 3

UPPSALA UNIVERSITET Lauren Lockwood 18 (46) Child Postnatal Check within 2 months of birth

<0.01

No 1627 812 (50%) 815 (50%) Yes 171 121 (71%) 50 (29%)

Missing 96 Mother’s Education <0.01 No education 1166 475 (41%) 691 (59%) Primary 495 316 (64%) 179 (36%)

Secondary 152 118 (78%) 34 (22%)

Higher 81 68 (84%) 13 (16%) Mother’s Media Exposure <0.01 Media exposure less than once per week

1477 679 (46%) 798 (54%)

Media exposure one or more times per week

417 298 (71%) 119 (29%)

Mother Working <0.01 No 1346 647 (48%) 699 (52%) Yes 548 330 (60%) 218 (40%) Mother’s Age 0.560 15-24 533 273 (51%) 260 (49%) 25-34 959 504 (53%) 455 (47%) 35-49 402 200 (50%) 202 (50%) Mother Covered by Health Insurance

<0.01

No 1834 929 (51%) 905 (49%) Yes 60 48 (80%) 12 (20%) Husband/Partner’s Age 0.033

15-24 77 40 (52%) 37 (48%) 25-34 724 399 (55%) 325 (45%) 35-44 736 375 (51%) 361 (49%) 45 and older 357 163 (46%) 194 (54%) Missing 107

UPPSALA UNIVERSITET Lauren Lockwood 19 (46) Husband/ Partner’s Education

<0.01

No education 859 337 (39%) 522 (61%) Primary 580 344 (59%) 236 (41%) Secondary 197 132 (67%) 65 (33%) Higher 151 109 (72%) 42 (28%) Missing 107 Husband/ Partner worked in the past 12 months

<0.01

No 193 63 (33%) 130 (67%) Yes 1701 914 (54%) 787 (46%) Number of children 5 years of age and younger in household de jure

<0.01

1 736 440 (60%) 296 (40%) 2 870 411 (47%) 459 (53%) >2 288 126 (44%) 162 (56%) Residence <0.01 Urban 389 301 (77%) 88 (23%) Rural 1505 676 (45%) 829 (55%) Wealth Quintile <0.01 Poorest 657 191 (29%) 466 (71%) Poorer 318 175 (55%) 143 (45%) Middle 274 154 (56%) 120 (44%) Richer 242 139 (57%) 103 (43%) Richest 403 318 (79%) 85 (21%) Altitude of Residence <0.01 Lowland 791 337 (43%) 454 (57%) Highland 1103 640 (58%) 463 (42%) Region <0.01 Tigray 214 164 (77%) 50 (23%) Affar 168 19 (11%) 149 (89%) Amhara 172 103 (60%) 69 (40%) Oromia 284 107 (38%) 177 (62%) Somali 218 74 (34%) 144 (66%) Benishangul 156 111 (71%) 45 (29%) SNNPR 226 110 (49%) 116 (51%)

UPPSALA UNIVERSITET Lauren Lockwood 20 (46) Gambela 134 49 (37%) 85 (63%) Harari 117 70 (60%) 47 (40%) Addis Adaba 97 89 (92%) 8 (8%) Dire Dawa 108 81 (75%) 27 (25%) Religion <0.01 Orthodox 589 410 (70%) 179 (30%) Catholic 15 9 (60%) 6 (40%) Protestant 337 165 (49%) 172 (51%) Muslim 913 388 (42%) 525 (58%) Traditional 26 3 (12%) 23 (88%) Other 14 2 (14%) 12 (86%) *One “don’t know” response for the child postnatal check within two months of birth was included in the “no” group

**Missing values only listed for the three characteristics for which there were missing values: child postnatal check within 2 months of birth, husband/partner’s education, and husband/partner’s age

Certain characteristics were significantly associated (p < 0.05) with full PCV-13 vaccination in the Chi-

square test: child’s birth order, child’s place of delivery, whether the child had a postnatal check-up

within two months of birth, mother’s level of education, mother’s media exposure, whether the mother

was working, whether the mother had health insurance, the age of the husband or partner, the husband or

partner’s level of education, whether the husband or partner had worked within the past twelve months,

the number of children aged five or younger in the household, whether the residence was urban or rural,

the household’s wealth quintile, the altitude of the household, geographic region, and religion. Three

predictor variables were found to have missing values: child postnatal check within two months of birth,

the maternal partner/husband’s age, and the maternal partner/husband’s level of education. Given that

there were relatively few missing values, between 5% and 6% for the three characteristics that had

missing values, these were not included in the bivariate or multiple logistic regression models presented

in Table 3.

4.2 Predictors of PCV-13 vaccination in children aged 12-13 months

At the level of the child, birth order, place of delivery, and whether the child had received a postnatal

checkup within two months of birth were factors found to be statistically significant predictors of full

PCV-13 vaccination status after bivariate logistic regression analysis. In Model I, a multiple logistic

regression analysis, which included all significant factors from the bivariate logistic regression analyses,

the only child-level factor found to be predictive of receipt of three PCV-13 doses was the place of

UPPSALA UNIVERSITET Lauren Lockwood 21 (46) delivery. Children delivered at a government hospital/health center were more likely to have received all

three PCV-13 doses compared to children born at home.

Familial factors found to be statistically significant predictors of full PCV-13 vaccination after bivariate

logistic regression analyses were mother’s education, mother’s media exposure, whether the mother was

working, whether the mother had health insurance, the age of the child’s mother’s husband/partner, the

level of educational attainment of the child’s mother’s husband/partner, and whether the child’s mother’s

husband/partner had worked in the past twelve months. However, after controlling for these factors in

Model I, the only statistically significant predictors of full PCV-13 vaccination remaining were maternal

education and whether her husband/partner had worked in the past 12 months. Children born to mothers

with primary or secondary education were more likely to have received all three doses of PCV-13

compared to those born to mothers with no education. Children born to mothers with higher than

secondary education also tended to be more likely to have received all three PCV-13 doses, but this

relationship was not statistically significant. Children were less likely to have received all three PCV-13

if the husband/partner in the household had not worked in the past 12 months.

Household factors found to be statistically significant predictors of full PCV-13 vaccination after

bivariate logistic regression analyses were the number of children under five years of age in the

household, whether the residence was located in a rural or urban setting, the altitude of the residence, and

the household wealth quintile. After inclusion in multiple logistic regression analysis with Model I, the

predictor that remained statistically significant was wealth quintile. Compared to the poorest households,

children in the poorer, middle, richer, and richest households were more likely to have received all three

doses of the PCV-13 vaccine.

Both societal factors explored were shown to be statistically significant predictors of full PCV-13

vaccination after both bivariate logistic regression analysis and multiple logistic regression analysis with

Model I. Results of the multiple logistic regression with Model I revealed that compared to children in

Tigray, children in Afar, Oromia, Somali, SNNPR, and Gambela were less likely to have received all

three PCV-13 doses. Children born to mothers belonging to traditional religions were also less likely to

have received all three PCV-13 doses compared to those born to Orthodox Christians.


Characteristic Crude OR

(CI 95%) Adjusted OR Model I (CI 95%)

Sex of child Male 0.95

(0.80-1.14)

Female 1 Child’s Birth Order 1 or 2 1 1

3 or 4 0.70 (0.56 -0.88)

1.05 (0.75-1.47)

5 or higher 0.48 (0.39-0.60)

0.78 (0.54-1.14)

Place of Delivery Home 1 1 Government Hospital/Health Center 4.22

(3.44-5.18) 1.84 (1.39-2.43)

Other (includes private hospitals/health centers, NGO hospitals/ health centers and other care providers)

4.29 (2.74-6.70)

1.27 (0.71-2.28)

Child Postnatal Check within 2 months No 1 1 Yes 2.43

(1.72-3.43) 1.19 (0.77-1.83)

Mother’s Education No education 1 1 Primary 2.57

(2.07-3.19) 1.52 (1.11-2.06)

Secondary 5.05 (3.39-7.52)

2.32 (1.24-4.33)

Higher 7.61 (4.16-13.93)

1.52 (0.64-3.64)

Table 3: Socioeconomic and sociodemographic characteristics of children included in secondary analysis of the 2016 Ethiopian Demographic and Health Survey tested against PCV-13 vaccination, presented with odds ratios (OR) and a 95% confidence interval (CI). Categories with OR=1 is the reference category.

UPPSALA UNIVERSITET Lauren Lockwood 23 (46) Mother’s Media Exposure Media exposure less than once per week 1 1

Media exposure one or more times per week 2.94 (2.33-3.73)

1.28 (0.89-1.82)

Mother Working No 1 1 Yes 1.64

(1.34-2.00) 1.14 (0.88-1.49)

Mother’s Age 15-24 1

25-34 1.06 (0.85-1.30)

35-49 0.94 (0.73-1.22)

Mother Covered by Health Insurance No 1 1 Yes 3.90

(2.06-7.38) 1.84 (0.88-3.87)

Husband/Partner’s Age 15-24 1.29

(0.79-2.11) 0.84 (0.42-1.68)

25-34 1.46 (1.13-1.89)

0.96 (0.66-1.39)

35-44 1.23 (0.95-1.60)

1.05 (0.76-1.46)

45 and older 1 1 Husband/ Partner’s Education No education 1 1 Primary 2.26

(1.82-2.80) 1.24 (0.93-1.64)

Secondary 3.15 (2.27-4.36)

0.92 (0.58-1.48)

Higher 4.02 (2.75-5.89)

0.93 (0.50-1.73)

UPPSALA UNIVERSITET Lauren Lockwood 24 (46) Husband/ Partner worked in the past 12 months

No 0.42 (0.30-0.57)

.63 (0.46-0.93)

Yes 1 1 Number of children 5 years of age and younger in household de jure

1 1 1 2 0.60

(0.49-0.74) 0.91 (0.70-1.19)

>2 0.52 (0.40-0.69)

1.39 (0.94-2.06)

Residence Urban 4.20

(3.24-5.43) 1.49 (0.90-2.47)

Rural 1 1 Wealth Quintile Poorest 1 1 Poorer 2.99

(2.26-3.94) 1.48 (1.05-2.09)

Middle 3.13 (2.34-4.19)

1.70 (1.18-2.47)

Richer 3.29 (2.43-4.47)

1.56 (1.05-2.30)

Richest 9.13 (6.81-12.23)

2.17 (1.25-3.78)

Altitude of Residence Lowland 0.54

(0.45-0.65) 0.99 (0.71-1.38)

Highland 1 1 Region Tigray 1 1 Affar 0.04

(0.02-0.07) 0.08 (0.03-0.17)

Amhara 0.46 (0.29-0.71)

0.73 (0.44-1.23)

Oromia 0.18 (0.12-0.27)

0.30 (0.17-0.52)

Somali 0.16 (0.10-0.24)

0.33 (0.17-0.66)

Benishangul 0.75 (0.47-1.20)

1.55 (0.84-2.89)

UPPSALA UNIVERSITET Lauren Lockwood 25 (46) SNNPR 0.29

(0.19-0.44) 0.37 (0.21-0.67)

Gambela 0.18 (0.11-0.28)

0.24 (0.12-0.49)

Harari 0.45 (0.28-0.74)

0.51 (0.25-1.01)

Addis Adaba 3.39 (1.54-7.47)

0.85 (0.32-2.24)

Dire Dawa 0.92 (0.53-1.57)

0.94 (0.45-1.98)

Religion Orthodox 1 1 Catholic 0.66

(0.23-1.87) 1.61 (0.50-5.25)

Protestant 0.42 (0.32-0.55)

0.95 (0.60-1.49)

Muslim 0.32 (0.26-0.40)

0.87 (0.58-1.30)

Traditional 0.06 (0.02-0.19)

0.16 (0.04-0.61)

Other 0.07 (0.02-0.33)

0.29 (0.05-1.55)

*Missing values listed in Table 2 not included in bivariate or multiple logistic regression models

UPPSALA UNIVERSITET Lauren Lockwood 26 (46) 5. Discussion

5.1 Key findings and analysis

Slightly more than half of children aged 12-23 months (51.5%) sampled in the 2016 Ethiopian

Demographic and Health Survey received all three doses of the PCV-13 vaccine. According to the

Ethiopia National Expanded Programme on Immunization, published in April of 2015, the Ethiopian

Ministry of Health’s target for receipt of three doses of PCV-13 in 2016 was 93%, considerably higher

than the coverage found in this study. Such a low proportion of fully-vaccinated children prevents the

exponential public health benefits of herd immunity for the strains included in the PCV-13 vaccine (24).

Picazo et al have previously cited that at vaccine coverage between 65 and 70% in children, there is a

significant drop in nasopharyngeal colonization by the bacterial strains covered in the vaccine in

unimmunized individuals (24). Therefore one may infer that a substantial improvement in pneumonia

prevention for vaccine-covered strains can be attained via herd immunity effects with a 15-20%

improvement in the proportion of fully vaccinated children, even before the Ethiopian Ministry of health

reaches their 93% target.

According to data presented in the 2016 EDHS report, the proportion of children aged 12-23 months who

received all three doses of PCV-13 tended to be higher than the proportion of children in the same age

cohort who received all basic vaccinations at any time before the survey (35). These basic vaccinations

were defined by the EDHS as one dose of the BCG vaccine (which protects against tuberculosis), three

doses of the DPT-HepB-Hib (which protects against diphtheria, hepatitis B virus, and H. influensae), three doses of polio vaccine, and one dose of measles vaccine (35). Data presented in the EDHS report,

reported only on patterns of immunization and background characteristics based on descriptive statistics,

rather than using logistic regression models to control for the effects of individual factors. In keeping

with the methods used in this secondary analysis, the EDHS also used all forms of report as acceptable

indicators of vaccination status: maternal report, written vaccination records in the home, and written

vaccination records in the health center (35). The finding that the proportion of children who had

completed a full course of PCV-13 immunization tended to be higher than the proportion of children who

had completed courses of all of their basic vaccinations is not particularly surprising, given that it is often

less logistically challenging to ensure that a child receives the course of a single immunization to

completion, compared to four. Exceptions to this pattern were, however, seen in Afar and Dire Dawa —

where the proportion of children that had received complete PCV-13 vaccination was lower than the

proportion that had received all basic vaccinations at any time before the survey—11% vs 15% and 75%

vs 76% respectively (35). Though these regions differed greatly in their proportions of vaccinated

children (both in terms of PCV-13 vaccination status and basic vaccination status) this finding may raise

questions around potential barriers to PCV-13 delivery at the regional level, compared to the more


established vaccinations included in the previously described “basic vaccinations”.

5.1.1 Predictors of PCV-13 Vaccination within the Social Ecological Framework

Results of the multiple logistic regression analysis with Model I revealed that factors at all levels of the

theoretical framework—individual, familial, household, and societal factors—were statistically

significant predictors of receipt of three doses of PCV-13 vaccination in children aged 12-23 months.

This finding adds to the body of published literature that highlights the relevance of interpersonal factors,

including factors at the familial and household levels, for a child’s immunization status (43). A

systematic review of the literature surrounding reasons related to non-vaccination and under-vaccination

in low and middle income countries between 1999 and 2000, found that low maternal education, low

socioeconomic status, living with a large family, and belonging to a minority ethnic or religious group

were all factors associated with non-vaccination and under-vaccination—a result that largely agrees with

the findings of this secondary analysis (44).

The child’s place of delivery was the only individual-level factor found to be a statistically significant

predictor of PCV-13 vaccination. Compared to delivery at home, delivery at government hospitals/health

centers was positively predictive of PCV-13 vaccination status, as opposed to delivery at health centers

categorized as “other”—including private hospitals/health centers, NGO hospitals/health centers, and

other care providers—which was not predictive, at a statistically significant level, of PCV-13 vaccination

status. This finding is supported by previous research that examined predictors of complete childhood

vaccination in East African countries (Ethiopia, Tanzania, Kenya, Burundi, Rwanda, Uganda) with

Demographic and Health Survey data from 2009-2011 and found that delivery at a government health

facility was associated with an increased odds of complete vaccination status in all countries studied with

the exception of Burundi (45). This predictor was found to have particularly large effect sizes in both

Ethiopia and Kenya, with children being born in government health facilities having twice the odds of

full vaccination status compared to children born at home (45). An additional previously published

analysis of EDHS data from 2011, by Lakew et al, also found that birth at a health facility was associated

with full child immunization coverage compared with children born at home, with approximately half of

children born at a health facility being fully immunized compared to approximately one fifth born at

home, though this study did not differentiate between private, public, or nongovernmental organization

health facilities (46). Further evidence in support of this finding was observed in children in the same age

group, 12-23 months of age, in Jaipur, Rajasthan, where vaccination status was once again found to be

significantly influenced by the child’s place of delivery (47). These findings may be indicative of

government hospitals and health centers having closer contact with national vaccination program plans

and priorities or more established vaccination campaign implementation protocols compared to private or

NGO hospitals and health centers.


At the familial level, the mother’s level of education and whether her husband/partner had worked in the

past twelve months were the only two factors found to be statistically significant predictors of PCV-13

vaccination. Compared to no education, both maternal primary and secondary education were positively

predictive of PCV-13 vaccination status at a statistically significant level, with adjusted odds ratios of

1.51 and 2.41, respectively. Maternal higher education was not, however, found to be a statistically

significant predictor of PCV-13 vaccination, compared to no education, though the adjusted odds ratio

for this group tended towards being positively predictive of PCV-13 vaccination—a finding which is

likely explained by the small sample size and wide confidence interval for this group. This result

congruent with a previous study of individual and community level determinants of immunization which

analyzed 2011 EDHS data and found that children born to mothers with a secondary education or higher

had 93% higher odds of being fully immunized compared with children born to mothers with no

education (48).

The second familial-level factor found to be statistically significant was whether the husband/partner of

the child’s mother had worked in the past twelve months. Compared to children whose mothers’

husbands/partners had worked in the past twelve months, children whose mothers’ partners/husbands had

been unemployed for the past 12 months were less likely to receive all three PCV-13 doses, with an

adjusted odds ratio of 0.63 in Model I. It is worth noting that the data gathered in the Women’s

Questionnaire collects data about the husband/partner of the respondent—without establishing his

relationship (paternal or non-paternal) to the children of the respondent (35). However, in considering

this finding, one could anticipate a substantial amount of overlap between this finding and what would

have been found if effects of paternal employment on vaccination status were assessed. The paternally-

linked determinants of child vaccination status are dramatically underrepresented in the literature, but

according to a study of individual and socioeconomic factors associated with immunization coverage in

Nigeria, paternal occupation was found to directly affect immunization coverage, based on linear

bivariate and multiple regression analyses (50). The level of educational attainment of the

husband/partner of the child’s mother was not, however, found to be a significant predictor of receipt of

three doses of PCV-13, in Model I, in this secondary analysis. This finding is unable to support

previously published research which found that paternal educational attainment, independent of maternal

educational attainment, was positively predictive of childhood measles vaccination status across six

countries: India, Nigeria, Pakistan, Ethiopia, Congo, and Indonesia (43). It is possible that this factor

does have an impact on PCV-13 vaccination, but due to the structure of Model I and this factor’s

potential correlation with another factor or other factors in the model, such as maternal education, this

impact could not be shown using this model.

At the household-level, wealth quintile was the only statistically significant predictor of PCV-13


vaccination identified after multiple logistic regression analysis with Model I. Compared to the children

in the poorest households, living in a poorer, middle, richer, or richest household was positively

predictive of PCV-13 vaccination with adjusted odds ratios of 1.48, 1.70, 1.56, and 2.17 respectively.

This finding is congruent with a previously published analysis of DHS data from 2003-2010 from several

countries in Sub-Saharan Africa, which found that children in the poorest households were 36% more

likely to be unimmunized compared to children in the richest households (51).

At the societal-level, both religion and region were found to be statistically significant predictors of

PCV-13 vaccination status in Model I. Compared to living in Tigray, living in Afar, Oromia, Somali,

SNNPR, Gambela was negatively predictive of PCV-13 vaccination status with adjusted odds ratios of

0.08, 0.30, 0.33, 0.37, and 0.24, respectively. However, compared to living in Tigray, living in

Benishangul, Harari, Addis Adaba, or Dire Dawa did not statistically significant predict PCV-13

vaccination status positively or negatively.

Belonging to a traditional religion was negatively predictive of PCV-13 vaccination status compared to

the reference religion Orthodox Christianity, with an adjusted odds ratio of 0.16, and traditional religion

was the only religious group for which there was a statistically significant relationship with PCV-13

vaccination status in Model I. The category of ‘traditional religion’ defined by the EDHS, contains

multiple distinct populations including the Sidama, Gurage, Oromo of Arsi, Guji and Borana, as well as

the Nilotic groups located near Ethiopia’s shared border with Sudan (52). This fact makes it challenging

to speculate in too much detail about the potential reasons behind this finding without risking

erroneously over-generalizing across highly diverse subpopulations. However, it is worth distinguishing

between traditional medicine and traditional religion, as traditional medicine practices have a rich history

in the Ethiopian context, with estimates of as much as 80% of the population using traditional medicine,

across many ethnic and religious populations, not only those practicing traditional religions (53). In fact,

immunization-like traditional medicine rituals to prevent small pox have been practiced, where healthy

individuals were inoculated with pus from persons infected with small pox (53). The Guji and Borana

populations practice traditional religion and are pastoralists, meaning that they are mobile populations,

moving seasonally as a means of feeding and watering their livestock (53,54). One study of nomadic

pastoral populations in the Somali region of Ethiopia, revealed exceptionally long delays in care seeking

for tuberculosis among the pastoral populations studied, with longer delays associated with long

distances to health care facilities and inadequate knowledge of tuberculosis (54). Additionally, when the

population studied finally sought care for their tuberculosis, the vast majority of them (87%) went to a

traditional medicine practitioner as their first health care seeking behavior (54). Given this information,

adherents to traditional religions may, plausibly, be overrepresented in nomadic pastoralist communities,

whose highly mobile lifestyle may be associated with cultural preferences for traditional medical


practices in addition to presenting logistical challenges in terms of maintaining adequate contact with the

biomedical healthcare system—or in terms of reaching these populations with immunization outreach

programs and other targeted public health interventions. However, this secondary analysis did not gather

data related to cultural attitudes toward healthcare seeking behavior or ease of access to/distance to the

nearest health care facility, so this could not be assessed.

5.2 Strengths and Weaknesses

A key strength of this study was the use of DHS data. The DHS produces high quality data with many

advantages including standardized data-collection procedures, trained data collection teams, high

response rates, and national coverage; this allows for a high degree internal validity and minimizes

potential risk of bias, including selection bias and measurement bias.

There were however several limitations to this study, primarily the inclusion of maternal report as a

measure of vaccination status. Maternal report is a substantially less trustworthy measure than the other

two vaccination status reports used (presence of a vaccination card in the home and presence of a

vaccination record at the health center). As one is unable to ascertain to what degree the maternal report

of vaccination status diverges from reality, without allocating resources to costly serology testing—

resources which could arguably be better allocated in such a setting—the outcome of even the most basic

descriptive statistics in this study must be interpreted with caution.

Maternal report as a measure of vaccination status was included for two reasons. First, this study sought

to avoid limiting the analysis to only children who had proof of vaccination either at home or in the

health center, as such documentation can be misplaced, even when mothers feel confident reporting their

children’s vaccination status. Secondly, the 2016 EDHS Report includes maternal report in its

calculations of vaccine coverage in the presentation of descriptive statistics on background characteristics

and vaccination coverage for different vaccines. For comparison with these data in the 2016 EDHS

report, maternal report was included. Finally, it is worth noting, that there is literature supporting the

quality of maternal report as an indicator of vaccination status, and that use of vaccination documentation

in the form of health center records or personal vaccination cards is not entirely error-free (55). A study

of maternal report of vaccinations in Egypt found that mothers’ reports of the vaccinations received by

their children were of very high quality (55). It is also of interest to note that errors in vaccination status

reporting tended toward under-reporting the vaccination status of children rather than over-reporting it—

in other words, incorrectly reporting that a child had not received a vaccine was much more common

than incorrectly reporting that a child had received a vaccine (55). Though specific to the Egyptian

context, the results of this study may be worth keeping in mind while considering the results of this

secondary analysis.


More broadly, many measurements in the DHS data rely on self-reported data, which can be considered a

limitation in this study. Self-reported data can be particularly unreliable when it comes to health behavior

data due to factors such as the social desirability bias (where responses are biased in a way that will be

viewed more favorably by others—for example over reporting good behaviors or under-reporting bad

behaviors) or the recall bias (where responses are dependent on the ability of the respondent to recall a

past event) (56). In even in instances that this is not the case, other factors can contribute to less reliable

self-report data, for example lack of reliable birth records when measuring age.

There were additional limitations to address regarding how vaccination coverage was defined. Firstly,

vaccination data was not collected for children who had died. This excludes a segment of the population

that is arguably of particular interest, given that PCV-13 vaccination is implemented largely as a measure

to address mortality in children under five years of age in Ethiopia. Additionally, children who received

one or two doses of PCV-13 were not included in analyses. As such, this study was unable to assess

whether certain factors were more predictive of receipt of the first dose of PCV-13 compared to two or

all three doses. Finally, the vaccination schedule was not taken into account in these analyses, but rather,

children reported to have received all three doses of PCV-13 were considered vaccinated. This is a

limitation because it is established that adherence to an established vaccination schedule is relevant for

vaccine efficacy (57). By labeling children who have received all three PCV-13 doses as “fully-

vaccinated”, despite the fact that some of them may have received the vaccine in a suboptimal dosing

schedule, vaccine “coverage” may be significantly overestimated due to the decreased efficacy of the

vaccine due to improper vaccination timing.

Finally it is worth mentioning is that sampling weights calculated by the EDHS were not used in this

analysis, as the Guide to DHS Statistics: Demographic and Health Surveys Methodology published in

2012 considered use of sample weights to be inappropriate for relational estimates such as regression and

correlation coefficients, which were the outcomes of interest for this study (40). The decision to exclude

the sampling weights in analysis may have biased the odds ratios toward over-sampled sub-populations

(58). There was also a discrepancy in sample size between the cohort of children aged 12-23 months

reported in the EDHS vaccination data (n=2004) and the cohort of children aged 12-23 months reported

in this study (n=1894). Despite methodical selection of cases and repetition of selections to avoid error,

this discrepancy remains.

UPPSALA UNIVERSITET Lauren Lockwood 32 (46) 5.3 Contextualizing findings for Global Health Goals

Despite the 53% improvement made in terms of global mortality in children under five years of age

during the years of the Millennium Development Goals, 1990 to 2015, the 67% reduction target failed to

be met by 2015 (59). This left room for an ambitious Sustainable Development Goal 3 target:

“…end preventable deaths of newborns and children under 5 years of age, with all

countries aiming to reduce neonatal mortality to at least as low as 12 per 1,000 live births

and under-5 mortality to at least as low as 25 per 1,000 live births [by 2030],”(60).

This study contributes a quite small piece to the puzzle of understanding the determinants of PCV-13

vaccination in the Ethiopian context; the understanding of PCV-13 vaccination in the Ethiopian context

is itself a modestly larger puzzle piece in the body of knowledge that informs measures of pneumonia

prevention in children globally, and ultimately contributes, in a fractional way, to the piecing together of

a well-informed global strategy to combat the preventable deaths in children before they reach their fifth

birthday.

Though not a limitation to this study based on its defined scope and aim, one would be remiss to neglect

to mention the other highly relevant factors at play on both the supply and demand side of the PCV-13

vaccination landscape in Ethiopia that were not addressed or explored in this study. On the supply side,

health system factors such as quality of care, availability of qualified healthcare providers (as well as

their workload), supply chain logistics including transportation, cold chain, and stock-outs of vaccine can

all create differential vaccine availability and ultimately affect coverage, according to previously

published findings (46). A mixed methods study of the health systems impacts of PCV introduction in

four sub-Saharan African countries reported that in Ethiopia there was a certain amount of difficulty with

the cold chain at the regional level as well as trouble with stock-outs in 8% of facilities (61). This same

study did not observe changes in the number or distribution of health workforce in conjunction with

introduction of PCV, but increases in health workforce workload was noted across countries studied—

Figure 3: A Puzzle Piece Puzzle Piece by Dori the Giant source: https://www.dorithegiant.com/2013/01/a-puzzle-piece-puzzle-piece.html

UPPSALA UNIVERSITET Lauren Lockwood 33 (46) both in the short and long term after PCV introduction (61). On the demand side, this study failed to

include measures of knowledge, attitudes, and beliefs of the primary caregiver of the children included in

this sample, in relation to their immunization practices—all of which are factors that can affect

immunization efforts in myriad ways. In a study published in 2016 titled Knowledge, Attitude and

Practice of Mothers Towards Immunization of Infants in Health Centres at Addis Ababa, Ethiopia

authors found that 55% of respondents had adequate knowledge of immunization of infants and 54% had

positive attitudes toward immunization—despite 84% of respondents having adequate vaccination

practices (62). Studies in the Indian context have shown that health knowledge was a promoter of

vaccination, as was having a positive attitude towards and seeing the value in vaccination in the Italian

context (63). Awareness/knowledge of vaccine preventable diseases was found to be a promoter of

vaccination practices in two Nigerian studies, and other studies observed that viewing the vaccine

preventable disease as dangerous—in the Taiwanese context—was also a promoter of vaccination

practices (63). All of these factors must be taken into consideration when attempting to understand

determinants of vaccination in a holistic way.

Zooming out to the larger goal of reduction of pneumonia mortality in children under five years of age, it

is important to understand that PCV-13 is not a silver bullet, but only one of the many important tools

available to the global health community in working toward this shared goal. In fact, it is possible that,

moving forward, additional iterations of PCVs will need to be introduced, with additional or alternative

serotypes to adapt to the epidemiological changes in etiology of childhood pneumonia globally. Evidence

from a population-based survey in the Upper River Region of The Gambia found that three years after

introduction of PCV-13, there was an associated increase in invasive pneumococcal disease caused by

non-PCV-13 serotype pathogens in children aged 2-59 months (18).

Additionally, there are several opportunities for improvements in factors associated not only with

pneumonia mortality but with other negative health and development outcomes including malnutrition,

non-exclusive breastfeeding during the first six months of life, poverty, indoor and outdoor air pollution,

HIV, measles, crowded living conditions, inadequate access to quality health care, and barriers to care

seeking (4,9). There is an opportunity and need for engagement of actors across disciplines and at all

levels of society from international organizations to civil societies, to address challenges from global air

pollution and adequate food production, delivery, and nutrition to appropriate pneumonia diagnostics and

treatment. This makes the integrated and silo-breaking character of the Sustainable Development Goals a

powerful and apt tool for addressing the complex challenge of pneumonia mortality in children under

five years of age.

UPPSALA UNIVERSITET Lauren Lockwood 34 (46) The past several decades have been characterized as a significant period of epidemiological transition,

traditionally defined as the shift from a disease burden largely composed of infectious diseases and

illnesses related to famine and deficiencies toward one of noncommunicable diseases, as a country

undergoes an extended period of economic development. This transition, however, has proven to be more

complex and dynamic than a one-way street toward a noncommunicable disease-heavy disease burden.

Environmental pollutants, urbanization, changes in community dynamics and lifestyle factors,

antimicrobial resistance, as well as vast socioeconomic status differences within countries are just a few

of the factors contributing to varied and complicated patterns of epidemiological change over time (64).

As such, global health researchers, policy makers, and other stakeholders must be vigilant to maintain an

updated understanding of how these factors interact in different dynamic contexts across the globe.

Moreover, they must be careful not to abandon funding and research priorities for diseases related to

infection and famine, such as childhood pneumonia, in light of the recent progress in this area—as there

is still significant progress that needs to be made. In other words don’t sell the skin until you’ve caught

the bear.

6. Conclusion

Sociodemographic and socioeconomic factors at every level of the adapted Social Ecological Model,

used in this study, were found to be predictive of receipt of three doses of PCV-13 in the sample

population of children aged 12-23 months in Ethiopia in 2016. These factors included the child’s place of

delivery, the child’s mother’s level of educational attainment, whether the husband/partner of the child’s

mother had worked in the past 12 months, the wealth quintile of the household, the region of residence,

and the religion of the child’s mother. The predictors observed in this study are congruent with previous

studies of vaccination status predictors, and this knowledge may facilitate targeted immunization efforts

to improve PCV-13 coverage in particularly at risk groups. There is great potential for improvement of

PCV-13 immunization coverage in Ethiopia, as only 51.5% of the nationally representative sample

received three doses of PCV-13—a coverage that is dramatically lower than the Ethiopian Ministry of

Health’s target of 93% coverage by 2016, and even considerably lower than the coverage needed for herd

immunity benefits (65%-70%) (24).

7. Acknowledgements

I would like to thank Andreas Mårtensson, Gbemisola Allwell-Brown, and Anna Wikman for their

thoughtful comments, support, and guidance throughout the writing of this thesis. Additionally, I wish to

thank Carina Källestål for being an encouraging and inspiring presence throughout the program. A big

UPPSALA UNIVERSITET Lauren Lockwood 35 (46) thanks to the brilliant women of the thesis seminar group, Luce Mosselmans, Lydia Ogunde, Lan Vu Ti,

Meron Tilahun, Emily Davidson for their feedback and positivity throughout the writing process. Finally

I must thank my partner Elias Westerlund for his patience, understanding, and extra generosity in our

shared custody of the computer charger during this time.

UPPSALA UNIVERSITET Lauren Lockwood 36 (46) 8. References

1. Omolo J, Amukoye E, Onyango D, Kikuvi G. Risk factors of severe pneumonia among children

aged 2-59 months in western Kenya: a case control study. 2017 May 24 [cited 2018 Jan 31]; Available

from: http://localhost:8080/xmlui/handle/123456789/3172

2. Daniel Geleta, Fasil Tessema, Haimanot Ewnetu. Determinants of Community Acquired Pneumonia

among Children in Kersa District, Southwest Ethiopia: Facility Based Case Control Study. J Pediatr

Neonatal Care [Internet]. 2016 [cited 2018 Feb 1];Volume 5(Issue 2). Available from:

https://pdfs.semanticscholar.org/878d/68f76d9b60ae52fca46f49976571ef9a4712.pdf

3. Haq IJ, Battersby AC, Eastham K, McKean M. Community acquired pneumonia in children.

BMJ. 2017 Mar 2;356:j686.

4. UNICEF, Data and Analytics, Division of Data, Research and Policy and, Health Section,

Programme Division. One is too many: Ending child deaths from pneumonia and diarrhoea [Internet].

UNICEF; 2016 Nov [cited 2018 Jan 17]. Available from: https://data.unicef.org/wp-

content/uploads/2016/11/UNICEF-Pneumonia-Diarrhoea-report2016-web-version_final.pdf

5. Murray PR, Rosenthal KS, Kobyashi GS, Pfaller MA. Role of Parasites in Disease | Medical

Microbiology [Internet]. 7th ed. Philidelphia, PA: Elsevier Saunders; 2013 [cited 2018 Feb 18].

Available from: https://studentconsult.inkling.com/read/medical-microbiology-murray-rosenthal-pfaller-

7th/chapter-78/role-of-parasites-in-disease

6. Murray PR, Rosenthal KS, Kobyashi GS, Pfaller MA. Pathogenesis of Fungal Disease | Medical

Microbiology [Internet]. 7th ed. Philidelphia, PA: Elsevier Saunders; 2013 [cited 2018 Feb 18].

Available from: https://studentconsult.inkling.com/read/medical-microbiology-murray-rosenthal-pfaller-

7th/chapter-66/chapter-66-introduction

7. Pneumonia [Internet]. Bill & Melinda Gates Foundation. [cited 2018 Jan 17]. Available from:

https://www.gatesfoundation.org/What-We-Do/Global-Health/Pneumonia

8. Gentile A, Bazán V. Prevention of pneumococcal disease through vaccination. Vaccine. 2011 Sep

14;29:C15–25.

9. Adegbola RA. Childhood Pneumonia as a Global Health Priority and the Strategic Interest of The

Bill & Melinda Gates Foundation. Clin Infect Dis. 2012 Apr 1;54(suppl_2):S89–92.

10. Immunogenicity - an overview | ScienceDirect Topics [Internet]. [cited 2018 Apr 17]. Available

UPPSALA UNIVERSITET Lauren Lockwood 37 (46) from: https://www-sciencedirect-com.proxy.kib.ki.se/topics/immunology-and-

microbiology/immunogenicity

11. Peltola H. Worldwide Haemophilus influenzae Type b Disease at the Beginning of the 21st

Century: Global Analysis of the Disease Burden 25 Years after the Use of the Polysaccharide Vaccine

and a Decade after the Advent of Conjugates. Clin Microbiol Rev. 2000 Apr 1;13(2):302–17.

12. Pinkbook | Principles of Vaccination | Epidemiology of VPDs | CDC [Internet]. 2017 [cited 2018

Apr 24]. Available from: https://www.cdc.gov/vaccines/pubs/pinkbook/prinvac.html

13. Vassiliou A. Commission Decision of 28/IV/2008 amending Decision 2002/253/EC laying down

case definitions for reporting communicable diseases to the Community network under Decision No

2119/98/EC of the European Parliament and of the Council [cited 2018 Apr 12]. Available from:

http://ec.europa.eu/health/ph_threats/com/docs/1589_2008_en.pdf

14. Jackson C, Mann A, Mangtani P, Fine P. Effectiveness of Haemophilus influenzae Type b

Vaccines Administered According to Various Schedules: Systematic Review and Meta-analysis of

Observational Data. Pediatr Infect Dis J. 2013 Nov;32(11):1261.

15. Bower C, Condon R, Payne J, Burton P, Watson C, Wild B. Measuring the impact of conjugate

vaccines on invasive Haemophilus influenzae type b infection in Western Australia. Aust N Z J Public

Health. 1998 Jan 1;22(1):67–72.

16. Hib vaccine - an overview | ScienceDirect Topics [Internet]. [cited 2018 Apr 11]. Available from:

https://www-sciencedirect-com.proxy.kib.ki.se/topics/immunology-and-microbiology/hib-vaccine

17. Serotypes and biotypes - Organism & Infectious Disease Model Project - SNOMED Confluence

[Internet]. [cited 2018 Apr 17]. Available from:

https://confluence.ihtsdotools.org/display/OIDM/Serotypes+and+biotypes

18. International Vaccine Access Center, John Hopkins University Bloomberg School of Public

Health. The Evidence Base for Pneumococcal Conjugate Vaccines (PCVs): 2017;215.

19. Invasive Pneumococcal Disease | 2010 Case Definition [Internet]. [cited 2018 Apr 11]. Available

from: /nndss/conditions/invasive-pneumococcal-disease/case-definition/2010/

20. Basic Information | Sepsis | CDC [Internet]. 2018 [cited 2018 Apr 11]. Available from:

https://www.cdc.gov/sepsis/basic/index.html

UPPSALA UNIVERSITET Lauren Lockwood 38 (46) 21. Federal Ministry of Health, Addis Ababa - 2015 - Ethiopia National Expanded Programme on

Immunizati.html [Internet]. [cited 2018 Feb 19]. Available from:

http://www.nationalplanningcycles.org/sites/default/files/country_docs/Ethiopia/ethiop_cmyp_latest_revi

sed_may_12_2015.pdf

22. The Immunisation Adivsory Centre. Quick answers to frequent pneumococcal vaccine questions

[Internet]. 2017 [cited 2018 Mar 1]. Available from:

http://www.immune.org.nz/sites/default/files/resources/Written%20Resources/VaccinePneumococcal201

70807V01Final.pdf

23. Conjugate vaccine. In: Wikipedia [Internet]. 2017. Available from:

https://en.wikipedia.org/w/index.php?title=Conjugate_vaccine&oldid=798035488

24. Picazo J, Ruiz-Contreras J, Casado-Flores J, Negreira S, Baquero F, Hernández-Sampelayo T, et

al. Effect of the different 13-valent pneumococcal conjugate vaccination uptakes on the invasive

pneumococcal disease in children: Analysis of a hospital-based and population-based surveillance study

in Madrid, Spain, 2007-2015. PLoS ONE [Internet]. 2017 Feb 16 [cited 2018 Apr 5];12(2). Available

from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5312951/

25. Kim TH, Johnstone J, Loeb M. Vaccine herd effect. Scand J Infect Dis. 2011 Sep;43(9):683–9.

26. DeAntonio R, Yarzabal J-P, Cruz JP, Schmidt JE, Kleijnen J. Epidemiology of community-

acquired pneumonia and implications for vaccination of children living in developing and newly

industrialized countries: A systematic literature review. Hum Vaccines Immunother. 2016 Jun

7;12(9):2422–40.

27. Tramper-Stranders GA. Childhood community-acquired pneumonia: A review of etiology- and

antimicrobial treatment studies. Paediatr Respir Rev. 2018 Mar 1;26:41–8.

28. Atkinson M, Lakhanpaul M, Smyth A, Vyas H, Weston V, Sithole J, et al. Comparison of oral

amoxicillin and intravenous benzyl penicillin for community acquired pneumonia in children (PIVOT

trial): a multicentre pragmatic randomised controlled equivalence trial. Thorax. 2007 Dec;62(12):1102–

6.

29. Central Statistical Agency, Addis Ababa, Ethiopia, ICF International. Ethiopia Demographic and

Health Survey 2011 [Internet]. Calverton, Maryland, USA; 2012 Mar [cited 2018 Jan 31]. Available

from: https://dhsprogram.com/pubs/pdf/fr255/fr255.pdf

UPPSALA UNIVERSITET Lauren Lockwood 39 (46) 30. Central Statistical Agency (CSA) [Ethiopia] and ICF. 2016. Ethiopia Demographic and Health

Survey 2016. Addis Ababa, Ethiopia, and Rockville, Maryland, USA: CSA and ICF.[cited 2018 Feb 2].

Available from: https://dhsprogram.com/pubs/pdf/FR328/FR328.pdf

31. Federal Ministry of Health, Addis Ababa. Ethiopia National Expanded Programme on

Immunization Comprehensive Multi-year Plan 2016-2020 [Internet]. Addis Ababa; 2015 Apr [cited 2018

Feb 19]. Available from:


sed_may_12_2015.pdf

32. Johansson KA, Memirie ST, Pecenka C, Jamison DT, Verguet S. Health Gains and Financial

Protection from Pneumococcal Vaccination and Pneumonia Treatment in Ethiopia: Results from an

Extended Cost-Effectiveness Analysis. PLOS ONE. 2015 Dec 9;10(12):e0142691.

33. Federal Ministry of Health, Addis Ababa. Ethiopia National Expanded Programme on

Immunization Comprehensive Multi-year Plan 2016-2020 [Internet]. Addis Ababa; 2015 Apr [cited 2018

Feb 19]. Available from:


sed_may_12_2015.pdf

34. The Social-Ecological Model: A Framework for Prevention|Violence Prevention|Injury

Center|CDC [Internet]. 2018 [cited 2018 Apr 24]. Available from:

https://www.cdc.gov/violenceprevention/overview/social-ecologicalmodel.html

35. Central Statistical Agency (CSA) [Ethiopia] and ICF. 2016. Ethiopia Demographic and Health

Survey 2016. Addis Ababa, Ethiopia, and Rockville, Maryland, USA: CSA and ICF. [Internet]. Central

Statistical Agency (CSA) [Ethiopia] and ICF. 2016. Ethiopia Demographic and Health Survey 2016.

Addis Ababa, Ethiopia, and Rockville, Maryland, USA: CSA and ICF.; [cited 2018 Feb 2]. Available

from: https://dhsprogram.com/pubs/pdf/FR328/FR328.pdf

36. Afar Triangle. In: Wikipedia [Internet]. 2018. Available from:

https://en.wikipedia.org/w/index.php?title=Afar_Triangle&oldid=823231527

37. Central Statistical Agency [Ethiopia] and ICF International. 2012. Ethiopia Demographic and Health

Survey 2011. Addis Ababa, Ethiopia and Calverton, Maryland, USA: Central Statistical Agency and ICF

International. [cited 2018 Jan 31]. Available from: https://dhsprogram.com/pubs/pdf/fr255/fr255.pdf

38. Ethiopia | Data [Internet]. [cited 2018 Feb 18]. Available from:

UPPSALA UNIVERSITET Lauren Lockwood 40 (46) https://data.worldbank.org/country/Ethiopia

39. 1.2 The lowlands and pastoralism in a national perspective [Internet]. [cited 2018 Apr 1].

Available from: http://www.fao.org/Wairdocs/ILRI/x5461E/x5461e05.htm

40. Guide_to_DHS_Statistics_29Oct2012_DHSG1.pdf [Internet]. [cited 2018 Apr 14]. Available

from: https://dhsprogram.com/pubs/pdf/DHSG1/Guide_to_DHS_Statistics_29Oct2012_DHSG1.pdf

41. The DHS Program - Protecting the Privacy of DHS Survey Respondents [Internet]. [cited 2018

Mar 1]. Available from: https://dhsprogram.com/What-We-Do/Protecting-the-Privacy-of-DHS-Survey-

Respondents.cfm

42. Carrel M, Rennie S. Demographic and health surveillance: longitudinal ethical considerations.

Bull World Health Organ. 2008 Aug;86(8):612–6.

43. Rammohan A, Awofeso N, Fernandez RC. Paternal education status significantly influences

infants’ measles vaccination uptake, independent of maternal education status. BMC Public Health. 2012

May 8;12:336.

44. Reasons related to non-vaccination and under-vaccination of children in low and middle income

countries: Findings from a systematic review of the published literature, 1999–2009 - ScienceDirect

[Internet]. [cited 2018 Apr 18]. Available from: https://www-sciencedirect-

com.proxy.kib.ki.se/science/article/pii/S0264410X11013661

45. Canavan ME, Sipsma HL, Kassie GM, Bradley EH. Correlates of Complete Childhood

Vaccination in East African Countries. PLOS ONE. 2014 Apr 21;9(4):e95709.

46. Lakew Y, Bekele A, Biadgilign S. Factors influencing full immunization coverage among 12–23

months of age children in Ethiopia: evidence from the national demographic and health survey in 2011.

BMC Public Health. 2015 Jul 30;15:728.

47. Masand R, Dixit AM, Gupta RK. Study of immunisation status of rural children (12-23 months

age) of district Jaipur, Rajasthan and factors influencing it: a hospital based study. J Indian Med Assoc.

2012 Nov;110(11):795–9.

48. Abadura SA, Lerebo WT, Kulkarni U, Mekonnen ZA. Individual and community level

determinants of childhood full immunization in Ethiopia: a multilevel analysis. BMC Public Health.

2015 Sep 28;15:972.

UPPSALA UNIVERSITET Lauren Lockwood 41 (46) 49. Dubé E, Vivion M, MacDonald NE. Vaccine hesitancy, vaccine refusal and the anti-vaccine

movement: influence, impact and implications. Expert Rev Vaccines. 2015 Jan 2;14(1):99–117.

50. Oleribe O, Kumar V, Awosika-Olumo A, Robinson SDT. Individual and socioeconomic factors

associated with childhood immunization coverage in Nigeria. Pan Afr Med J [Internet]. 2017 24 [cited

2018 Apr 23];26(220). Available from: http://www.panafrican-med-

journal.com/content/article/26/220/full/

51. Wiysonge CS, Uthman OA, Ndumbe PM, Hussey GD. Individual and Contextual Factors

Associated with Low Childhood Immunisation Coverage in Sub-Saharan Africa: A Multilevel Analysis.

PLOS ONE. 2012 May 25;7(5):e37905.

52. Karbo T. Religion and social cohesion in Ethiopia. Int J Peace Dev Stud. 2013 Jul 31;4(3):43–52.

53. Kassaye KD, Amberbir A, Getachew B, Mussema Y. A historical overview of traditional

medicine practices and policy in Ethiopia. Ethiop J Health Dev. 2006 Jan 1;20(2):127–34.

54. Gele AA, Bjune G, Abebe F. Pastoralism and delay in diagnosis of TB in Ethiopia. BMC Public

Health. 2009 Jan 7;9:5.

55. Langsten R, Hill K. The accuracy of mothers’ reports of child vaccination: evidence from rural

Egypt. Soc Sci Med. 1998 May 1;46(9):1205–12.

56. Althubaiti A. Information bias in health research: definition, pitfalls, and adjustment methods. J

Multidiscip Healthc. 2016 May 4;9:211–7.

57. World Health Organization. Pneumococcal vaccines WHO position paper – 2012. [cited 2018 Apr

23]. Available from: http://www.who.int/wer/2012/wer8714.pdf

58. The DHS Program User Forum: Weighting data!» Using weights in regression analysis [Internet].

[cited 2018 Apr 14]. Available from: https://userforum.dhsprogram.com/index.php?t=msg&goto=72&

59. The Millenium Development Goals Report 2015. [cited 2018 Jan 17]. Available from:

http://www.un.org/millenniumgoals/2015_MDG_Report/pdf/MDG%202015%20rev%20(July%201).pdf

60. Health [Internet]. United Nations Sustainable Development. [cited 2018 Jan 17]. Available from:

http://www.un.org/sustainabledevelopment/health/

61. Torres-Rueda S, Burchett HE, Griffiths UK, Ongolo-Zogo P, Edengue J-M, Kitaw Y, et al. New

pneumococcal conjugate vaccine introductions in four sub-Saharan African countries: a cross-country

UPPSALA UNIVERSITET Lauren Lockwood 42 (46) analysis of health systems’ impacts. Afr Health Sci. 2015 Sep;15(3):868–77.

62. Birhanu S, Anteneh A, Kibie Y, Jejaw A. Knowledge, Attitude and Practice of Mothers Towards

Immunization of Infants in Health Centres at Addis Ababa, Ethiopia. Am J Health Res. 2016 Feb

16;4(1):6.

63. Larson HJ, Jarrett C, Eckersberger E, Smith DMD, Paterson P. Understanding vaccine hesitancy

around vaccines and vaccination from a global perspective: A systematic review of published literature,

2007–2012. Vaccine. 2014 Apr 17;32(19):2150–9.

64. WHO EMRO | The epidemiological transition | Volume 2, issue 1 | EMHJ volume 2, 1996

[Internet]. [cited 2018 Jan 31]. Available from: http://www.emro.who.int/emhj-volume-2-1996/volume-

2-issue-1/article2.html


Appendix

Attached in PDF

ETHIO

PIAC

ENTR

AL STA

TISTICA

L AG

ENC

Y (CSA

)

LOC

ALITY

NA

ME

NA

ME

OF H

OU

SE

HO

LD H

EA

D

CLU

STE

R N

UM

BE

R

HO

US

EH

OLD

NU

MB

ER

NA

ME

AN

D LIN

E N

UM

BE

R O

F WO

MA

N. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

HO

US

EH

OLD

SE

LEC

TED

FOR

FEM

ALE

GE

NITA

L MU

TILATIO

N A

ND

DV

? (1=YE

S, 2=N

O)

. . . . . . . . . . . . . . . . . . . . . . . .

DA

TED

AY

MO

NTH

YE

AR

INTE

RV

IEW

ER

'SN

AM

EIN

T. NO

.

RE

SU

LT*R

ES

ULT*

NE

XT V

ISIT:

DA

TETO

TAL N

UM

BE

RTIM

EO

F VIS

ITS

*RE

SU

LT CO

DE

S:

1 CO

MP

LETE

D4 R

EFU

SE

D2 N

OT A

T HO

ME

5 PA

RTLY

CO

MP

LETE

D7 O

THE

R3 P

OS

TPO

NE

D6 IN

CA

PA

CITA

TED

LAN

GU

AG

E O

FLA

NG

UA

GE

OF

NA

TIVE

LAN

GU

AG

ETR

AN

SLA

TOR

US

ED

QU

ES

TION

NA

IRE

**IN

TER

VIE

W**

OF R

ES

PO

ND

EN

T**(Y

ES

= 1, NO

= 2)

LAN

GU

AG

E O

F**LA

NG

UA

GE

CO

DE

S:

QU

ES

TION

NA

IRE

**01 E

NG

LISH

03 TIGR

IGN

A05 LA

NG

UA

GE

502 A

MH

AR

IC04 O

RO

MIFFA

06 LAN

GU

AG

E 6

NA

ME

SP

EC

IFY

DEM

OG

RA

PHIC

AN

D H

EALTH

SUR

VEYW

OM

AN

'S QU

ESTION

NA

IRE

IDEN

TIFICA

TION

INTER

VIEWER

VISITS

12

3FIN

AL V

ISIT

01

NU

MB

ER

ENG

LISH

SU

PE

RV

ISO

RFIE

LD E

DITO

RO

FFICE

ED

ITOR

KE

YE

D B

Y

NU

MB

ER

NA

ME

NU

MB

ER

NU

MB

ER

W-1

• 391Appendix E

RESPO

ND

ENT AG

REES

RESPO

ND

ENT D

OES N

OT AG

REE

TO BE IN

TERVIEW

ED. .

1TO

BE INTER

VIEWED

. . 2

END

NO

.

101H

OU

RS

. . . . . . . . . . . . . . . . . . . . . . . . .

MIN

UTE

S. . . . . . . . . . . . . . . . . . . . . . . . .

102YE

AR

S. . . . . . . . . . . . . . . . . . . . . . . . .

ALW

AYS. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 95

VIS

ITOR

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 96

103U

RB

AN

AR

EA

. . . . . . . . . . . . . . . . . . . . . . . . . . . . 1

RU

RAL AR

EA. . . . . . . . . . . . . . . . . . . . . . . . . . . .

2

104R

EGIO

N C

OD

E

ZON

E CO

DE

OU

TSIDE

OF E

THIO

PIA. . . . . . . . . . . . . . . . . . .

96

105M

ON

TH. . . . . . . . . . . . . . . . . . . . . . . . .

DO

N'T K

NO

W M

ON

TH. . . . . . . . . . . . . . . . . . . . . .

98

YEA

R. . . . . . . . . . . . . . . .

DO

N'T K

NO

W YE

AR

. . . . . . . . . . . . . . . . . . . . . . 9998

106AG

E IN C

OM

PLETED YEAR

S. . . . . . . .

107YES

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1

NO

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2

111

108P

RIM

AR

Y. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

1S

EC

ON

DA

RY

. . . . . . . . . . . . . . . . . . . . . . . . . . . . 2

TECH

NIC

AL/VOC

ATION

AL. .

. . . .

. . . .

. . . .

3H

IGH

ER

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 4

105IF LESS TH

AN O

NE YEAR

, REC

OR

D ‘00’ YEAR

S.

How

long have you been living continuously in (NAM

E O

F CU

RR

ENT C

ITY, TOW

N O

R VILLAG

E OF

RESID

ENC

E)?

INTR

OD

UC

TION

AND

CO

NSEN

T

SECTIO

N 1. R

ESPON

DEN

T'S BACKG

RO

UN

D

QU

ESTION

S AND

FILTERS

CO

DIN

G C

ATEGO

RIES

SKIP

DATE

Hello. M

y name is _______________________________________. I am

working w

ith Central Statistical Agency (C

SA). We are conducting a

survey about health and other topics all over Ethiopia. The information w

e collect will help the governm

ent to plan health services. Your household w

as selected for the survey. The questions usually take about 30 to 60 minutes. All of the answ

ers you give will be confidential and

will not be shared w

ith anyone other than mem

bers of our survey team. You don't have to be in the survey, but w

e hope you will agree to

answer the questions since your view

s are important. If I ask you any question you don't w

ant to answer, just let m

e know and I w

ill go on to the next question or you can stop the interview

at any time.

In case you need more inform

ation about the survey, you may contact the person listed on the card that has already been given to your

household.

Do you have any questions?

May I begin the interview

now?

SIGN

ATUR

E OF IN

TERVIEW

ER

CO

MP

AR

E A

ND

CO

RR

EC

T 105 AN

D/O

R 106

IF INC

ON

SISTENT.

REC

OR

D TH

E TIME.

In what m

onth and year were you born?

How

old were you at your last birthday?

Have you ever attended school?

What is the highest level of school you attended:

primary, secondary, technical/vocational or higher?

Just before you moved here, did you live in an urban or

in a rural area?

Before you moved here, w

hich region and zone did you live in?

W-2

392 •Appendix E

NO

.

SECTIO

N 1. R

ESPON

DEN

T'S BACKG

RO

UN

D

QU

ESTION

S AND

FILTERS

CO

DIN

G C

ATEGO

RIES

SKIP

109

[GR

AD

E/YE

AR

S]

. . . . . . . . . . . . .

110

PRIM

ARY, SEC

ON

DAR

Y OR

HIG

HER

TECH

NIC

AL/VOC

ATION

AL

111C

AN

NO

T RE

AD

AT A

LL. . . . . . . . . . . . . . . . . . .

1ABLE TO

READ

ON

LY PART O

FTH

E S

EN

TENC

E. . . . . . . . . . . . . . . . . . . . . . . . .

2ABLE TO

READ

WH

OLE SEN

TENC

E. . . . . . . . . .

3N

O C

ARD

WITH

REQ

UIR

EDLAN

GU

AGE

4

BLIN

D/V

ISU

ALLY IM

PA

IRE

D. . . . . . . . . . . . . . . .

5

112

CO

DE '2', '3'

CO

DE '1' O

R '5'

OR

'4'C

IRC

LED114

CIR

CLED

113AT LEAST O

NC

E A WEEK

. . . . . . . . . . . . . . . . . . . 1

LESS THAN

ON

CE A W

EEK. . . . . . . . . . . . . . . .

2N

OT A

T ALL

. . . . . . . . . . . . . . . . . . . . . . . . . . . . 3

114AT LEAST O

NC

E A WEEK

. . . . . . . . . . . . . . . . . . . 1

LESS THAN

ON

CE A W

EEK. . . . . . . . . . . . . . . .

2N

OT A

T ALL

. . . . . . . . . . . . . . . . . . . . . . . . . . . . 3

115AT LEAST O

NC

E A WEEK

. . . . . . . . . . . . . . . . . . . 1

LESS THAN

ON

CE A W

EEK. . . . . . . . . . . . . . . .

2N

OT A

T ALL

. . . . . . . . . . . . . . . . . . . . . . . . . . . . 3

116YES

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1

NO

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2

118

117YES

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1

NO

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2

118YES

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1

NO

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2

119YES

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1

NO

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2

122

120YES

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1

NO

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2

122

121A

LMO

ST E

VE

RY D

AY. . . . . . . . . . . . . . . . . . . . . .

1AT LEAST O

NC

E A WEEK

. . . . . . . . . . . . . . . . . . . 2

LESS THAN

ON

CE A W

EEK. . . . . . . . . . . . . . . .

3N

OT A

T ALL

. . . . . . . . . . . . . . . . . . . . . . . . . . . . 4

113

Do you ow

n a mobile telephone?

Do you use your m

obile phone for any financial transactions?

Do you have an account in a bank or other financial

institution that you yourself use?

Do you listen to the radio at least once a w

eek, less than once a w

eek or not at all?

Do you w

atch television at least once a week, less than

once a week or not at all?

(SPECIFY LAN

GU

AGE)

CH

ECK 108:

Now

I would like you to read this sentence to m

e.

SHO

W C

ARD

TO R

ESPON

DEN

T.

IF RESPO

ND

ENT C

ANN

OT R

EAD W

HO

LE SEN

TENC

E,PR

OBE: C

an you read any part of the sentence to me?

CH

ECK 111:

Have you ever used the internet?

In the last 13 months, have you used the internet?

Do you read a new

spaper or magazine at least once a

week, less than once a w

eek or not at all?

IF CO

MPLETED

LESS THAN

ON

E YEAR AT TH

AT LEVEL, R

ECO

RD

'00'.

What is the highest [G

RAD

E/YEARS] you com

pleted at that level?

During the last one m

onth, how often did you use the

internet: almost every day, at least once a w

eek, less than once a w

eek, or not at all?

IF NEC

ESSARY, PR

OBE FO

R U

SE FRO

M AN

Y LO

CATIO

N, W

ITH AN

Y DEVIC

E.

W-3

• 393Appendix E

NO

.

SECTIO

N 1. R

ESPON

DEN

T'S BACKG

RO

UN

D

QU

ESTION

S AND

FILTERS

CO

DIN

G C

ATEGO

RIES

SKIP

122O

RTH

OD

OX

. . . . . . . . . . . . . . . . . . . . . . . . . . . . 1

CA

THO

LIC. . . . . . . . . . . . . . . . . . . . . . . . . . . .

2P

RO

TES

TAN

T. . . . . . . . . . . . . . . . . . . . . . . . . . . .

3M

US

LIM. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

4TR

AD

ITION

AL

. . . . . . . . . . . . . . . . . . . . . . . . . . . . 5

OTH

ER96

123

ETHN

ICITY

. . . . . . . . . . . . . . . . . . . . . .

What is your ethnicity?

What is your religion?

REC

OR

D TH

E MAJO

R ETH

NIC

GR

OU

P

W-4

394 •Appendix E

NO

.

201Y

ES

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1

NO

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2

206

202Y

ES

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1

NO

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2

204

203a)

a)S

ON

S A

T HO

ME

. . . . . . . . . . . . . . . . b)

b)D

AU

GH

TER

S A

T HO

ME

. . . . . . .

204Y

ES

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1

NO

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2

206

205a)

a)S

ON

S E

LSE

WH

ER

E. . . . . . . . . .

b)b)

DA

UG

HTE

RS

ELS

EW

HE

RE

. . . . .

206

YE

S. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

1N

O. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

2208

207a)

a)B

OY

S D

EA

D. . . . . . . . . . . . . . . .

b)b)

GIR

LS D

EA

D. . . . . . . . . . . . . . . .

208TO

TAL B

IRTH

S. . . . . . . . . . . . . . . . . . .

209

YE

SN

O

210

ON

E O

R M

OR

EN

O B

IRTH

S226

BIR

THS

SK

IPC

OD

ING

CA

TEG

OR

IES

QU

ES

TION

S A

ND

FILTER

S

SE

CTIO

N 2. R

EP

RO

DU

CTIO

N

CH

EC

K 208:

CH

EC

K 208:

SU

M A

NS

WE

RS

TO 203, 205, A

ND

207, AN

D E

NTE

R

TOTA

L. IF NO

NE

, RE

CO

RD

'00'.

IF NO

NE

, RE

CO

RD

'00'.

And how

many girls have died?

How

many boys have died?

Have you ever given birth to a boy or girl w

ho was born

alive but later died?

IF NO

, PR

OB

E: A

ny baby who cried, w

ho made any

movem

ent, sound, or effort to breathe, or who show

ed any other signs of life even if for a very short tim

e?

PR

OB

E A

ND

C

OR

RE

CT 201-208

AS

NE

CE

SS

AR

Y.

Just to make sure that I have this right: you have had in TO

TAL _____ births during your life. Is that correct?

How

many sons live w

ith you?

Do you have any sons or daughters to w

hom you have

given birth who are now

living with you?

Now

I would like to ask about all the births you have had

during your life. Have you ever given birth?

And how

many daughters live w

ith you?

IF NO

NE

, RE

CO

RD

'00'.

And how

many daughters are alive but do not live

with you?

How

many sons are alive but do not live w

ith you?

Do you have any sons or daughters to w

hom you have

given birth who are alive but do not live w

ith you?

IF NO

NE

, RE

CO

RD

'00'.

W-5

• 395Appendix E

IF ALIV

E:

01B

OY

1S

ING

1YE

S1

YES

1

GIR

L2

MU

LT2

NO

2N

O2

02H

OU

SE

HO

LDYE

S1

BO

Y1

SIN

G1

YES

1YE

S1

LINE

NU

MB

ER

NO

2G

IRL

2M

ULT

2N

O2

NO

2(S

KIP

TO 221)

03H

OU

SE

HO

LDYE

S1

BO

Y1

SIN

G1

YES

1YE

S1

LINE

NU

MB

ER

NO

2G

IRL

2M

ULT

2N

O2

NO

2(S

KIP

TO 221)

04H

OU

SE

HO

LDYE

S1

BO

Y1

SIN

G1

YES

1YE

S1

LINE

NU

MB

ER

NO

2G

IRL

2M

ULT

2N

O2

NO

2(S

KIP

TO 221)

05H

OU

SE

HO

LDYE

S1

BO

Y1

SIN

G1

YES

1YE

S1

LINE

NU

MB

ER

NO

2G

IRL

2M

ULT

2N

O2

NO

2(S

KIP

TO 221)

YEA

R

YEA

R

(SK

IP

TO 220)

AG

E IN

AG

E IN

YEA

RS

(SK

IP

TO 220)

DA

Y

MO

NTH

MO

NTH

DA

YYE

AR

S

Is (N

AM

E)

still alive?

How

old w

as (N

AM

E) at

(NA

ME

)'s last birthday?

Is (N

AM

E)

living w

ith you?

What

name w

as given to your (first/ next) baby?

RE

CO

RD

N

AM

E.

BIR

TH

HIS

TOR

Y N

UM

BE

R.

On w

hat day, m

onth, and year w

as (NA

ME

) born?

Is (N

AM

E)

a boy or a girl?

Were

any of these births tw

ins?

3 2 1

YEA

RS

MO

NTH

S

DA

YS

(NE

XT BIR

TH)

SE

CTIO

N 2. R

EP

RO

DU

CTIO

N

RE

CO

RD

A

GE

IN

CO

MP

-LE

TED

YE

AR

S.

RE

CO

RD

DA

YS IF

LES

S TH

AN

1 M

ON

TH; M

ON

THS

IF LE

SS

THA

N TW

O

YEA

RS

; OR

YEA

RS

.

RE

CO

RD

H

OU

SE

HO

LD

LINE

NU

MB

ER

O

F CH

ILD.

RE

CO

RD

'00' IF C

HILD

NO

T LIS

TED

IN

HO

US

EH

OLD

.

Were there

any other live births betw

een (N

AM

E O

F P

RE

VIO

US

B

IRTH

) and (N

AM

E),

including any children w

ho died after birth?

LINE

NU

MB

ER

HO

US

EH

OLD

211N

ow I w

ould like to record the names of all your births, w

hether still alive or not, starting with the first one you had.

RE

CO

RD

NA

ME

S O

F ALL TH

E B

IRTH

S IN

212. RE

CO

RD

TWIN

S A

ND

TRIP

LETS

ON

SE

PA

RA

TE R

OW

S. IF TH

ER

E A

RE

MO

RE

THA

N 10

BIR

THS

, US

E A

N A

DD

ITION

AL Q

UE

STIO

NN

AIR

E, S

TAR

TING

WITH

THE

SE

CO

ND

RO

W.

IF ALIV

E:

IF DE

AD

:IF A

LIVE

:

How

old was (N

AM

E)

when (he/she) died?

IF '13 months' O

R '1

YR', A

SK

: Did

(NA

ME

) have (his/her) first birthday?

THE

N A

SK

: Exactly

how m

any months old

was (N

AM

E) w

hen (he/she) died?

216215

214213

212219

221220

218217

(SK

IP

TO 220)

YEA

RS

3(N

EXT

BIR

TH)

YEA

R

(AD

D

BIR

TH)

(NE

XT B

IRTH

)

DA

YA

GE

IND

AYS

1YE

AR

S(A

DD

B

IRTH

)M

ON

THM

ON

THS

2

DA

YS1

MO

NTH

S2

YEA

RS

3

(AD

D

BIR

TH)

MO

NTH

MO

NTH

S2

(SK

IP

TO 220)

YEA

RS

3(N

EXT

BIR

TH)

YEA

R

DA

YA

GE

IND

AYS

1YE

AR

S

(AD

D

BIR

TH)

MO

NTH

MO

NTH

S2

(SK

IP

TO 220)

YEA

RS

3(N

EXT

BIR

TH)

YEA

R

DA

YA

GE

IND

AYS

1YE

AR

S

W-6

396 •Appendix E

IF ALIV

E:

Is (N

AM

E)

still alive?

How

old w

as (N

AM

E) at

(NA

ME

)'s last birthday?

Is (N

AM

E)

living w

ith you?

What

name w

as given to your (first/ next) baby?

RE

CO

RD

N

AM

E.

BIR

TH

HIS

TOR

Y N

UM

BE

R.

On w

hat day, m

onth, and year w

as (NA

ME

) born?

Is (N

AM

E)

a boy or a girl?

Were

any of these births tw

ins?

RE

CO

RD

A

GE

IN

CO

MP

-LE

TED

YE

AR

S.

RE

CO

RD

DA

YS IF

LES

S TH

AN

1 M

ON

TH; M

ON

THS

IF LE

SS

THA

N TW

O

YEA

RS

; OR

YEA

RS

.

RE

CO

RD

H

OU

SE

HO

LD

LINE

NU

MB

ER

O

F CH

ILD.

RE

CO

RD

'00' IF C

HILD

NO

T LIS

TED

IN

HO

US

EH

OLD

.

Were there

any other live births betw

een (N

AM

E O

F P

RE

VIO

US

B

IRTH

) and (N

AM

E),

including any children w

ho died after birth?

IF ALIV

E:

IF DE

AD

:IF A

LIVE

:

How

old was (N

AM

E)

when (he/she) died?

IF '13 months' O

R '1

YR', A

SK

: Did

(NA

ME

) have (his/her) first birthday?

THE

N A

SK

: Exactly

how m

any months old

was (N

AM

E) w

hen (he/she) died?

216215

214213

212219

221220

218217

06H

OU

SE

HO

LDYE

S1

BO

Y1

SIN

G1

YES

1YE

S1

LINE

NU

MB

ER

NO

2G

IRL

2M

ULT

2N

O2

NO

2(S

KIP

TO 221)

07H

OU

SE

HO

LDYE

S1

BO

Y1

SIN

G1

YES

1YE

S1

LINE

NU

MB

ER

NO

2G

IRL

2M

ULT

2N

O2

NO

2(S

KIP

TO 221)

08H

OU

SE

HO

LDYE

S1

BO

Y1

SIN

G1

YES

1YE

S1

LINE

NU

MB

ER

NO

2G

IRL

2M

ULT

2N

O2

NO

2(S

KIP

TO 221)

09H

OU

SE

HO

LDYE

S1

BO

Y1

SIN

G1

YES

1YE

S1

LINE

NU

MB

ER

NO

2G

IRL

2M

ULT

2N

O2

NO

2(S

KIP

TO 221)

10H

OU

SE

HO

LDYE

S1

BO

Y1

SIN

G1

YES

1YE

S1

LINE

NU

MB

ER

NO

2G

IRL

2M

ULT

2N

O2

NO

2(S

KIP

TO 221)

DA

YD

AYS

1YE

AR

S

MO

NTH

AG

E IN

(AD

D

BIR

TH)

YEA

R

DA

YA

GE

IND

AYS

1YE

AR

S

MO

NTH

S2

YEA

RS

3(S

KIP

TO

220)

(AD

D

BIR

TH)

MO

NTH

MO

NTH

S2

(SK

IP

TO 220)

YEA

RS

3(N

EXT

BIR

TH)

YEA

R

DA

YA

GE

IND

AYS

1YE

AR

S

(AD

D

BIR

TH)

MO

NTH

MO

NTH

S2

(SK

IP

TO 220)

YEA

RS

3(N

EXT

BIR

TH)

YEA

R

DA

YA

GE

IND

AYS

1YE

AR

S

(NE

XT B

IRTH

)

(AD

D

BIR

TH)

MO

NTH

MO

NTH

S2

(SK

IP

TO 220)

YEA

RS

3(N

EXT

BIR

TH)

YEA

R

DA

YA

GE

IND

AYS

1YE

AR

S

(AD

D

BIR

TH)

MO

NTH

MO

NTH

S2

(SK

IP

TO 220)

YEA

RS

3(N

EXT

BIR

TH)

YEA

R

W-7

• 397Appendix E

NO

.

222Y

ES

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1

(RE

CO

RD

BIR

TH(S

) IN TA

BLE

)N

O. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

2

223

NU

MB

ER

SN

UM

BE

RS

AR

EA

RE

SA

ME

DIFFE

RE

NT

(PR

OB

E A

ND

RE

CO

NC

ILE)

224N

UM

BE

R O

F BIR

THS

. . . . . . . . . . . . . . . . . . .

NO

NE

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0

226

225

226Y

ES

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1

NO

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2

UN

SU

RE

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 8

227M

ON

THS

. . . . . . . . . . . . . . . . . . . . .

228Y

ES

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1

230N

O. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

2

229

ON

E O

R M

OR

EN

ON

E

a)b)

LATE

R. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

1N

O M

OR

E/N

ON

E. . . . . . . . . . . . . . . . . . . . . . . .

2

230Y

ES

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1

NO

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2

239

231M

ON

TH. . . . . . . . . . . . . . . . . . . . . . . .

YE

AR

. . . . . . . . . . . . .

230

CWhen you got pregnant, did you w

ant to get pregnant at that tim

e?

Are you pregnant now

?

When did the last such pregnancy end?

Have you ever had a pregnancy that m

iscarried, was

aborted, or ended in a stillbirth?

SE

CTIO

N 2. R

EP

RO

DU

CTIO

N

CO

DIN

G C

ATE

GO

RIE

SQ

UE

STIO

NS

AN

D FILTE

RS

SK

IP

CH

EC

K 208: TO

TAL N

UM

BE

R O

F BIR

THS

Did you w

ant to have a baby later on or did you not w

ant any more

children?

Did you w

ant to have a baby later on or did you not w

ant any children?

C CO

MP

AR

E 208 W

ITH N

UM

BE

R O

F BIR

THS

IN B

IRTH

HIS

TOR

Y

RE

CO

RD

NU

MB

ER

OF C

OM

PLE

TED

MO

NTH

S.

Have you had any live births since the birth of (N

AM

E

OF LA

ST B

IRTH

)?

CH

EC

K 215: E

NTE

R TH

E N

UM

BE

R O

F BIR

THS

IN

2003-2008FOR

EA

CH

BIR

TH IN

2003-2008, EN

TER

'B' IN

THE

MO

NTH

OF B

IRTH

IN TH

E C

ALE

ND

AR

. WR

ITE

THE

NA

ME

OF TH

E C

HILD

TO TH

E LE

FT OF TH

E 'B

' CO

DE

. FOR

EA

CH

BIR

TH, A

SK

THE

NU

MB

ER

O

F CO

MP

LETE

D M

ON

THS

THE

PR

EG

NA

NC

Y LA

STE

D A

ND

RE

CO

RD

'P' IN

EA

CH

OF TH

E

PR

EC

ED

ING

MO

NTH

S A

CC

OR

DIN

G TO

THE

DU

RA

TION

OF P

RE

GN

AN

CY

. (NO

TE: TH

E N

UM

BE

R O

F 'P

's MU

ST B

E O

NE

LES

S TH

AN

THE

NU

MB

ER

OF M

ON

THS

THA

T THE

PR

EG

NA

NC

Y LA

STE

D.)

How

many m

onths pregnant are you?

EN

TER

'P's IN

THE

CA

LEN

DA

R,

BE

GIN

NIN

G W

ITH TH

E M

ON

TH O

F IN

TER

VIE

W A

ND

FOR

THE

TOTA

L N

UM

BE

R O

F CO

MP

LETE

D M

ON

THS

.

W-8

398 •Appendix E

NO

.

SE

CTIO

N 2. R

EP

RO

DU

CTIO

N

CO

DIN

G C

ATE

GO

RIE

SQ

UE

STIO

NS

AN

D FILTE

RS

SK

IP

232

234

239

LINE

NO

.

01Y

ES

. . . . . . . . . . 1

NO

. . . . . . . . . . 2

236

02Y

ES

. . . . . . . . . . 1

NO

. . . . . . . . . . 2

236

03Y

ES

. . . . . . . . . . 1

NO

. . . . . . . . . . 2

236

04Y

ES

. . . . . . . . . . 1

236N

O. . . . . . . . . .

2

236

237Y

ES

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1

NO

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2

239

238M

ON

TH. . . . . . . . . . . . . . . . . . . . . . . .

YE

AR

. . . . . . . . . . . . .

CN

UM

BE

R O

F MO

NTH

S

When did the last such pregnancy that term

inated before 2003 end?

Did you have any m

iscarriages, abortions or stillbirths that ended before 2003?

YE

AR

MO

NTH

NE

XT LIN

E

NE

XT LIN

E

In what m

onth and year did the preceding such pregnancy end?

NE

XT LIN

E

YE

AR

MO

NTH

CH

EC

K 231:

NU

MB

ER

OF M

ON

THS

NU

MB

ER

OF M

ON

THS

How

many m

onths pregnant w

ere you w

hen that pregnancy ended?

235233

234

MO

NTH

YE

AR

FOR

EA

CH

PR

EG

NA

NC

Y TH

AT D

ID N

OT E

ND

IN A

LIVE

BIR

TH IN

2003-2008 OR

LATE

R, E

NTE

R 'T' IN

TH

E C

ALE

ND

AR

IN TH

E M

ON

TH TH

AT TH

E P

RE

GN

AN

CY

TER

MIN

ATE

D A

ND

'P' FO

R TH

E

RE

MA

ININ

G N

UM

BE

R O

F CO

MP

LETE

D M

ON

THS

OF P

RE

GN

AN

CY

.

IF THE

RE

AR

E M

OR

E TH

AN

FOU

R P

RE

GN

AN

CIE

S TH

AT D

ID N

OT E

ND

IN A

LIVE

BIR

TH, U

SE

AN

A

DD

ITION

AL Q

UE

STIO

NN

AIR

E S

TAR

TING

ON

THE

SE

CO

ND

LINE

.

Since January 2003,

have you had any other pregnancies that did not result in a live birth?

NU

MB

ER

OF M

ON

THS

LAS

T PR

EG

NA

NC

Y

EN

DE

D IN

2003-2008

LAS

T PR

EG

NA

NC

Y

EN

DE

D IN

2002 OR

E

AR

LIER

W-9

• 399Appendix E

NO

.

SE

CTIO

N 2. R

EP

RO

DU

CTIO

N

CO

DIN

G C

ATE

GO

RIE

SQ

UE

STIO

NS

AN

D FILTE

RS

SK

IP

239D

AY

S A

GO

. . . . . . . . . . . . . 1

WE

EK

S A

GO

. . . . . . . . . . . . . 2

MO

NTH

S A

GO

. . . . . . . . . . . . . 3

YE

AR

S A

GO

. . . . . . . . . . . . . 4

IN M

EN

OP

AU

SE

/H

AS

HA

D H

YS

TER

EC

TOM

Y. . . . . . . . . .

994

BE

FOR

E LA

ST B

IRTH

. . . . . . . . . . . . . . . . . . . 995

NE

VE

R M

EN

STR

UA

TED

. . . . . . . . . . . . . . . . 996

240Y

ES

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1

NO

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2

DO

N'T K

NO

W. . . . . . . . . . . . . . . . . . . . . . . . . . .

8

241JU

ST B

EFO

RE

HE

R P

ER

IOD

BE

GIN

S. . . . . . . . . .

1D

UR

ING

HE

R P

ER

IOD

. . . . . . . . . . . . . . . . . . . . . 2

RIG

HT A

FTER

HE

R P

ER

IOD

HA

S E

ND

ED. . . . . . . 3

HA

LFWA

Y B

ETW

EE

N TW

O P

ER

IOD

S. . . . . . .

4

OTH

ER

6

DO

N'T K

NO

W. . . . . . . . . . . . . . . . . . . . . . . . . . .

8

242Y

ES

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1

NO

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2

DO

N'T K

NO

W. . . . . . . . . . . . . . . . . . . . . . . . . . .

8

242

When did your last m

enstrual period start?

(SP

EC

IFY)

After the birth of a child, can a w

oman becom

e pregnant before her m

enstrual period has returned?

Is this time just before her period begins, during her

period, right after her period has ended, or halfway

between tw

o periods?

From one m

enstrual period to the next, are there certain days w

hen a wom

an is more likely to becom

e pregnant?

(DA

TE, IF G

IVE

N)

W-10

400 •Appendix E

301

01Y

ES

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1

NO

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2

02Y

ES

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1

NO

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2

03Y

ES

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1

NO

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2

04Y

ES

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1

NO

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2

05Y

ES

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1

NO

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2

06Y

ES

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1

NO

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2

07Y

ES

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1

NO

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2

08Y

ES

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1

NO

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2

09Y

ES

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1

NO

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2

10Y

ES

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1

NO

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2

11Y

ES

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1

NO

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2

12Y

ES

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1

NO

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2

13Y

ES

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1

NO

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2

14Y

ES

, MO

DE

RN

ME

THO

D

1

YE

S, TR

AD

ITION

AL M

ETH

OD

2

NO

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 3

(SP

EC

IFY)

Now

I would like to talk about fam

ily planning - the various ways or m

ethods that a couple can use to delay or avoid a pregnancy. H

ave you ever heard of (ME

THO

D)?

Female S

terilization.P

RO

BE

: Wom

en can have an operation to avoid having any more

children.

Injectables.P

RO

BE

: Wom

en can have an injection by a health provider that stops them

from becom

ing pregnant for one or more m

onths.

IUD

.P

RO

BE

: Wom

en can have a loop or coil placed inside them by a

doctor or a nurse which can prevent pregnancy for one or m

ore years.

Male S

terilization.P

RO

BE

: Men can have an operation to avoid having any m

ore children.

Have you heard of any other w

ays or methods that w

omen or m

en can use to avoid pregnancy?

Em

ergency Contraception.

PR

OB

E: A

s an emergency m

easure, within three days after they have

unprotected sexual intercourse, wom

en can take special pills to prevent pregnancy.

Withdraw

al.P

RO

BE

: Men can be careful and pull out before clim

ax.

Rhythm

Method.

PR

OB

E: To avoid pregnancy, w

omen do not have sexual intercourse

on the days of the month they think they can get pregnant.

Female C

ondom.

PR

OB

E: W

omen can place a sheath in their vagina before sexual

intercourse.

Male C

ondom.

PR

OB

E: M

en can put a rubber sheath on their penis before sexual intercourse.

Pill.

PR

OB

E: W

omen can take a pill every day to avoid becom

ing pregnant.

Implants.

PR

OB

E: W

omen can have one or m

ore small rods placed in their

upper arm by a doctor or nurse w

hich can prevent pregnancy for one or m

ore years.

Lactational Am

enorrhea Method (LA

M).

PR

OB

E: U

p to six months after childbirth, before the m

enstrual period has returned, w

omen use a m

ethod requiring frequent breastfeeding day and night.

SE

CTIO

N 3. C

ON

TRA

CE

PTIO

N

Standard D

ays Method.

PR

OB

E: A

wom

an uses a string of colored beads to know the days

she can get pregnant. On the days she can get pregnant, she uses a

condom or does not have sexual intercourse.

(SP

EC

IFY)

W-11

• 401Appendix E

NO

.

302

NO

T PR

EG

NA

NT

PR

EG

NA

NT

OR

UN

SU

RE

303Y

ES

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1

NO

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2

312

304FE

MA

LE S

TER

ILIZATIO

N. . . . . . . . . . . . . . . . . . .

AM

ALE

STE

RILIZA

TION

. . . . . . . . . . . . . . . . . . . . . B

IUD

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . C

INJE

CTA

BLE

S. . . . . . . . . . . . . . . . . . . . . . . . . . .

D309

IMP

LAN

TS. . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

EP

ILL. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

FM

ALE

CO

ND

OM

. . . . . . . . . . . . . . . . . . . . . . . . . . . G

306FE

MA

LE C

ON

DO

M. . . . . . . . . . . . . . . . . . . . . . . .

HE

ME

RG

EN

CY

CO

NTR

AC

EP

TION

. . . . . . . . . . . . . I

STA

ND

AR

D D

AY

S M

ETH

OD

. . . . . . . . . . . . . . . . J

LAC

TATIO

NA

L AM

EN

OR

RH

EA

ME

THO

D. . . . . . .

KR

HY

THM

ME

THO

D. . . . . . . . . . . . . . . . . . . . . . . .

LW

ITHD

RA

WA

L. . . . . . . . . . . . . . . . . . . . . . . . . . .

MO

THE

R M

OD

ER

N M

ETH

OD

. . . . . . . . . . . . . . . . X

OTH

ER

TRA

DITIO

NA

L ME

THO

D. . . . . . . . . . . . .

Y

305C

HO

ICE

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 01

IPLA

N. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

02S

TYLE

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 03

309O

THE

R96

DO

N'T K

NO

W. . . . . . . . . . . . . . . . . . . . . . . . . . .

98

306S

EN

SA

TION

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 01

HIW

OT TR

US

T. . . . . . . . . . . . . . . . . . . . . . . . . . .

02M

EM

BE

RS

ON

LY. . . . . . . . . . . . . . . . . . . . . . . .

03G

OLD

04G

EA

NS

05D

UR

EX

06M

OO

DS

07309

OTH

ER

96

DO

N'T K

NO

W. . . . . . . . . . . . . . . . . . . . . . . . . . .

98

IF DO

N'T K

NO

W TH

E B

RA

ND

, AS

K TO

SE

E TH

E

PA

CK

AG

E.

(SP

EC

IFY)

What is the brand nam

e of the pills you are using?

IF DO

N'T K

NO

W TH

E B

RA

ND

, AS

K TO

SE

E TH

E

PA

CK

AG

E.

(SP

EC

IFY)

What is the brand nam

e of the condoms you are using?

307

SE

CTIO

N 3. C

ON

TRA

CE

PTIO

N

QU

ES

TION

S A

ND

FILTER

SC

OD

ING

CA

TEG

OR

IES

SK

IP

CH

EC

K 226:

312

Are you or your partner currently doing som

ething or using any m

ethod to delay or avoid getting pregnant?

Which m

ethod are you using?

RE

CO

RD

ALL M

EN

TION

ED

.

IF MO

RE

THA

N O

NE

ME

THO

D M

EN

TION

ED

, FO

LLOW

SK

IP IN

STR

UC

TION

FOR

HIG

HE

ST

ME

THO

D IN

LIST.

309

W-12

402 •Appendix E

NO

.

SE

CTIO

N 3. C

ON

TRA

CE

PTIO

N

QU

ES

TION

S A

ND

FILTER

SC

OD

ING

CA

TEG

OR

IES

SK

IP

307PU

BLIC

SECTO

RG

OV

ER

NM

EN

T HO

SP

ITAL

. . . . . . . . . . . . . . . . 11

GO

VE

RN

ME

NT H

EA

LTH S

TATIO

N/C

EN

TER

. . 12

GO

VE

RN

ME

NT H

EA

LTH P

OS

T. . . . . . . . . .

13O

THE

R P

UB

LIC S

EC

TOR

16

NG

OHE

ALTH

FAC

ILITY21

OTH

ER

NG

O H

EA

LTH FA

CILITY

26

PRIVA

TE MED

ICA

L SECTO

RP

RIV

ATE

HO

SP

ITAL

. . . . . . . . . . . . . 31

PR

IVA

TE C

LINIC

. . . . . . . . . . . . . 32

OTH

ER

PR

IVA

TE M

ED

ICA

L SE

CTO

R

36

OTH

ER

96

DO

N'T K

NO

W. . . . . . . . . . . . . . . . . . . . . . . . . . .

98

308M

ON

TH. . . . . . . . . . . . . . . . . . . . . . . .

YE

AR

. . . . . . . . . . . . .

309M

ON

TH. . . . . . . . . . . . . . . . . . . . . . . .

YE

AR

. . . . . . . . . . . . .

310

NO

YE

S

310

PRO

BE TO ID

ENTIFY TH

E TYPE OF SO

UR

CE.

IF UN

AB

LE TO

DE

TER

MIN

E IF P

UB

LIC O

R P

RIV

ATE

S

EC

TOR

, WR

ITE TH

E N

AM

E O

F THE

PLA

CE

.

(NA

ME

OF P

LAC

E)

(SP

EC

IFY)

In what facility did the sterilization take place?

(SP

EC

IFY)

CH

EC

K 308 A

ND

309, 215 AN

D 231: A

NY

BIR

TH O

R P

RE

GN

AN

CY

TER

MIN

ATIO

N A

FTER

MO

NTH

AN

D Y

EA

R O

F S

TAR

T OF U

SE

OF C

ON

TRA

CE

PTIO

N IN

308 OR

309

GO

BA

CK

TO 308 O

R 309, P

RO

BE

AN

D R

EC

OR

D M

ON

TH A

ND

YEAR

AT START O

F CO

NTIN

UO

US U

SE OF C

UR

REN

T ME

THO

D

(MU

ST B

E A

FTER

LAS

T BIR

TH O

R P

RE

GN

AN

CY

Since w

hat month and year have you been using

(CU

RR

ENT M

ETH

OD

) without stopping?

PR

OB

E: For how

long have you been using (CU

RR

ENT

ME

THO

D) now

without stopping?

In what m

onth and year was the sterilization perform

ed?

(SP

EC

IFY)

(SP

EC

IFY)

W-13

• 403Appendix E

311

THE

N C

ON

TINU

ETH

EN

(SK

IP TO

324)

312

312AM

ON

THM

ON

THM

ON

TH

312BYE

S. . . . . . . . . . . . . . . .

1YE

S. . . . . . . . . . . . . . . .

1YE

S. . . . . . . . . . . . . . . .

1N

O. . . . . . . . . . . . . . . .

2N

O. . . . . . . . . . . . . . . .

2N

O. . . . . . . . . . . . . . . .

2(S

KIP

TO 312I)

(SK

IP TO

312I)(S

KIP

TO 312I)

312CM

ETH

OD

CO

DE

. . M

ETH

OD

CO

DE

. . M

ETH

OD

CO

DE

. .

312DIM

ME

DIA

TELY

. . . . . 00

IMM

ED

IATE

LY. . . . .

00IM

ME

DIA

TELY

. . . . . 00

MO

NTH

S. .

MO

NTH

S. .

MO

NTH

S. .

DA

TE G

IVE

N. . . . . . . . 95

DA

TE G

IVE

N. . . . . . . . 95

DA

TE G

IVE

N. . . . . . . . 95

312EM

ON

THM

ON

THM

ON

TH

312FM

ON

THS

. . M

ON

THS

. . M

ON

THS

. .

DA

TE G

IVE

N. . . . . . . . 95

DA

TE G

IVE

N. . . . . . . . 95

DA

TE G

IVE

N. . . . . . . . 95

312GM

ON

THM

ON

THM

ON

TH

312HR

EA

SO

NR

EA

SO

NR

EA

SO

NS

TOP

PE

D. . . . .

STO

PP

ED

. . . . . S

TOP

PE

D. . . . .

312I

SE

CTIO

N 3. C

ON

TRA

CE

PTIO

N(C

AP

I OP

TION

)

EN

TER

CO

DE

FOR

ME

THO

D U

SE

D IN

MO

NTH

OF

INTE

RV

IEW

IN TH

E C

ALE

ND

AR

AN

D E

AC

H

MO

NTH

BA

CK

TO JA

NU

AR

Y 2003 .

CH

EC

K 308 A

ND

309:

EN

TER

CO

DE

FOR

ME

THO

D U

SE

D IN

MO

NTH

OF

INTE

RV

IEW

IN TH

E C

ALE

ND

AR

AN

D IN

EA

CH

M

ON

TH B

AC

K TO

THE

DA

TE S

TAR

TED

US

ING

.

I would like to ask you som

e questions about the times you or your partner m

ay have used a method to avoid getting pregnant during the last

few years.

CC

YEA

R IS

2003-2008YE

AR

IS 2002 O

R E

AR

LIER

US

E C

ALE

ND

AR

TO P

RO

BE

FOR

EA

RLIE

R P

ER

IOD

S O

F US

E A

ND

NO

NU

SE

, STA

RTIN

G W

ITH M

OS

T RE

CE

NT U

SE

, BA

CK

TO

JAN

UA

RY 2003. U

SE

NA

ME

S O

F CH

ILDR

EN

, DA

TES

OF B

IRTH

, AN

D P

ER

IOD

S O

F PR

EG

NA

NC

Y AS

RE

FER

EN

CE

P

OIN

TS.

CO

LUM

N 3

CO

LUM

N 2

CO

LUM

N 1

CWhy did you stop using

(ME

THO

D)?

For how m

any months did you

use (ME

THO

D)?

How

many m

onths after (E

VE

NT) in (M

ON

TH/YE

AR

) did you start to use (M

ETH

OD

)?

RE

CO

RD

MO

NTH

AN

D YE

AR

R

ES

PO

ND

EN

T STA

RTE

D

US

ING

ME

THO

D.

CIR

CLE

'95' IF RE

SP

ON

DE

NT

GIV

ES

THE

DA

TE O

F S

TAR

TING

TO U

SE

THE

M

ETH

OD

.

CIR

CLE

'95' IF RE

SP

ON

DE

NT

GIV

ES

THE

DA

TE O

F TE

RM

INA

TION

OF U

SE

.

YEA

R

YEA

R

YEA

R

YEA

R

RE

CO

RD

MO

NTH

AN

D YE

AR

R

ES

PO

ND

EN

T STO

PP

ED

U

SIN

G M

ETH

OD

.

MO

NTH

AN

D YE

AR

OF

STA

RT O

F INTE

RV

AL O

F U

SE

OR

NO

N-U

SE

.

Which m

ethod was that?

Betw

een (EV

EN

T) in (M

ON

TH/YE

AR

) and (EV

EN

T) in (M

ON

TH/YE

AR

), did you or your partner use any m

ethod of contraception?

YEA

R

YEA

R

(SK

IP TO

312F)(S

KIP

TO 312F)

(SK

IP TO

312F)

GO

BA

CK

TO 312A

IN N

EXT

CO

LUM

N; O

R, IF N

O M

OR

E

GA

PS

, GO

TO 313.

GO

BA

CK

TO 312A

IN N

EXT

CO

LUM

N; O

R, IF N

O M

OR

E

GA

PS

, GO

TO 313.

GO

BA

CK

TO 312A

IN N

EW

Q

UE

STIO

NN

AIR

E; O

R, IF N

O

MO

RE

GA

PS

, GO

TO 313.

YEA

R

YEA

R

YEA

R

(SK

IP TO

312H)

(SK

IP TO

312H)

(SK

IP TO

312H)

W-14

404 •Appendix E

NO

.

313

NO

ME

THO

D U

SE

DA

NY

ME

THO

D U

SE

D

314Y

ES

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1

NO

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2

315N

O C

OD

E C

IRC

LED

. . . . . . . . . . . . . . . . . . . . . 00

326FE

MA

LE S

TER

ILIZATIO

N. . . . . . . . . . . . . . . . . . .

01319

MA

LE S

TER

ILIZATIO

N. . . . . . . . . . . . . . . . . . . . .

02327

IUD

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 03

INJE

CTA

BLE

S. . . . . . . . . . . . . . . . . . . . . . . . . . .

04IM

PLA

NTS

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 05

PILL

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 06

MA

LE C

ON

DO

M. . . . . . . . . . . . . . . . . . . . . . . . . . .

07FE

MA

LE C

ON

DO

M. . . . . . . . . . . . . . . . . . . . . . . .

08E

ME

RG

EN

CY

CO

NTR

AC

EP

TION

. . . . . . . . . . . . . 09

STA

ND

AR

D D

AY

S M

ETH

OD

. . . . . . . . . . . . . . . . 10

LAC

TATIO

NA

L AM

EN

OR

RH

EA

ME

THO

D. . . . . . .

11R

HY

THM

ME

THO

D. . . . . . . . . . . . . . . . . . . . . . . .

12323

WITH

DR

AW

AL

. . . . . . . . . . . . . . . . . . . . . . . . . . . 13

OTH

ER

MO

DE

RN

ME

THO

D. . . . . . . . . . . . . . . .

95O

THE

R TR

AD

ITION

AL M

ETH

OD

. . . . . . . . . . . . . 96

316PU

BLIC

SECTO

RG

OV

ER

NM

EN

T HO

SP

ITAL

. . . . . . . . . . . . . . . . 11

GO

VE

RN

ME

NT H

EA

LTH S

TATIO

N/C

EN

TER

. . 12

GO

VE

RN

ME

NT H

EA

LTH P

OS

T. . . . . . . . . .

13P

UB

LIC P

HA

RM

AC

Y. . . . . . . . . . . . . . . . . . . . . 14

OTH

ER

PU

BLIC

SE

CTO

R16

NG

OHE

ALTH

FAC

ILITY21

OTH

ER

NG

O H

EA

LTH FA

CILITY

26

PRIVA

TE MED

ICA

L SECTO

RP

RIV

ATE

HO

SP

ITA L. . . . . . . . . . . . . . . . . . . . . 31

PR

IVA

TE C

LINIC

. . . . . . . . . . . . . . . . . . . . . 32

PR

IVA

TE P

HA

RM

AC

Y. . . . . . . . . . . . . . . .

. . 33

OTH

ER

PR

IVA

TE M

ED

ICA

L SE

CTO

R36

OTH

ER SO

UR

CE

SH

OP

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 41

FRIE

ND

/RE

LATIV

E. . . . . . . . . . . . . . . . . . . . .

42

OTH

ER

96

317IU

D. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

03IN

JEC

TAB

LES

. . . . . . . . . . . . . . . . . . . . . . . . . . . 04

IMP

LAN

TS. . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

05P

ILL. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

06M

ALE

CO

ND

OM

. . . . . . . . . . . . . . . . . . . . . . . . . . . 07

323FE

MA

LE C

ON

DO

M. . . . . . . . . . . . . . . . . . . . . . . .

08E

ME

RG

EN

CY

CO

NTR

AC

EP

TION

. . . . . . . . . . . . . 09

STA

ND

AR

D D

AY

S M

ETH

OD

. . . . . . . . . . . . . . . . 10

OTH

ER

MO

DE

RN

ME

THO

D. . . . . . . . . . . . . . . .

95O

THE

R TR

AD

ITION

AL M

ETH

OD

. . . . . . . . . . . . . 96

323

CH

EC

K 304:

CIR

CLE

ME

THO

D C

OD

E:

IF MO

RE

THA

N O

NE

ME

THO

D C

OD

E C

IRC

LED

IN

304, CIR

CLE

CO

DE

FOR

HIG

HE

ST M

ETH

OD

IN LIS

T.

You first started using (C

UR

RE

NT M

ETH

OD

) in (DA

TE

FRO

M 308 O

R 309). W

here did you get it at that time?

CH

EC

K 304:

CIR

CLE

ME

THO

D C

OD

E:

IF MO

RE

THA

N O

NE

ME

THO

D C

OD

E C

IRC

LED

IN

304, CIR

CLE

CO

DE

FOR

HIG

HE

ST M

ETH

OD

IN LIS

T.

(SP

EC

IFY)

(SP

EC

IFY)

(SP

EC

IFY)

322

SE

CTIO

N 3. C

ON

TRA

CE

PTIO

N

CO

DIN

G C

ATE

GO

RIE

SS

KIP

326

315

QU

ES

TION

S A

ND

FILTER

S

(NA

ME

OF P

LAC

E)

(SP

EC

IFY)

PRO

BE TO ID

ENTIFY TH

E TYPE OF SO

UR

CE.

IF UN

AB

LE TO

DE

TER

MIN

E IF P

UB

LIC O

R P

RIV

ATE

S

EC

TOR

, WR

ITE TH

E N

AM

E O

F THE

PLA

CE

.

CH

EC

K TH

E C

ALE

ND

AR

FOR

US

E O

F AN

Y C

ON

TRA

CE

PTIV

E M

ETH

OD

IN A

NY

MO

NTH

Have you ever used anything or tried in any w

ay to delay or avoid getting pregnant?

W-15

• 405Appendix E

NO

.

SE

CTIO

N 3. C

ON

TRA

CE

PTIO

N

CO

DIN

G C

ATE

GO

RIE

SS

KIP

QU

ES

TION

S A

ND

FILTER

S

318Y

ES

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1

321N

O. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

2320

319Y

ES

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1

321N

O. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

2

320Y

ES

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1

NO

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2

322

321Y

ES

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1

NO

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2

322

AN

YO

THE

R'Y

ES

'

a)b)

YE

S. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

1324

NO

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2

323Y

ES

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1

NO

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2

324FE

MA

LE S

TER

ILIZATIO

N. . . . . . . . . . . . . . . . . . .

01M

ALE

STE

RILIZA

TION

. . . . . . . . . . . . . . . . . . . . . 02

IUD

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 03

INJE

CTA

BLE

S. . . . . . . . . . . . . . . . . . . . . . . . . . .

04IM

PLA

NTS

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 05

PILL

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 06

MA

LE C

ON

DO

M. . . . . . . . . . . . . . . . . . . . . . . . . . .

07FE

MA

LE C

ON

DO

M. . . . . . . . . . . . . . . . . . . . . . . .

08E

ME

RG

EN

CY

CO

NTR

AC

EP

TION

. . . . . . . . . . . . . 09

STA

ND

AR

D D

AY

S M

ETH

OD

. . . . . . . . . . . . . . . . 10

LAC

TATIO

NA

L AM

EN

OR

RH

EA

ME

THO

D. . . . . . .

11R

HY

THM

ME

THO

D. . . . . . . . . . . . . . . . . . . . . . . .

12327

WITH

DR

AW

AL

. . . . . . . . . . . . . . . . . . . . . . . . . . . 13

OTH

ER

MO

DE

RN

ME

THO

D. . . . . . . . . . . . . . . .

95O

THE

R TR

AD

ITION

AL M

ETH

OD

. . . . . . . . . . . . . 96

327

Were you told w

hat to do if you experienced side effects or problem

s?

When you got sterilized, w

ere you told about side effects or problem

s you might have w

ith the method?

At that tim

e, were you told about side effects or

problems you m

ight have with the m

ethod?

CH

EC

K 318 A

ND

319:

CH

EC

K 304:

CIR

CLE

ME

THO

D C

OD

E:

IF MO

RE

THA

N O

NE

ME

THO

D C

OD

E C

IRC

LED

IN

304, CIR

CLE

CO

DE

FOR

HIG

HE

ST M

ETH

OD

IN LIS

T.

Were you ever told by a health w

orker about other m

ethods of family planning that you could use?

When you obtained

(CU

RR

EN

T ME

THO

D

FRO

M 315) from

(S

OU

RC

E O

F M

ETH

OD

FRO

M 307

OR

316), were you told

about other methods of

family planning that you

could use?

327

Were you ever told by a health w

orker about side effects or problem

s you might have w

ith the method?

At that tim

e, were you

told about other m

ethods of family

planning that you could use?

W-16

406 •Appendix E

NO

.

SE

CTIO

N 3. C

ON

TRA

CE

PTIO

N

CO

DIN

G C

ATE

GO

RIE

SS

KIP

QU

ES

TION

S A

ND

FILTER

S

325PU

BLIC

SECTO

RG

OV

ER

NM

EN

T HO

SP

ITAL

. . . . . . . . . . . . . . . . 11

GO

VE

RN

ME

NT H

EA

LTH S

TATIO

N/C

EN

TER

. . 12

GO

VE

RN

ME

NT H

EA

LTH P

OS

T. . . . . . . . . .

13P

UB

LIC P

HA

RM

AC

Y. . . . . . . . . . . . . . . . . . . . . 14

OTH

ER

PU

BLIC

SE

CTO

R16

NG

OHE

ALTH

FAC

ILITY. . . . . . . . . . . . . . . . . . . . .

21O

THE

R N

GO

HE

ALTH

FAC

ILITY

26

327PR

IVATE M

EDIC

AL SEC

TOR

PR

IVA

TE H

OS

PITA

L. . . . . . . . . . . . . . . . . . . . . 31

PR

IVA

TE C

LINIC

. . . . . . . . . . . . . . . . . . . . . 32

PR

IVA

TE P

HA

RM

AC

Y. . . . . . . . . . . . . . . . . . .

33O

THE

R P

RIV

ATE

ME

DIC

AL S

EC

TOR

36

OTH

ER SO

UR

CE

SH

OP

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 41

FRIE

ND

/RE

LATI V. . . . . . . . . . . . . . . . . . . . . . . .

42

OTH

ER

96

326Y

ES

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1

NO

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2

327Y

ES

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1

NO

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2

329

328Y

ES

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1

NO

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2

329

YE

SN

O

a)b)

YE

S. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

1N

O. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

2401

330Y

ES

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1

NO

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2

(SP

EC

IFY)

Where did you obtain (C

UR

RE

NT M

ETH

OD

) the last tim

e?

(SP

EC

IFY)

(SP

EC

IFY)

(NA

ME

OF P

LAC

E)

(SP

EC

IFY)

Do you know

of a place where you can obtain a m

ethod of fam

ily planning?

Did any staff m

ember at the health facility speak to you

about family planning m

ethods?

In the last 13 months, w

ere you visited by a health w

orker?

CH

EC

K 202: LIV

ING

CH

ILDR

ENIn the last 13 m

onths, have you visited a health facility for care for yourself?

In the last 13 months,

have you visited a health facility for care for yourself or your children?

Did the health w

orker talk to you about family planning?

PRO

BE TO ID

ENTIFY TH

E TYPE OF SO

UR

CE.

IF UN

AB

LE TO

DE

TER

MIN

E IF P

UB

LIC O

R P

RIV

ATE

S

EC

TOR

, WR

ITE TH

E N

AM

E O

F THE

PLA

CE

.

W-17

• 407Appendix E

401

402

403B

IRTH

BIR

THH

ISTO

RY

HIS

TOR

YN

UM

BE

R. . . . . . . . . . .

NU

MB

ER

. . . . . . . . . . .

404

LIVIN

GD

EA

DLIV

ING

DE

AD

405YE

S. . . . . . . . . . . . . . . . . . . . . . .

1YE

S. . . . . . . . . . . . . . . . . . . . . . .

1(S

KIP

TO 408)

(SK

IP TO

426)N

O

. . . . . . . . . . . . . . . . . . . . . . . 2

NO

. . . . . . . . . . . . . . . . . . . . . . .

2

406C

HE

CK

208:

a)b)

LATE

R. . . . . . . . . . . . . . . . . . . .

1LA

TER

. . . . . . . . . . . . . . . . . . . . 1

NO

MO

RE

/NO

NE

. . . . . . . . . . . 2

NO

MO

RE

/NO

NE

. . . . . . . . . . . 2

(SK

IP TO

408)(S

KIP

TO 426)

407M

ON

THS

. . . . . . . . 1

MO

NTH

S. . . . . . . .

1

YEA

RS

. . . . . . . . 2

YEA

RS

. . . . . . . . 2

DO

N'T K

NO

W. . . . . . . . . . . . . . 998

DO

N'T K

NO

W. . . . . . . . . . . . . . 998

408YE

S. . . . . . . . . . . . . . . . . . . . . . .

1N

O. . . . . . . . . . . . . . . . . . . . . . .

2(S

KIP

TO 414)

409H

EALTH PER

SON

NEL

DO

CTO

R. . . . . . . . . . . . . . . . .

AN

UR

SE

. . . . . . . . . . . . . . . . . B

MID

WIFE

. . . . . . . . . . . . . . . . . C

HE

ALTH

OFFIC

ER

. . . . . . . . D

HE

ALTH

EXTE

NS

ION

WO

RK

ER

E

OTH

ER PER

SON

TRA

DITIO

NA

L BIR

THA

TTEN

DA

NT

. . . . . . . . . . . F

OTH

ER

X

Did you w

ant to have a baby later on, or did you not w

ant any children?

How

much longer did you w

ant to wait?

SE

CTIO

N 4. P

RE

GN

AN

CY A

ND

PO

STN

ATA

L CA

RE

Now

I would like to ask som

e questions about your children born in the last five years. (We w

ill talk about each separately.)

When you got pregnant w

ith (NA

ME

), did you w

ant to get pregnant at that time?

CH

EC

K 224:

NA

ME

NA

ME

472

NE

XT-TO-LA

ST B

IRTH

LAS

T BIR

TH

(SP

EC

IFY)

CH

EC

K 215. R

EC

OR

D TH

E B

IRTH

HIS

TOR

Y NU

MB

ER

IN 403 A

ND

THE

NA

ME

AN

D S

UR

VIV

AL S

TATU

S IN

404 FOR

EA

CH

B

IRTH

IN 2003-2008. A

SK

THE

QU

ES

TION

S A

BO

UT A

LL OF TH

ES

E B

IRTH

S. B

EG

IN W

ITH TH

E LA

ST B

IRTH

.IF TH

ER

E A

RE

MO

RE

THA

N 2 B

IRTH

S, U

SE

LAS

T CO

LUM

N O

F AD

DITIO

NA

L QU

ES

TION

NA

IRE

(S).

ON

LY O

NE

B

IRTH

MO

RE

THA

N

ON

E B

IRTH

BIR

TH H

ISTO

RY N

UM

BE

R FR

OM

212 IN

BIR

TH H

ISTO

RY.

FRO

M 212 A

ND

216:

PR

OB

E TO

IDE

NTIFY E

AC

H TYP

E O

F P

ER

SO

N A

ND

RE

CO

RD

ALL

Whom

did you see?

Anyone else?

ON

E O

R M

OR

E B

IRTH

S

IN 2003-2008

NO

BIR

THS

IN

2003-2008

Did you w

ant to have a baby later on, or did you not w

ant any more

children?

Did you see anyone for antenatal care for

this pregnancy?

W-18

408 •Appendix E

NO

.

410H

OM

EH

ER

HO

ME

. . . . . . . . . . . . . . A

OTH

ER

HO

ME

. . . . . . . . . . . B

PUB

LIC SEC

TOR

GO

VE

RN

ME

NT H

OS

PITA

L. .

CG

OV

ER

NM

EN

T HE

ALTH

CE

NTE

R/S

TATIO

N. . . . .

DG

OV

ER

NM

EN

T HE

ALTH

PO

ST

. . . . . . . . . . . . . . E

OTH

ER

PU

BLIC

SE

CTO

R

F

NG

OHE

ALTH

FAC

ILITY. . . . . . . .

GO

THE

R N

GO

HE

ALTH

FA

CILITY

. . . . . . . . . . . . . . H

PRIVATE M

EDIC

AL SECTO

RP

RIV

ATE

HO

SP

ITAL

IP

RIV

ATE

CLI N. . . . . . . . . . . . . .

JO

THE

R P

RIV

ATE

ME

DIC

AL S

EC

TOR

K

OTH

ER

X

411M

ON

THS

. . . . . . . . . . .

DO

N'T K

NO

W. . . . . . . . . . . . . .

98

412N

UM

BE

RO

F TIME

S. . . . .

DO

N'T K

NO

W. . . . . . . . . . . . . .

98

412AYE

S. . . . . . . . . . . . . . . . . . . . . . .

1N

O. . . . . . . . . . . . . . . . . . . . . . .

2412C

412BV

AG

INA

L BLE

ED

ING

. . . . . . . . .. . A

VA

GIN

AL G

US

H O

FFLU

ID. . . . . . . . . . . .

. . . . . .. B

SE

VE

RE

HE

AD

AC

HE. . . . . . . . . . .

CB

LUR

RE

D V

ISIO

N. . . . . . . . . .. .

DFE

VE

R . . . . . .. . .. . . . . . . .. . . . .

EA

BD

OM

INA

L PA

IN. . . . . . . .. . . . .

FC

ON

VU

LSIO

N . . . . . . . . . . . . . . . . G

OTH

ER

X(S

PE

CIFY)

412CYE

S. . . . . . . . . . . . . . . . . . . . . . .

1N

O. . . . . . . . . . . . . . . . . . . . . . .

2

412DP

LAC

E O

F BIR

THA

SU

PP

LOIE

S N

EE

DE

D FO

R B

IRTH

BE

ME

RG

EN

CY TR

AN

SP

OR

ATIO

NC

MO

NE

Y/EM

ER

GE

NC

Y FUN

DD

PE

OP

LE TO

SU

PP

OR

T DU

RIN

GA

FTER

BIR

THE

PO

TEN

TIAL B

LOO

D D

ON

OR

SF

OTH

ER

SX

SP

EC

IFY

(SP

EC

IFY)

(SP

EC

IFY)

How

many m

onths pregnant were you

when you first received antenatal care for

this pregnancy?

How

many tim

es did you receive antenatal care during this pregnancy?

(SP

EC

IFY)

NA

ME

NA

ME

PR

OB

E TO

IDE

NTIFY TH

E TYP

E O

F S

OU

RC

E.

LAS

T BIR

TH

QU

ES

TION

S A

ND

FILTER

S

Where did you receive antenatal care for

this pregnancy?

Anyw

here else?

SE

CTIO

N 4. P

RE

GN

AN

CY A

ND

PO

STN

ATA

L CA

RE

NE

XT-TO-LA

ST B

IRTH

IF UN

AB

LE TO

DE

TER

MIN

E IF P

UB

LIC

OR

PR

IVA

TE S

EC

TOR

, WR

ITE TH

E

NA

ME

OF TH

E P

LAC

E.

During (any of) your antenatal care visit(s),

were you told about the signs of

pregnancy complications or danger sign of

pregnancy?

During any of your anenatal visit w

ere you told about birth prepardness plan?

Which signs of pregnancy com

plications w

ere you told about?

413

(NA

ME

OF P

LAC

E)

Which plans w

ere you told about?

W-19

• 409Appendix E

NO

.N

AM

EN

AM

E

LAS

T BIR

TH

QU

ES

TION

S A

ND

FILTER

S SE

CTIO

N 4. P

RE

GN

AN

CY A

ND

PO

STN

ATA

L CA

RE

NE

XT-TO-LA

ST B

IRTH

413

YES

NO

a)a)

BP

. . . . . . . . . . . 1

2b)

b)U

RIN

E. . . . . . . .

12

c)c)

BLO

OD

. . . . . . . . 1

2d)

d) N

utritional Couseling

12

414YE

S. . . . . . . . . . . . . . . . . . . . . . .

1N

O. . . . . . . . . . . . . . . . . . . . . . .

2(S

KIP

TO 417)

DO

N'T K

NO

W. . . . . . . . . . . . . .

8

414AYE

S, TT C

AR

D S

EE

N1

YES

, TT CA

RD

NO

T SE

EN

. . . . . 2

NE

VE

R H

AD

A C

AR

D. . . . . . . .

3

415TIM

ES

. . . . . . . . . . . . . . . . .

DO

N'T K

NO

W. . . . . . . . . . . . . .

8

4162 O

R M

OR

EO

THE

RTIM

ES

(SK

IP TO

420)

417YE

S. . . . . . . . . . . . . . . . . . . . . . .

1N

O. . . . . . . . . . . . . . . . . . . . . . .

2(S

KIP

TO 420)

DO

N'T K

NO

W. . . . . . . . . . . . . .

8

418

TIME

S. . . . . . . . . . . . . . . . .

DO

N'T K

NO

W. . . . . . . . . . . . . .

8

419C

HE

CK

418:

a)b)

YEA

RS

AG

O. . . . .

420YE

S. . . . . . . . . . . . . . . . . . . . . . .

1N

O. . . . . . . . . . . . . . . . . . . . . . .

2(S

KIP

TO 422)

DO

N'T K

NO

W. . . . . . . . . . . . . .

8

421

DA

YS. . . . .

DO

N'T K

NO

W. . . . . . . . . . . . . . 998

422YE

S. . . . . . . . . . . . . . . . . . . . . . .

1N

O. . . . . . . . . . . . . . . . . . . . . . .

2D

ON

'T KN

OW

. . . . . . . . . . . . . . 8

Did any health w

orker give you N

utritional Counseling?

Did you ever receive a TT vaccination

card?

ON

LY O

NE

M

OR

E TH

AN

O

NE

TIME

During this pregnancy, w

ere you given an injection in the arm

or shoulder to prevent the baby from

getting tetanus, that is, convulsions after birth?

During this pregnancy, how

many tim

es did you get a tetanus injection?

Did you give a blood sam

ple?

As part of your antenatal care during this

pregnancy, were any of the follow

ing done at least once:

At any tim

e before this pregnancy, did you receive any tetanus injections?

Before this pregnancy, how

many tim

es did you receive a tetanus injection?

CH

EC

K 415:

Was your blood pressure m

easured?

During this pregnancy, did you take any

drug for intestinal worm

s?

During this pregnancy, w

ere you given or did you buy any iron tablets?

During the w

hole pregnancy, for how m

any days did you take the tablets?

IF AN

SW

ER

IS N

OT N

UM

ER

IC, P

RO

BE

FO

R A

PP

RO

XIMA

TE N

UM

BE

R O

F D

AYS

.

SH

OW

TAB

LETS

/SYR

UP

.

IF 7 OR

MO

RE

TIME

S, R

EC

OR

D '7'.

How

many years

ago did you receive that tetanus injection?

How

many years

ago did you receive the last tetanus injection prior to this pregnancy?

Did you give a urine sam

ple?

W-20

410 •Appendix E

NO

.N

AM

EN

AM

E

LAS

T BIR

TH

QU

ES

TION

S A

ND

FILTER

S SE

CTIO

N 4. P

RE

GN

AN

CY A

ND

PO

STN

ATA

L CA

RE

NE

XT-TO-LA

ST B

IRTH

426V

ER

Y LAR

GE

. . . . . . . . . . . . . . 1

VE

RY LA

RG

E. . . . . . . . . . . . . .

1LA

RG

ER

THA

NLA

RG

ER

THA

NA

VE

RA

GE

. . . . . . . . . . . . . . 2

AV

ER

AG

E. . . . . . . . . . . . . .

2A

VE

RA

GE

. . . . . . . . . . . . . . . . . 3

AV

ER

AG

E. . . . . . . . . . . . . . . . .

3S

MA

LLER

THA

NS

MA

LLER

THA

NA

VE

RA

GE

. . . . . . . . . . . . . . 4

AV

ER

AG

E. . . . . . . . . . . . . .

4V

ER

Y SM

ALL

. . . . . . . . . . . . . . 5

VE

RY S

MA

LL. . . . . . . . . . . . . .

5D

ON

'T KN

OW

. . . . . . . . . . . . . . 8

DO

N'T K

NO

W. . . . . . . . . . . . . .

8

427YE

S. . . . . . . . . . . . . . . . . . . . . . .

1YE

S. . . . . . . . . . . . . . . . . . . . . . .

1N

O. . . . . . . . . . . . . . . . . . . . . . .

2N

O. . . . . . . . . . . . . . . . . . . . . . .

2(S

KIP

TO 429)

(SK

IP TO

429)D

ON

'T KN

OW

. . . . . . . . . . . . . . 8

DO

N'T K

NO

W. . . . . . . . . . . . . .

8

428K

G FR

OM

CA

RD

KG

FRO

M C

AR

D

1.

1.

KG

FRO

M R

EC

ALL

KG

FRO

M R

EC

ALL

2.

2.

DO

N'T K

NO

W. . . . . . . . . . .

99998D

ON

'T KN

OW

. . . . . . . . . . . 99998

429H

EALTH PER

SON

NEL

HEALTH

PERSO

NN

ELD

OC

TOR

. . . . . . . . . . . . . . A

DO

CTO

R. . . . . . . . . . . . . .

AN

UR

SE

. . . .

. . . .

. . . .

BN

UR

SE

. . . .

. . . .

. . . .

BM

IDW

IFE. . . . . . . . . . . . . .

CM

IDW

IFE. . . . . . . . . . . . . .

CH

EA

LTH O

FFICE

R. . . . . . . .

DH

EA

LTH O

FFICE

R. . . . . . . .

DH

EA

LTH E

XTEN

SIO

N W

OR

KE

RE

HE

ALTH

EXTE

NS

ION

WO

RK

ER

E

OTH

ER PER

SON

OTH

ER PER

SON

TRA

DITIO

NA

L BIR

THTR

AD

ITION

AL B

IRTH

ATTE

ND

AN

T. . . . . . . . . . .

FA

TTEN

DA

NT

. . . . . . . . . . . F

OTH

ER

OTH

ER

XX

NO

ON

E A

SS

ISTE

D. . . . . . . . . . .

YN

O O

NE

AS

SIS

TED

. . . . . . . . . . . Y

430H

OM

EH

OM

EH

ER

HO

ME

. . . . . . . . . . . . . . 11

HE

R H

OM

E. . . . . . . . . . . . . .

11(S

KIP

TO 434)

(SK

IP TO

434)O

THE

R H

OM

E. . . . . . . . . . .

12O

THE

R H

OM

E. . . . . . . . . . .

12

PUB

LIC SEC

TOR

PUB

LIC SEC

TOR

GO

VE

RN

ME

NT H

OS

PITA

L. .

21G

OV

ER

NM

EN

T HO

SP

ITAL

. . 21

GO

VE

RN

ME

NT H

EA

LTHG

OV

ER

NM

EN

T HE

ALTH

CE

NTE

R. . . . .

22C

EN

TER

. . . . . . . . . . . . . . 22

GO

VE

RN

ME

NT H

EA

LTHG

OV

ER

NM

EN

T HE

ALTH

PO

ST

. . . . . . . . . . . . . . 23

PO

ST

. . . . . . . . . . . . . . 23

OTH

ER

PU

BLIC

SE

CTO

RO

THE

R P

UB

LIC S

EC

TOR

2626

NG

ON

GO

HE

ALTH

FAC

ILITY. .

31H

EA

LTH FA

CILITY

. . 31

OTH

ER

NG

O H

EA

LTHO

THE

R N

GO

HE

ALTH

FAC

ILITYFA

CILITY

3636

PRIVATE M

EDIC

AL SECTO

RPR

IVATE MED

ICAL SEC

TOR

PR

IVA

TE H

OS

PITA

L. .

41P

RIV

ATE

HO

SP

ITAL

. . 41

PR

IVA

TE C

LINIC

42P

RIV

ATE

CLIN

IC42

OTH

ER

PR

IVA

TEO

THE

R P

RIV

ATE

ME

DIC

AL S

EC

TOR

ME

DIC

AL S

EC

TOR

4646

OTH

ER

96O

THE

R96

(SK

IP TO

434)(S

KIP

TO 434)

(SP

EC

IFY)(S

PE

CIFY)

IF RE

SP

ON

DE

NT S

AYS

NO

ON

E

AS

SIS

TED

, PR

OB

E TO

DE

TER

MIN

E

WH

ETH

ER

AN

Y AD

ULTS

WE

RE

P

RE

SE

NT A

T THE

DE

LIVE

RY.

PR

OB

E TO

IDE

NTIFY TH

E TYP

E O

F S

OU

RC

E.

IF UN

AB

LE TO

DE

TER

MIN

E IF P

UB

LIC

OR

PR

IVA

TE S

EC

TOR

, WR

ITE TH

E

NA

ME

OF TH

E P

LAC

E.

Where did you give birth to (N

AM

E)?

(NA

ME

OF P

LAC

E)

(SP

EC

IFY)(S

PE

CIFY)

PR

OB

E FO

R TH

E TYP

E(S

) OF

PE

RS

ON

(S) A

ND

RE

CO

RD

ALL

ME

NTIO

NE

D.

(SP

EC

IFY)(S

PE

CIFY)

(SP

EC

IFY)

(SP

EC

IFY)(S

PE

CIFY)

(SP

EC

IFY)

RE

CO

RD

WE

IGH

T IN K

ILOG

RA

MS

FR

OM

HE

ALTH

CA

RD

, IF AV

AILA

BLE

.

When (N

AM

E) w

as born, was (N

AM

E)

very large, larger than average, average, sm

aller than average, or very small?

Was (N

AM

E) w

eighed at birth?

How

much did (N

AM

E) w

eigh?

Who assisted w

ith the delivery of (NA

ME

)?

Anyone else?

W-21

• 411Appendix E

NO

.N

AM

EN

AM

E

LAS

T BIR

TH

QU

ES

TION

S A

ND

FILTER

S SE

CTIO

N 4. P

RE

GN

AN

CY A

ND

PO

STN

ATA

L CA

RE

NE

XT-TO-LA

ST B

IRTH

431H

OU

RS

. . . . . . . . 1

DA

YS. . . . . . . .

2

WE

EK

S. . . . . . . .

3

DO

N'T K

NO

W. . . . . . . . . . . . . . 998

432YE

S. . . . . . . . . . . . . . . . . . . . . . .

1YE

S. . . . . . . . . . . . . . . . . . . . . . .

1N

O. . . . . . . . . . . . . . . . . . . . . . .

2N

O. . . . . . . . . . . . . . . . . . . . . . .

2(S

KIP

TO 434)

(SK

IP TO

434)

433B

EFO

RE

. . . . . . . . . . . . . . . . . . . . 1

BE

FOR

E. . . . . . . . . . . . . . . . . . . .

1A

FTER

. . . . . . . . . . . . . . . . . . . . 2

AFTE

R. . . . . . . . . . . . . . . . . . . .

2

433AYE

S. . . . . . . . . . . . . . . . . . . . . . .

1YE

S. . . . . . . . . . . . . . . . . . . . . . .

1N

O. . . . . . . . . . . . . . . . . . . . . . .

2N

O. . . . . . . . . . . . . . . . . . . . . . .

2D

ON

'T KN

OW

. . . . . . . . . . . . . . 8

DO

N'T K

NO

W. . . . . . . . . . . . . .

8

433BYE

S. . . . . . . . . . . . . . . . . . . . . . .

1YE

S. . . . . . . . . . . . . . . . . . . . . . .

1N

O. . . . . . . . . . . . . . . . . . . . . . .

2N

O. . . . . . . . . . . . . . . . . . . . . . .

2D

ON

'T KN

OW

. . . . . . . . . . . . . . 8

DO

N'T K

NO

W. . . . . . . . . . . . . .

8

434YE

S. . . . . . . . . . . . . . . . . . . . . . .

1YE

S. . . . . . . . . . . . . . . . . . . . . . .

1N

O. . . . . . . . . . . . . . . . . . . . . . .

2N

O. . . . . . . . . . . . . . . . . . . . . . .

2D

ON

'T KN

OW

. . . . . . . . . . . . . . 8

DO

N'T K

NO

W. . . . . . . . . . . . . .

8

434AYE

S. . . . . . . . . . . . . . . . . . . . . . .

1YE

S. . . . . . . . . . . . . . . . . . . . . . .

1N

O. . . . . . . . . . . . . . . . . . . . . . .

2N

O. . . . . . . . . . . . . . . . . . . . . . .

2434C

DO

N'T K

NO

W. . . . . . . . . . . . . .

8D

ON

'T KN

OW

. . . . . . . . . . . . . . 8

434BA

NY TYP

E O

F OIL.. . . . . . . . . . . . .

AA

NY TYP

E O

F OIL.. . . . . . . . . . . . .

AD

UN

G. . . . . . . . . . . . . . . . . . . . . . .

BD

UN

G. . . . . . . . . . . . . . . . . . . . . . .

BA

SH

. . . . . . . . . . . . . . . . . . . . . . . C

AS

H. . . . . . . . . . . . . . . . . . . . . . .

CO

INTM

EN

T. . . . . . . . . . . . . . . . .

DO

INTM

EN

T. . . . . . . . . . . . . . . . .

D

OTH

ER

XO

THE

RX

434CC

OD

EC

OD

E11, 12, O

R 96

OTH

ER

11, 12, OR

96O

THE

RC

IRC

LED

CIR

CLE

D

(SK

IP TO

449)(S

KIP

TO 459)

Imm

ediatley after birth was (N

AM

E ) given

Vitam

in K injection?

Imm

ediately after birth was TTC

EYE

ointm

ent applied to (NA

ME

)s eye?

Was anything applied on the um

bilical cord after(N

AM

E)s delivery?

What w

as applied?

CH

EC

K 430: P

LAC

E O

F DE

LIVE

RY

434C

(SP

EC

IFY)

How

long after (NA

ME

) was delivered did

you stay there?

Was (N

AM

E) delivered by caesarean, that

is, did they cut your belly open to take the baby out?

When w

as the decision made to have the

caesarean section? Was it before or after

your labor pains started?

Imm

ediately after the birth, was (N

AM

E)

put directly on the bare skin of your chest?

IF LES

S TH

AN

ON

E D

AY,

RE

CO

RD

HO

UR

S;

IF LES

S TH

AN

ON

E W

EE

K,

RE

CO

RD

DA

YS.

(SP

EC

IFY)

W-22

412 •Appendix E

NO

.N

AM

EN

AM

E

LAS

T BIR

TH

QU

ES

TION

S A

ND

FILTER

S SE

CTIO

N 4. P

RE

GN

AN

CY A

ND

PO

STN

ATA

L CA

RE

NE

XT-TO-LA

ST B

IRTH

435

YES

. . . . . . . . . . . . . . . . . . . . . . . 1

NO

. . . . . . . . . . . . . . . . . . . . . . . 2

(SK

IP TO

438)

436H

OU

RS

. . . . . . . . 1

DA

YS. . . . . . . . . . .

2

WE

EK

S. . . . . . . .

3

DO

N'T K

NO

W. . . . . . . . . . . . . . 998

437H

EALTH PER

SON

NEL

DO

CTO

R. . . . . . . . . . . . . . . . .

11N

UR

SE

. . . . . . . . . . . . . . . . . 12

MID

WIFE

. . . . . . . . . . . . . . . . . 13

HE

ALTH

OFFIC

ER

. . . . . . . . 14

HE

ALTH

EXTE

NS

ION

WO

RK

ER15

OTH

ER PER

SON

TRA

DITIO

NA

L BIR

THA

TTEN

DA

NT

. . . . . . . . . . . 21

OTH

ER

96

437AYE

S. . . . . . . . . . . . . . . . . . . . . . .

1N

O. . . . . . . . . . . . . . . . . . . . . . .

2(S

KIP

TO 438)

437BH

EA

VY V

AG

INA

L BLE

ED

ING

. . A

FEV

ER

. . . .

. . . .

. . . .

. . B

SM

ELLY V

AG

INA

L BLE

ED

ING

. . C

DE

PR

ES

SIO

N. . . .

. . . .

. . . .

D

OTH

ER

X

438

YES

. . . . . . . . . . . . . . . . . . . . . . . 1

NO

. . . . . . . . . . . . . . . . . . . . . . . 2

(SK

IP TO

441)D

ON

'T KN

OW

. . . . . . . . . . . . . . 8

439H

OU

RS

. . . . . . . . 1

DA

YS. . . . . . . . . . .

2

WE

EK

S. . . . . . . .

3

DO

N'T K

NO

W. . . . . . . . . . . . . . 998

440H

EALTH PER

SON

NEL

DO

CTO

R. . . . . . . . . . . . . . . . .

11N

UR

SE

. . . . . . . . 12

MID

WIFE

. . . . . . . . . . . . . . 13

HE

ALTH

OFFIC

ER

. . . . . . . . 14

HE

ALTH

EXTE

NS

ION

WO

RK

ER15

OTH

ER PER

SON

TRA

DITIO

NA

L BIR

THA

TTEN

DA

NT

. . . . . . . . . . . 21

OTH

ER

96

(SP

EC

IFY)

PR

OB

E FO

R M

OS

T QU

ALIFIE

D

Before discharge from

the health facility w

ere you told of danger signs of maternal

health after delivery?

(SP

EC

IFY)

Who checked on (N

AM

E)’s health at that

time?

IF LES

S TH

AN

ON

E D

AY,

RE

CO

RD

HO

UR

S;

IF LES

S TH

AN

ON

E W

EE

K,

RE

CO

RD

DA

YS.

(SP

EC

IFY)

How

long after delivery was (N

AM

E)’s

health first checked?

I would like to talk to you about checks on

your health after delivery, for example,

someone asking you questions about your

health or examining you. D

id anyone check on your health w

hile you were still in

the facility?

PR

OB

E FO

R M

OS

T QU

ALIFIE

D

PE

RS

ON

.

IF LES

S TH

AN

ON

E D

AY,

RE

CO

RD

HO

UR

S;

IF LES

S TH

AN

ON

E W

EE

K,

RE

CO

RD

DA

YS.

Who checked on your health at that tim

e?

How

long after delivery did the first check take place?

Now

I would like to talk to you about

checks on (NA

ME

)’s health after delivery – for exam

ple, someone exam

ining (NA

ME

), checking the cord, or seeing if (N

AM

E) is

OK

. Did anyone check on (N

AM

E)’s health

while you w

ere still in the facility?

Which danger signs of m

aternal health w

ere you told about?

W-23

• 413Appendix E

NO

.N

AM

EN

AM

E

LAS

T BIR

TH

QU

ES

TION

S A

ND

FILTER

S SE

CTIO

N 4. P

RE

GN

AN

CY A

ND

PO

STN

ATA

L CA

RE

NE

XT-TO-LA

ST B

IRTH

440AYE

S. . . . . . . . . . . . . . . . . . . . . . .

1N

O. . . . . . . . . . . . . . . . . . . . . . .

2(S

KIP

TO 440C

)

440BFE

ED

ING

LES

S. .

. . . .

. . . .

ATO

O C

OLD

OR

TOO

HO

T. .

. . B

TOO

SLE

EP

Y. .

. . . .

. . . .

. . C

CO

NV

ULS

ION

. . . .

. . . .

. . D

FAS

T BR

EA

THIN

G. .

. . . .

. . E

UM

BILIC

US

RE

D/P

U. .

. . . .

. . F

PU

S IN

EYE

. . . .

. . . .

. . . .

GFE

VE

R. .

. . . .

. . . .

. . . .

H

OTH

ER

X(S

PE

CIFY)

440CYE

S. . . . . . . . . . . . . . . . . . . . . . .

1N

O. . . . . . . . . . . . . . . . . . . . . . .

2

441YE

S. . . . . . . . . . . . . . . . . . . . . . .

1N

O. . . . . . . . . . . . . . . . . . . . . . .

2(S

KIP

TO 445)

442H

OU

RS

. . . . . . . . 1

DA

YS. . . . . . . . . . .

2

WE

EK

S. . . . . . . .

3

DO

N'T K

NO

W. . . . . . . . . . . . . . 998

443H

EALTH PER

SON

NEL

DO

CTO

R. . . . . . . . . . . . . . . . .

11N

UR

SE

. . . . . . . . 12

MID

WIFE

. . . . . . . . . . . . . . 13

HE

ALTH

OFFIC

ER

. . . . . . . . 14

HE

ALTH

EXTE

NS

ION

WO

RK

ER15

OTH

ER PER

SON

TRA

DITIO

NA

L BIR

THA

TTEN

DA

NT

. . . . . . . . . . . 21

OTH

ER

96


e?

(SP

EC

IFY)

Before discharge from

the health facility w

ere you told danger signs of newborn

health?

Now

I want to talk to you about w

hat happened after you left the facility. D

id anyone check on your health after you left the facility?

IF LES

S TH

AN

ON

E D

AY,

RE

CO

RD

HO

UR

S;

IF LES

S TH

AN

ON

E W

EE

K,

RE

CO

RD

DA

YS.

Were you inform

ed when to return to the

health facility?

Which danger signs of new

born health w

ere you told about?

PR

OB

E FO

R M

OS

T QU

ALIFIE

D

How

long after delivery did that check take place?

W-24

414 •Appendix E

NO

.N

AM

EN

AM

E

LAS

T BIR

TH

QU

ES

TION

S A

ND

FILTER

S SE

CTIO

N 4. P

RE

GN

AN

CY A

ND

PO

STN

ATA

L CA

RE

NE

XT-TO-LA

ST B

IRTH

444H

OM

EH

ER

HO

ME

. . . . . . . . . . . . . . 11

OTH

ER

HO

ME

. . . . . . . . . . . 12

PUB

LIC SEC

TOR

GO

VE

RN

ME

NT H

OS

PITA

L. .

21G

OV

ER

NM

EN

T HE

ALTH

STA

TION

/. . . . . . . . . . . . . . 22

GO

VE

RN

ME

NT H

EA

LTHP

OS

T. . . . . . . . . . . . . .

23O

THE

R P

UB

LIC S

EC

TOR

26

NG

OHE

ALTH

FAC

ILITY. .

31O

THE

R N

GO

ME

DIC

AL H

EA

LTH FA

CILITY36

PRIVATE M

EDIC

AL SECTO

RP

RIV

ATE

HO

SP

ITAL

41P

RIV

ATE

CLIN

IC42

OTH

ER

PR

IVA

TEM

ED

ICA

L SE

CTO

R43

OTH

ER

96

445YE

S. . . . . . . . . . . . . . . . . . . . . . .

1N

O. . . . . . . . . . . . . . . . . . . . . . .

2(S

KIP

TO 457)

DO

N'T K

NO

W. . . . . . . . . . . . . .

8

(SP

EC

IFY)

(SP

EC

IFY)

Where did the check take place?

(SP

EC

IFY)

(SP

EC

IFY)


(NA

ME

)’s health after you left (FAC

ILITY IN

430). Did any health care provider or a

traditional birth attendant check on (N

AM

E)’s health in the tw

o months after

you left (FAC

ILITY IN 430)?

PR

OB

E TO

IDE

NTIFY TH

E TYP

E O

F S

OU

RC

E.

IF UN

AB

LE TO

DE

TER

MIN

E IF P

UB

LIC

OR

PR

IVA

TE S

EC

TOR

, WR

ITE TH

E

NA

ME

OF TH

E P

LAC

E.

(NA

ME

OF P

LAC

E)

W-25

• 415Appendix E

NO

.N

AM

EN

AM

E

LAS

T BIR

TH

QU

ES

TION

S A

ND

FILTER

S SE

CTIO

N 4. P

RE

GN

AN

CY A

ND

PO

STN

ATA

L CA

RE

NE

XT-TO-LA

ST B

IRTH

446H

OU

RS

. . . . . . . . 1

DA

YS. . . . . . . . . . .

2

WE

EK

S. . . . . . . .

3

DO

N'T K

NO

W. . . . . . . . . . . . . . 998

447H

EALTH PER

SON

NEL

DO

CTO

R. . . . . . . . . . . . . . . . .

11N

UR

SE

. . . . . . . . 12

MID

WIFE

. . . . . . . . . . . . . . 13

HE

ALTH

OFFIC

ER

14H

EA

LTH E

XTEN

SIO

N W

OR

KE

R15

OTH

ER PER

SON

TRA

DITIO

NA

L BIR

THA

TTEN

DA

NT

. . . . . . . . . . . 21

OTH

ER

96

448H

OM

EH

ER

HO

ME

. . . . . . . . . . . . . . 11

OTH

ER

HO

ME

. . . . . . . . . . . 12

PUB

LIC SEC

TOR

GO

VE

RN

ME

NT H

OS

PITA

L. .

21G

OV

ER

NM

EN

T HE

ALTH

CE

NTE

R. . . . . . . . . . . . . .

22G

OV

ER

NM

EN

T HE

ALTH

PO

ST

. . . . . . . . . . . . . . 23

OTH

ER

PU

BLIC

SE

CTO

R

26

NG

OHE

ALTH

FAC

ILITY. .

. . . . . 31

OTH

ER

NG

OH

EA

LTH FA

CILITY

36

PRIVATE M

EDIC

AL SECTO

RP

RIV

ATE

HO

SP

ITAL

. . . . . . . . 41

PR

IVA

TE C

LINIC

. . . . . . . . . . . 42

OTH

ER

PR

IVA

TEM

ED

ICA

L SE

CTO

R46

OTH

ER

96

(SK

IP TO

457)

449

YES

. . . . . . . . . . . . . . . . . . . . . . . 1

NO

. . . . . . . . . . . . . . . . . . . . . . . 2

(SK

IP TO

453)

PR

OB

E FO

R M

OS

T QU

ALIFIE

D

(SP

EC

IFY)

(SP

EC

IFY)

Where did this check of (N

AM

E) take

place?

(NA

ME

OF P

LAC

E)

IF LES

S TH

AN

ON

E D

AY,

RE

CO

RD

HO

UR

S;

IF LES

S TH

AN

ON

E W

EE

K,

RE

CO

RD

DA

YS.

Who checked on (N

AM

E)’s health at that

time?

(SP

EC

IFY)

(SP

EC

IFY)

PR

OB

E TO

IDE

NTIFY TH

E TYP

E O

F S

OU

RC

E.

IF UN

AB

LE TO

DE

TER

MIN

E IF P

UB

LIC

OR

PR

IVA

TE S

EC

TOR

, WR

ITE TH

E

NA

ME

OF TH

E P

LAC

E.


your health after delivery, for example,

someone asking you questions about your

health or examining you. D

id anyone check on your health after you gave birth to (N

AM

E)?

(SP

EC

IFY)

How

many hours, days or w

eeks after the birth of (N

AM

E) did that check take place?

W-26

416 •Appendix E

NO

.N

AM

EN

AM

E

LAS

T BIR

TH

QU

ES

TION

S A

ND

FILTER

S SE

CTIO

N 4. P

RE

GN

AN

CY A

ND

PO

STN

ATA

L CA

RE

NE

XT-TO-LA

ST B

IRTH

450H

OU

RS

. . . . . . . . 1

DA

YS. . . . . . . . . . .

2

WE

EK

S. . . . . . . .

3

DO

N'T K

NO

W. . . . . . . . . . . . . . 998

451H

EALTH PER

SON

NEL

DO

CTO

R. . . . . . . . . . . . . . . . .

11N

UR

SE

. . . . . . . . 12

MID

WIFE

. . . . . . . . . . . . . . 13

HE

ALTH

OFFIC

ER

14H

EA

LTH E

XTEN

SIO

N W

OR

KE

R15

OTH

ER PER

SON

TRA

DITIO

NA

L BIR

THA

TTEN

DA

NT

. . . . . . . . . . . 21

OTH

ER

96

452H

OM

EH

ER

HO

ME

. . . . . . . . . . . . . . 11

OTH

ER

HO

ME

. . . . . . . . . . . 12

PUB

LIC SEC

TOR

GO

VE

RN

ME

NT H

OS

PITA

L. .

21G

OV

ER

NM

EN

T HE

ALTH

CE

NTE

R. . . . . . . . . . . . . .

22G

OV

ER

NM

EN

T HE

ALTH

PO

ST

. . . . . . . . . . . . . . 23

OTH

ER

PU

BLIC

SE

CTO

R

26

NG

OHE

ALTH

FAC

ILITY. .

31O

THE

R N

GO

HE

ALTH

FAC

ILITY

36

PRIVATE M

EDIC

AL SECTO

RP

RIV

ATE

HO

SP

ITAL

41P

RIV

ATE

CLIN

IC42

OTH

ER

PR

IVA

TEM

ED

ICA

L SE

CTO

R46

OTH

ER

96

453

YES

. . . . . . . . . . . . . . . . . . . . . . . 1

NO

. . . . . . . . . . . . . . . . . . . . . . . 2

(SK

IP TO

457)D

ON

'T KN

OW

. . . . . . . . . . . . . . 8

PR

OB

E FO

R M

OS

T QU

ALIFIE

D

(SP

EC

IFY)

IF UN

AB

LE TO

DE

TER

MIN

E IF P

UB

LIC

OR

PR

IVA

TE S

EC

TOR

, WR

ITE TH

E

NA

ME

OF TH

E P

LAC

E.

(SP

EC

IFY)

(SP

EC

IFY)

How

long after delivery did the first check take place?

IF LES

S TH

AN

ON

E D

AY,

RE

CO

RD

HO

UR

S;

IF LES

S TH

AN

ON

E W

EE

K,

RE

CO

RD

DA

YS.


(NA

ME

)’s health after delivery – for exam

ple, someone exam

ining (NA

ME

), checking the cord, or seeing if (N

AM

E) is

OK

. In the two m

onths after (NA

ME

) was

born, did any health care provider or a traditional birth attendant check on (N

AM

E)'s health?


e?

PR

OB

E TO

IDE

NTIFY TH

E TYP

E O

F S

OU

RC

E.

(NA

ME

OF P

LAC

E)

(SP

EC

IFY)

(SP

EC

IFY)

Where did this first check take place?

W-27

• 417Appendix E

NO

.N

AM

EN

AM

E

LAS

T BIR

TH

QU

ES

TION

S A

ND

FILTER

S SE

CTIO

N 4. P

RE

GN

AN

CY A

ND

PO

STN

ATA

L CA

RE

NE

XT-TO-LA

ST B

IRTH

454H

OU

RS

AFTE

RB

IRTH

. . . . . 1

DA

YS A

FTER

B

IRTH

. . . . . 2

WE

EK

S A

FTER

BIR

TH. . . . .

3

DO

N'T K

NO

W. . . . . . . . . . . . . . 998

455H

EALTH PER

SON

NEL

DO

CTO

R. . . . . . . . . . . . . . . . .

11N

UR

SE

. . . . . . . . 12

MID

WIFE

. . . . . . . . . . . . . . 13

HE

ALTH

OFFIC

ER

14H

EA

LTH E

XTEN

SIO

N W

OR

KE

R15

OTH

ER PER

SON

TRA

DITIO

NA

L BIR

THA

TTEN

DA

NT

. . . . . . . . . . . 21

OTH

ER

96

456H

OM

EH

ER

HO

ME

. . . . . . . . . . . . . . 11

OTH

ER

HO

ME

. . . . . . . . . . . 12

PUB

LIC SEC

TOR

GO

VE

RN

ME

NT H

OS

PITA

L. .

21G

OV

ER

NM

EN

T HE

ALTH

STA

TION

/. . . . . . . . . . . . . . 22

GO

VE

RN

ME

NT H

EA

LTHP

OS

T. . . . . . . . . . . . . .

23O

THE

R P

UB

LIC S

EC

TOR

26

NG

OHE

ALTH

FAC

ILITY. .

31O

THE

R N

GO

HE

ALTH

FAC

ILITY

36

PRIVATE M

EDIC

AL SECTO

RP

RIV

ATE

HO

SP

ITAL

41P

RIV

ATE

CLIN

IC42

OTH

ER

PR

IVA

TEM

ED

ICA

L SE

CTO

R46

OTH

ER

96

(SP

EC

IFY)

IF LES

S TH

AN

ON

E D

AY,

RE

CO

RD

HO

UR

S;

IF LES

S TH

AN

ON

E W

EE

K,

RE

CO

RD

DA

YS.

PR

OB

E FO

R M

OS

T QU

ALIFIE

D

(SP

EC

IFY)

(SP

EC

IFY)

(SP

EC

IFY)

How

many hours, days or w

eeks after the birth of (N

AM

E) did the first check take

place?

Who checked on (N

AM

E)'s health at that

time?

(SP

EC

IFY)

(NA

ME

OF P

LAC

E)

Where did this first check of (N

AM

E) take

place?

IF UN

AB

LE TO

DE

TER

MIN

E IF P

UB

LIC

OR

PR

IVA

TE S

EC

TOR

, WR

ITE TH

E

NA

ME

OF TH

E P

LAC

E.

PR

OB

E TO

IDE

NTIFY TH

E TYP

E O

F S

OU

RC

E.

W-28

418 •Appendix E

NO

.N

AM

EN

AM

E

LAS

T BIR

TH

QU

ES

TION

S A

ND

FILTER

S SE

CTIO

N 4. P

RE

GN

AN

CY A

ND

PO

STN

ATA

L CA

RE

NE

XT-TO-LA

ST B

IRTH

457

YES

NO

DK

a)a)

CO

RD

. . . . . . . . 1

28

b)b)

TEM

P.

. . . . . 1

28

c)c)

SIG

NS

. . . . . 1

28

d)d)

CO

UN

SE

LB

RE

AS

T-FE

ED

12

8e)

e)O

BS

ER

VE

BR

EA

ST-

FEE

D1

28

458YE

S. . . . . . . . . . . . . . . . . . . . . . .

1(S

KIP

TO 460)

NO

. . . . . . . . . . . . . . . . . . . . . . . 2

(SK

IP TO

461)

459YE

S. . . . . . . . . . . . . . . . . . . . . . .

1N

O. . . . . . . . . . . . . . . . . . . . . . .

2(S

KIP

TO 463)

460M

ON

THS

. . . . . . . . . . . M

ON

THS

. . . . . . . . . . .

DO

N'T K

NO

W. . . . . . . . . . . . . .

98D

ON

'T KN

OW

. . . . . . . . . . . . . . 98

461N

OT

PR

EG

NA

NT

PR

EG

NA

NT

OR

UN

SU

RE

(SK

IP TO

463)

462YE

S. . . . . . . . . . . . . . . . . . . . . . .

1N

O. . . . . . . . . . . . . . . . . . . . . . .

2(S

KIP

TO 464)

463M

ON

THS

. . . . . . . . . . . M

ON

THS

. . . . . . . . . . .

DO

N'T K

NO

W. . . . . . . . . . . . . .

98D

ON

'T KN

OW

. . . . . . . . . . . . . . 98

464YE

S. . . . . . . . . . . . . . . . . . . . . . .

1YE

S. . . . . . . . . . . . . . . . . . . . . . .

1(S

KIP

TO 466)

NO

. . . . . . . . . . . . . . . . . . . . . . . 2

NO

. . . . . . . . . . . . . . . . . . . . . . . 2

465LIV

ING

DE

AD

(SK

IP TO

470)(G

O TO

471)

466

IMM

ED

IATE

LY. . . . . . . . . . . . . . 000

HO

UR

S. . . . . . . .

1

DA

YS. . . . . . . .

2

467YE

S. . . . . . . . . . . . . . . . . . . . . . .

1N

O. . . . . . . . . . . . . . . . . . . . . . .

2

Counsel you on danger signs for

newborns?

Have you had sexual intercourse since the

birth of (NA

ME

)?

How

long after birth did you first put (N

AM

E) to the breast?

In the first three days after delivery, was

(NA

ME

) given anything to drink other than breast m

ilk?

IF LES

S TH

AN

1 HO

UR

,R

EC

OR

D ‘00' H

OU

RS

;IF LE

SS

THA

N 24 H

OU

RS

,R

EC

OR

D H

OU

RS

;O

THE

RW

ISE

, RE

CO

RD

DA

YS.

Did you ever breastfeed (N

AM

E)?

CH

EC

K 226: IS

RE

SP

ON

DE

NT

PR

EG

NA

NT?

CH

EC

K 404: IS

CH

ILD LIV

ING

?

Has your m

enstrual period returned since the birth of (N

AM

E)?

Did your period return betw

een the birth of (N

AM

E) and your next pregnancy?

For how m

any months after the birth of

(NA

ME

) did you not have sexual intercourse?

During the first tw

o days after (NA

ME

)’s birth, did any health care provider do the follow

ing:

Exam

ine the cord?M

easure (NA

ME

)’s temperature?

For how m

any months after the birth of

(NA

ME

) did you not have a period?

Observe (N

AM

E) breastfeeding?

Counsel you on breastfeeding?

W-29

• 419Appendix E

NO

.N

AM

EN

AM

E

LAS

T BIR

TH

QU

ES

TION

S A

ND

FILTER

S SE

CTIO

N 4. P

RE

GN

AN

CY A

ND

PO

STN

ATA

L CA

RE

NE

XT-TO-LA

ST B

IRTH

468LIV

ING

DE

AD

LIVIN

GD

EA

D

(GO

TO 471)

(GO

TO 471)

469YE

S. . . . . . . . . . . . . . . . . . . . . . .

1N

O. . . . . . . . . . . . . . . . . . . . . . .

2

470YE

S. . . . . . . . . . . . . . . . . . . . . . .

1YE

S. . . . . . . . . . . . . . . . . . . . . . .

1N

O. . . . . . . . . . . . . . . . . . . . . . .

2N

O. . . . . . . . . . . . . . . . . . . . . . .

2D

ON

'T KN

OW

. . . . . . . . . . . . . . 8

DO

N'T K

NO

W. . . . . . . . . . . . . .

8

471

Are you still breastfeeding (N

AM

E)?

Did (N

AM

E) drink anything from

a bottle w

ith a nipple yesterday or last night?

GO

BA

CK

TO 405 IN

NE

XT-TO-LA

ST

CO

LUM

N O

F NE

W

QU

ES

TION

NA

IRE

; OR

, IF NO

MO

RE

B

IRTH

S, G

O TO

472.

GO

BA

CK

TO 405 IN

NE

XT CO

LUM

N;

OR

, IF NO

MO

RE

BIR

THS

, GO

TO

472.

CH

EC

K 404: IS

CH

ILD LIV

ING

?

W-30

420 •Appendix E

FISTU

LA

NO

.Q

UE

STIO

NS

AN

D FILTE

RS

CO

DIN

G C

ATE

GO

RIE

SS

KIP

472

YE

S. . . . . . . . . . . . . . . . . . . . . . . .

1474

NO

. . . . . . . . . . . . . . . . . . . . . . . . . . 2

473Y

ES

. . . . . . . . . . . . . . . . . . . . . . . . 1

NO

. . . . . . . . . . . . . . . . . . . . . . . . . . 2

501

474A

FTER

DE

LIVE

RE

D B

AB

Y. . . . . . . . .

1A

FTER

HA

D S

TILLBIR

T. . . . . . . . . . .

2N

EITH

ER

. . . . . . . . . . . . . . . . . . . . . . 3

476

475N

OR

MA

L LAB

OR

/DE

LIVE

RY

. . . . . 1

PR

OLO

NG

ED

AN

D V

ER

Y D

IFFICU

LTLA

BO

R/D

ELIV

ER

Y. . . . . . . . . . . . .

2

476S

EXU

AL A

SS

AU

LT. . . . . . . . . . . . .

1P

ELV

IC S

UR

GE

RY

. . . . . . . . . . . . . 2

OTH

ER

6

DO

N'T K

NO

W. . . . . . . . . . . . . . . . .

8478

477N

UM

BE

R O

F DA

YS

AFTE

RD

ELIV

ER

Y/O

THE

R E

VE

NT

(EN

TER

90 IF 90 DA

YS

OR

MO

RE

)

478Y

ES

. . . . . . . . . . . . . . . . . . . . . . . . 1

480N

O. . . . . . . . . . . . . . . . . . . . . . . . . .

2

479D

O N

OT K

NO

W C

AN

BE

FIXED. . . . . A

DO

NO

T KN

OW

WH

ER

E TO

GO. . . . .

BTO

O E

XPE

NS

IVE

. . . . . . . . . . . . . . . CTO

O FA

R. . . . . . . . . . . . . . . . . . . .

DR

EC

OR

D A

LL ME

NTIO

NE

D.

PO

OR

QU

ALITY

OF C

AR

E. . . . . . .

EC

OU

LD N

OT G

ET P

ER

MIS

SIO

N. . . .F

EM

BA

RR

AS

SM

EN

T. . . . . . . . . . . . . G

PR

OB

LEM

DIS

AP

PE

AR

ED. . . . . . .

H

OTH

ER

X

480H

EA

LTH FA

CILITY

. . . . . . . . . . . . . . . 1

RE

LIGIO

N/TR

AD

ITIO. . . . . . . . . . . . .

2

PR

OB

E A

ND

RE

CO

RD

ALL M

EN

TION

ED

.O

THE

R96

481Y

ES

. . . . . . . . . . . . . . . . . . . . . . . . 1

NO

. . . . . . . . . . . . . . . . . . . . . . . . . . 2

483

482Y

ES

, STO

PP

ED

CO

MP

LETE

LY. . . . .

1N

OT STO

PPED BU

T RED

UC

ED. . . . .

2N

OT S

TOP

PE

D A

T ALL

. . . . . . . . . 3

DID

NO

T RE

CE

IVE

TRE

ATM

E N. . . . . 4

483Y

ES

. . . . . . . . . . . . . . . . . . . . . . .

1N

O. . . . . . . . . . . . . . . . . . . . . . . .

2

Why have you not sought treatm

ent?

From w

hom (W

HE

RE

) did you last seek treatment?

477

What do you think caused this problem

?

How

many days after [C

AU

SE

OF P

RO

BLE

M FR

OM

474 OR

476] did the leakage start?

(SP

EC

IFY)

Have you sought treatm

ent for this condition?

Did this problem

start after a normal labor and delivery, or you

had a prolonged and difficult labor to deliver your baby or had stillbirth?

Som

etimes a w

oman can have a problem

of constant (use continuous) leakage of urine and/or stool from

her vagina during the day and night, in sitting and stading position. This problem

usually occurs after a prolonged and difficult childbirth, but m

ay also occur after a sexual assault, after pelvic surgery, or after other traum

a.

Have you ever experienced a constant (a continuous) leakage

of urine and/or stool from your vagina during the day and night?

Have you ever heard of this problem

?

Did this problem

start after you delivered a baby or had a stillbirth?

Were you suppported by your husband/partner w

hile you expereinced a constant leakage of urine or stool from

you vagina.

(SP

EC

IFY)

(SP

EC

IFY)

Did the treatm

ent stop the leakage completely?

IF NO

: Did the treatm

ent reduce the leakage?

501

Did you have an operation to fix the problem

?

W-31

• 421Appendix E

NO

.

501A

ON

E O

R M

OR

E B

IRTH

S IN

2005-2008N

O B

IRTH

S IN

2005-2008

502A

BIR

TH H

ISTO

RY

NU

MB

ER

. . . . . . . . . .

503A

LIVIN

GD

EA

D

504AY

ES

, HA

S O

NLY

A C

AR

D. . . . . . . . . . . . . . . . . . .

1507A

YE

S, H

AS

ON

LY A

N O

THE

R D

OC

UM

EN

T. . . . .

2Y

ES

, HA

S C

AR

D A

ND

OTH

ER

DO

CU

ME

NT

. . . . . 3

507AN

O, N

O C

AR

D A

ND

NO

OTH

ER

DO

CU

ME

NT

. . 4

505AY

ES

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1

NO

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2

506A

CO

DE

'2' CIR

CLE

DC

OD

E '4' C

IRC

LED

507AY

ES

, ON

LY C

AR

D S

EE

N. . . . . . . . . . . . . . . . . . .

1Y

ES

, ON

LY O

THE

R D

OC

UM

EN

T SE

EN

. . . . . . . 2

YE

S, C

AR

D A

ND

OTH

ER

DO

CU

ME

NT S

EE

N. .

3N

O C

AR

D A

ND

NO

OTH

ER

DO

CU

ME

NT S

EE

N. .

4511A

511A

501B

RE

CO

RD

THE

NA

ME

AN

D B

IRTH

HIS

TOR

Y N

UM

BE

R FR

OM

212 OF TH

E LA

ST C

HILD

BO

RN

IN 2005-2008.

SE

CTIO

N 5A

. CH

ILD IM

MU

NIZA

TION

(LAS

T BIR

TH)

QU

ES

TION

S A

ND

FILTER

SC

OD

ING

CA

TEG

OR

IES

SK

IP

CH

EC

K 215 IN

THE

BIR

TH H

ISTO

RY

: AN

Y B

IRTH

S IN

2005-2008?

CH

EC

K 504A

:

CH

EC

K 216 FO

R C

HILD

:

NA

ME

OF LA

ST B

IRTH

Do you have a card or other docum

ent where (N

AM

E)'s

vaccinations are written dow

n?

Did you ever have a vaccination card for (N

AM

E)?

601

May I see the card or other docum

ent where (N

AM

E)'s


n?

W-32

422 •Appendix E

NO

.

BIR

TH H

ISTO

RY

NU

MB

ER

. . . . . . . . . .

508A

509A

NO

YE

S

510AY

ES

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1

(THE

N S

KIP

TO 525A

)

NO

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2

DO

N'T K

NO

W. . . . . . . . . . . . . . . . . . . . . . . . . . .

8

QU

ES

TION

S A

ND

FILTER

S

OR

AL P

OLIO

VA

CC

INE

(OP

V) 1

OR

AL P

OLIO

VA

CC

INE

(OP

V) 2

DP

T-HE

P.B

-HIB

(PE

NTA

VA

LEN

T) 3

PN

EU

MO

CO

CC

AL 1

(PR

OB

E FO

R V

AC

CIN

ATIO

NS

AN

D W

RITE

‘66' IN

THE

CO

RR

ES

PO

ND

ING

DA

Y C

OLU

MN

IN 508A

)

525A

525A

CH

EC

K 508A

: 'BC

G' TO

'[ME

AS

LES

CO

NTA

ININ

G V

AC

CIN

E] 2' A

LL RE

CO

RD

ED

?

In addition to what is recorded on (this docum

ent/these docum

ents), did (NA

ME

) receive any other vaccinations, including vaccinations received in cam

paigns or imm

unization days or child health days?

ME

AS

LES

VITA

MIN

A (M

OS

T RE

CE

NT)

DP

T-HE

P.B

-HIB

(PE

NTA

VA

LEN

T) 2

WR

ITE ‘44' IN

‘DA

Y' C

OLU

MN

IF CA

RD

SH

OW

S TH

AT A

DO

SE

WA

S G

IVE

N, B

UT N

O D

ATE

IS R

EC

OR

DE

D.

SE

CTIO

N 5A

. CH

ILD IM

MU

NIZA

TION

(LAS

T BIR

TH)

SK

IP

NA

ME

OF LA

ST B

IRTH

CO

PY

DA

TES

FRO

M TH

E C

AR

D.

DA

YM

ON

THY

EA

R

BC

G

PN

EU

MO

CO

CC

AL 2

PN

EU

MO

CO

CC

AL 3

RO

TAV

IRU

S 1

RO

TAV

IRU

S 2

OR

AL P

OLIO

VA

CC

INE

(OP

V) 0 (B

IRTH

DO

SE

)

OR

AL P

OLIO

VA

CC

INE

(OP

V) 3

DP

T-HE

P.B

-HIB

(PE

NTA

VA

LEN

T) 1

RE

CO

RD

'YE

S' O

NLY

IF THE

RE

SP

ON

DE

NT

ME

NTIO

NS

AT LE

AS

T ON

E O

F THE

VA

CC

INA

TION

S

IN 508A

THA

T AR

E N

OT R

EC

OR

DE

D A

S H

AV

ING

B

EE

N G

IVE

N.

CO

DIN

G C

ATE

GO

RIE

S

W-33

• 423Appendix E

NO

.

BIR

TH H

ISTO

RY

NU

MB

ER

. . . . . . . . . .

QU

ES

TION

S A

ND

FILTER

S

SE

CTIO

N 5A

. CH

ILD IM

MU

NIZA

TION

(LAS

T BIR

TH)

SK

IP

NA

ME

OF LA

ST B

IRTH

CO

DIN

G C

ATE

GO

RIE

S

511AY

ES

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1

NO

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2

DO

N'T K

NO

W. . . . . . . . . . . . . . . . . . . . . . . . . . .

8

512AY

ES

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1

NO

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2

DO

N'T K

NO

W. . . . . . . . . . . . . . . . . . . . . . . . . . .

8

514AY

ES

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1

NO

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2

DO

N'T K

NO

W. . . . . . . . . . . . . . . . . . . . . . . . . . .

8

515AFIR

ST TW

O W

EE

KS

. . . . . . . . . . . . . . . . . . . . . 1

LATE

R. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

2

516AN

UM

BE

R O

F TIME

S. . . . . . . . . . . . . . . . . . .

517AY

ES

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1

NO

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2

DO

N'T K

NO

W. . . . . . . . . . . . . . . . . . . . . . . . . . .

8

518AN

UM

BE

R O

F TIME

S. . . . . . . . . . . . . . . . . . .

519AY

ES

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1

NO

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2

DO

N'T K

NO

W. . . . . . . . . . . . . . . . . . . . . . . . . . .

8

520AN

UM

BE

R O

F TIME

S. . . . . . . . . . . . . . . . . . .

521AY

ES

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1

NO

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2

DO

N'T K

NO

W. . . . . . . . . . . . . . . . . . . . . . . . . . .

8

522AN

UM

BE

R O

F TIME

S. . . . . . . . . . . . . . . . . . .

523AY

ES

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1

NO

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2

DO

N'T K

NO

W. . . . . . . . . . . . . . . . . . . . . . . . . . .

8

525AY

ES

NO

DK

a)a)

PLU

MP

Y'N

UT. . . . . . . . . . . . . . . .

12

8

b)b)

PLU

MP

Y'D

OZ

. . . . . . . . . . . . . 1

28

526A

How

many tim

es did (NA

ME

) receive the pentavalent vaccine?

Did (N

AM

E) receive the first oral polio vaccine in the

first two w

eeks after birth or later?

How

many tim

es did (NA

ME

) receive the oral polio vaccine?

Did (N

AM

E) ever receive any vaccinations to prevent

(NA

ME

) from getting diseases, including vaccinations

received in campaigns or im

munization days or child

health days?

Has (N

AM

E) ever received a B

CG

vaccination against tuberculosis, that is, an injection in the arm

or shoulder that usually causes a scar?

Has (N

AM

E) ever received oral polio vaccine, that is,

two drops in the m

outh to prevent polio?

PLU

MP

Y'D

OZ?

Has (N

AM

E) ever received a pentavalent vaccination,

that is, an injection usually given on the left upper thigh som

etimes at the sam

e time as polio drops?

In the last 7 days was (N

AM

E) given:

Has (N

AM

E) ever received a pneum

ococcal vaccination, that is, an injection usually given on the right upper thigh to prevent pneum

onia?

How

many tim

es did (NA

ME

) receive the pneumococcal

vaccine?

Has (N

AM

E) ever received a rotavirus vaccination, that

is, liquid in the mouth to prevent diarrhea?

PLU

MP

Y'N

UT?

How

many tim

es did (NA

ME

) receive the rotavirus vaccine?

Has (N

AM

E) ever received a m

easles vaccination, that is, an injection in the arm

to prevent measles given at 9

months?

517A

525A

519A

521A

523A

CO

NTIN

UE

WITH

501B.

W-34

424 •Appendix E

NO

.

501B

MO

RE

BIR

THS

IN 2005-2008

NO

MO

RE

BIR

THS

IN 2005-2008

502B

BIR

TH H

ISTO

RY

NU

MB

ER

. . . . . . . . . .

503B

LIVIN

GD

EA

D

504BY

ES

, HA

S O

NLY

A C

AR

D. . . . . . . . . . . . . . . . . . .

1507B

YE

S, H

AS

ON

LY A

N O

THE

R D

OC

UM

EN

T. . . . .

2Y

ES

, HA

S C

AR

D A

ND

OTH

ER

DO

CU

ME

NT

. . . . . 3

507BN

O, N

O C

AR

D A

ND

NO

OTH

ER

DO

CU

ME

NT

. . 4

505BY

ES

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1

NO

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2

506B

CO

DE

'2' CIR

CLE

DC

OD

E '4' C

IRC

LED

507BY

ES

, ON

LY C

AR

D S

EE

N. . . . . . . . . . . . . . . . . . .

1Y

ES

, ON

LY O

THE

R D

OC

UM

EN

T SE

EN

. . . . . . . 2

YE

S, C

AR

D A

ND

OTH

ER

DO

CU

ME

NT S

EE

N. .

3N

O C

AR

D A

ND

NO

OTH

ER

DO

CU

ME

NT S

EE

N. .

4511B

601

SE

CTIO

N 5B

. CH

ILD IM

MU

NIZA

TION

(NE

XT-TO-LA

ST B

IRTH

)

QU

ES

TION

S A

ND

FILTER

SC

OD

ING

CA

TEG

OR

IES

SK

IP

CH

EC

K 215 IN

THE

BIR

TH H

ISTO

RY

: AN

Y M

OR

E B

IRTH

S IN

2005-2008?

CH

EC

K 504B

:

RE

CO

RD

THE

NA

ME

AN

D B

IRTH

HIS

TOR

Y N

UM

BE

R FR

OM

212 OF TH

E N

EXT-TO

-LAS

T CH

ILD B

OR

N IN

2005-2008.

526B

Do you have a card or other docum

ent where (N

AM

E)'s


n?

Did you ever have a vaccination card for (N

AM

E)?

NA

ME

OF N

EXT-TO

-LA

ST B

IRTH

CH

EC

K 216 FO

R C

HILD

:

511B

May I see the card or other docum

ent where (N

AM

E)'s


n?

W-35

• 425Appendix E

NO

.

BIR

TH H

ISTO

RY

NU

MB

ER

. . . . . . . . . .

508B

509B

NO

YE

S

510BY

ES

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1

(THE

N S

KIP

TO 525B

)

NO

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2

DO

N'T K

NO

W. . . . . . . . . . . . . . . . . . . . . . . . . . .

8

NA

ME

OF N

EXT-TO

-LA

ST B

IRTH

SE

CTIO

N 5B

. CH

ILD IM

MU

NIZA

TION

(NE

XT-TO-LA

ST B

IRTH

)

QU

ES

TION

S A

ND

FILTER

SC

OD

ING

CA

TEG

OR

IES

SK

IP

OR

AL P

OLIO

VA

CC

INE

(OP

V) 3

CO

PY

DA

TES

FRO

M TH

E C

AR

D.

WR

ITE ‘44' IN

‘DA

Y' C

OLU

MN

IF CA

RD

SH

OW

S TH

AT A

DO

SE

WA

S G

IVE

N, B

UT N

O D

ATE

IS R

EC

OR

DE

D.

DA

YM

ON

THY

EA

R

BC

G

OR

AL P

OLIO

VA

CC

INE

(OP

V) 0 (B

IRTH

DO

SE

)

OR

AL P

OLIO

VA

CC

INE

(OP

V) 1

OR

AL P

OLIO

VA

CC

INE

(OP

V) 2

VITA

MIN

A (M

OS

T RE

CE

NT)

DP

T-HE

P.B

-HIB

(PE

NTA

VA

LEN

T) 1

DP

T-HE

P.B

-HIB

(PE

NTA

VA

LEN

T) 2

DP

T-HE

P.B

-HIB

(PE

NTA

VA

LEN

T) 3

PN

EU

MO

CO

CC

AL 1

PN

EU

MO

CO

CC

AL 2

PN

EU

MO

CO

CC

AL 3

RO

TAV

IRU

S 1

RO

TAV

IRU

S 2

ME

AS

LES

CH

EC

K 508B

: 'BC

G' TO

'[ME

AS

LES

CO

NTA

ININ

G V

AC

CIN

E] 2' A

LL RE

CO

RD

ED

?

525B

In addition to what is recorded on (this docum

ent/these docum

ents), did (NA

ME

) receive any other vaccinations, including vaccinations received in cam

paigns or imm

unization days or child health days?(P

RO

BE

FOR

VA

CC

INA

TION

S A

ND

WR

ITE ‘66' IN

TH

E C

OR

RE

SP

ON

DIN

G D

AY

CO

LUM

N IN

508B)

RE

CO

RD

'YE

S' O

NLY

IF THE

RE

SP

ON

DE

NT

ME

NTIO

NS

AT LE

AS

T ON

E O

F THE

VA

CC

INA

TION

S

IN 508B

THA

T AR

E N

OT R

EC

OR

DE

D A

S H

AV

ING

B

EE

N G

IVE

N.

525B

W-36

426 •Appendix E

NO

.

BIR

TH H

ISTO

RY

NU

MB

ER

. . . . . . . . . . N

AM

E O

F NE

XT-TO-

LAS

T BIR

TH

SE

CTIO

N 5B

. CH

ILD IM

MU

NIZA

TION

(NE

XT-TO-LA

ST B

IRTH

)

QU

ES

TION

S A

ND

FILTER

SC

OD

ING

CA

TEG

OR

IES

SK

IP

511BY

ES

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1

NO

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2

DO

N'T K

NO

W. . . . . . . . . . . . . . . . . . . . . . . . . . .

8

512BY

ES

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1

NO

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2

DO

N'T K

NO

W. . . . . . . . . . . . . . . . . . . . . . . . . . .

8

514BY

ES

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1

NO

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2

DO

N'T K

NO

W. . . . . . . . . . . . . . . . . . . . . . . . . . .

8

515BFIR

ST TW

O W

EE

KS

. . . . . . . . . . . . . . . . . . . . . 1

LATE

R. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

2

516BN

UM

BE

R O

F TIME

S. . . . . . . . . . . . . . . . . . .

517BY

ES

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1

NO

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2

DO

N'T K

NO

W. . . . . . . . . . . . . . . . . . . . . . . . . . .

8

518BN

UM

BE

R O

F TIME

S. . . . . . . . . . . . . . . . . . .

519BY

ES

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1

NO

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2

DO

N'T K

NO

W. . . . . . . . . . . . . . . . . . . . . . . . . . .

8

520BN

UM

BE

R O

F TIME

S. . . . . . . . . . . . . . . . . . .

521BY

ES

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1

NO

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2

DO

N'T K

NO

W. . . . . . . . . . . . . . . . . . . . . . . . . . .

8

522BN

UM

BE

R O

F TIME

S. . . . . . . . . . . . . . . . . . .

523BY

ES

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1

NO

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2

DO

N'T K

NO

W. . . . . . . . . . . . . . . . . . . . . . . . . . .

8

525BY

ES

NO

DK

a)a)

PLU

MP

Y'N

UT

. . . . . . . . . . . . . 1

28

b)b)

PLU

MP

Y'D

OZ

. . . . . . . . . . . . . 1

28

526B

601

Did (N

AM

E) ever receive any vaccinations to prevent

(NA

ME

) from getting diseases, including vaccinations

received in campaigns or im

munization days or child

health days?

525B

Has (N

AM

E) ever received a B

CG

vaccination against tuberculosis, that is, an injection in the arm

or shoulder that usually causes a scar?

Has (N

AM

E) ever received oral polio vaccine, that is,

two drops in the m

outh to prevent polio?517B

523B

How

many tim

es did (NA

ME

) receive the rotavirus vaccine?

Has (N

AM

E) ever received a m

easles vaccination, that is, an injection in the arm

to prevent measles given at

nine months?

Did (N

AM

E) receive the first oral polio vaccine in the

first two w

eeks after birth or later?

How

many tim

es did (NA

ME

) receive the oral polio vaccine?

Has (N

AM

E) ever received a pentavalent vaccination,

that is, an injection usually given on the left upper thigh som

etimes at the sam

e time as polio drops?

519B

How

many tim

es did (NA

ME

) receive the pentavalent vaccine?

Has (N

AM

E) ever received a pneum

ococcal vaccination, that is, an injection usually given on the right upper thigh to prevent pneum

onia?521B

CH

EC

K 215 IN

BIR

TH H

ISTO

RY

: AN

Y M

OR

E B

IRTH

S IN

2005-2008?

MO

RE

BIR

THS

IN

2005-2008N

O M

OR

E B

IRTH

S

IN 2005-2008

(GO

TO 502B

IN A

N

AD

DITIO

NA

L Q

UE

STIO

NN

AIR

E)

How

many tim

es did (NA

ME

) receive the pneumococcal

vaccine?

Has (N

AM

E) ever received a rotavirus vaccination, that

is, liquid in the mouth to prevent diarrhea?

In the last 7 days was (N

AM

E) given:

PLU

MP

Y'N

UT?

PLU

MP

Y'D

OZ?

W-37

• 427Appendix E

601

602

603B

IRTH

BIR

THH

ISTO

RY

HIS

TOR

YN

UM

BE

R. . . . . . . . . .

NU

MB

ER

. . . . . . . . . .

604

LIVIN

GD

EA

DLIV

ING

DE

AD

(SK

IP TO

646)(S

KIP

TO 646)

605Y

ES

. . . . . . . . . . . . . . . . . . . . . 1

YE

S. . . . . . . . . . . . . . . . . . . . .

1N

O. . . . . . . . . . . . . . . . . . . . .

2N

O. . . . . . . . . . . . . . . . . . . . .

2D

ON

'T KN

OW

. . . . . . . . . . . . . 8

DO

N'T K

NO

W. . . . . . . . . . . . .

8

606Y

ES

. . . . . . . . . . . . . . . . . . . . . 1

YE

S. . . . . . . . . . . . . . . . . . . . .

1N

O

. . . . . . . . . . . . . . . . . . . . . 2

NO

. . . . . . . . . . . . . . . . . . . . .

2D

ON

'T KN

OW

. . . . . . . . . . . . . 8

DO

N'T K

NO

W. . . . . . . . . . . . .

8

607Y

ES

. . . . . . . . . . . . . . . . . . . . . 1

YE

S. . . . . . . . . . . . . . . . . . . . .

1N

O

. . . . . . . . . . . . . . . . . . . . . 2

NO

. . . . . . . . . . . . . . . . . . . . .

2D

ON

'T KN

OW

. . . . . . . . . . . . . 8

DO

N'T K

NO

W. . . . . . . . . . . . .

8

608Y

ES

. . . . . . . . . . . . . . . . . . . . . 1

YE

S. . . . . . . . . . . . . . . . . . . . .

1N

O

. . . . . . . . . . . . . . . . . . . . . 2

NO

. . . . . . . . . . . . . . . . . . . . .

2(S

KIP

TO 618)

(SK

IP TO

618)D

ON

'T KN

OW

. . . . . . . . . . . . . 8

DO

N'T K

NO

W. . . . . . . . . . . . .

8

SE

CTIO

N 6. C

HILD

HE

ALTH

AN

D N

UTR

ITION

CH

EC

K 224:

Now


e questions about your children born in the last five years. (We w

ill talk about each separately.)

BIR

TH H

ISTO

RY

NU

MB

ER

FRO

M 212

IN B

IRTH

HIS

TOR

Y.

NA

ME

NA

ME

FRO

M 212 A

ND

216:

CH

EC

K 215: R

EC

OR

D TH

E B

IRTH

HIS

TOR

Y N

UM

BE

R IN

603 AN

D TH

E N

AM

E A

ND

SU

RV

IVA

L STA

TUS

IN 604 FO

R E

AC

H

BIR

TH IN

2003-2008. AS

K TH

E Q

UE

STIO

NS

AB

OU

T ALL O

F THE

SE

BIR

THS

. BE

GIN

WITH

THE

LAS

T BIR

TH.

IF THE

RE

AR

E M

OR

E TH

AN

2 BIR

THS

, US

E LA

ST C

OLU

MN

OF A

DD

ITION

AL Q

UE

STIO

NN

AIR

E(S

).

NE

XT-TO-LA

ST B

IRTH

LAS

T BIR

TH

ON

E O

R M

OR

E B

IRTH

S

IN 2003-2008

NO

BIR

THS

IN

2003-2008648

Has (N

AM

E) had diarrhea in the last 2

weeks?

SH

OW

CO

MM

ON

TYP

ES

OF

AM

PU

LES

/CA

PS

ULE

S/S

YR

UP

S.

In the last six months, w

as (NA

ME

) given a vitam

in A dose like [this/any of these]?

In the last seven days, was (N

AM

E) given

iron pills, sprinkles with iron, or iron syrup

like [this/any of these]?

Was (N

AM

E) given any drug for intestinal

worm

s in the last six months?

SH

OW

CO

MM

ON

TYP

ES

OF

PILLS

/SP

RIN

KLE

S/S

YR

UP

S.

W-38

428 •Appendix E

NO

.

609

YE

SN

O

a)b)

MU

CH

LES

S. . . . . . . . . . . . . . . .

1M

UC

H LE

SS

. . . . . . . . . . . . . . . . 1

SO

ME

WH

AT LE

SS

. . . . . . . . . . 2

SO

ME

WH

AT LE

SS

. . . . . . . . . . 2

AB

OU

T THE

SA

ME

. . . . . . . . . . 3

AB

OU

T THE

SA

ME

. . . . . . . . . . 3

MO

RE

. . . . . . . . . . . . . . . . . . . 4

MO

RE

. . . . . . . . . . . . . . . . . . . 4

NO

THIN

G TO

DR

INK

. . . . . . . 5

NO

THIN

G TO

DR

INK

. . . . . . . 5

DO

N'T K

NO

W. . . . . . . . . . . . .

8D

ON

'T KN

OW

. . . . . . . . . . . . . 8

610M

UC

H LE

SS

. . . . . . . . . . . . . . . . 1

MU

CH

LES

S. . . . . . . . . . . . . . . .

1S

OM

EW

HA

T LES

S. . . . . . . . . .

2S

OM

EW

HA

T LES

S. . . . . . . . . .

2A

BO

UT TH

E S

AM

E. . . . . . . . . .

3A

BO

UT TH

E S

AM

E. . . . . . . . . .

3M

OR

E. . . . . . . . . . . . . . . . . . .

4M

OR

E. . . . . . . . . . . . . . . . . . .

4S

TOP

PE

D FO

OD

. . . . . . . . . . 5

STO

PP

ED

FOO

D. . . . . . . . . .

5N

EV

ER

GA

VE

FOO

D. . . . . . .

6N

EV

ER

GA

VE

FOO

D. . . . . . .

6D

ON

'T KN

OW

. . . . . . . . . . . . . 8

DO

N'T K

NO

W. . . . . . . . . . . . .

8

611Y

ES

. . . . . . . . . . . . . . . . . . . . . 1

YE

S. . . . . . . . . . . . . . . . . . . . .

1N

O

. . . . . . . . . . . . . . . . . . . . . 2

NO

. . . . . . . . . . . . . . . . . . . . .

2(S

KIP

TO 615)

(SK

IP TO

615)

CH

EC

K 464: E

VE

R B

RE

AS

TFED

?

Now

I would like

to know how

m

uch (NA

ME

) w

as given to drink during the diarrhea including breastm

ilk. Was

(NA

ME

) given less than usual to drink, about the sam

e am

ount, or more

than usual to drink?

IF LES

S,

PR

OB

E: W

as (N

AM

E) given

much less than

usual to drink or som

ewhat less?

Now

I would like

to know how

m

uch (NA

ME

) w

as given to drink during the diarrhea. W

as (N

AM

E) given

less than usual to drink, about the sam

e am

ount, or more

than usual to drink?

IF LES

S,

PR

OB

E: W

as (N

AM

E) given

much less than

usual to drink or som

ewhat less?

When (N

AM

E) had diarrhea, w

as (NA

ME

) given less than usual to eat, about the sam

e amount, m

ore than usual, or nothing to eat?

IF LES

S, P

RO

BE

: Was (N

AM

E) given

much less than usual to eat or som

ewhat

less?

Did you seek advice or treatm

ent for the diarrhea from

any source?

NA

ME

QU

ES

TION

S A

ND

FILTER

S

SE

CTIO

N 6. C

HILD

HE

ALTH

AN

D N

UTR

ITION

NE

XT-TO-LA

ST B

IRTH

LAS

T BIR

TH

NA

ME

W-39

• 429Appendix E

NO

.N

AM

EQ

UE

STIO

NS

AN

D FILTE

RS

SE

CTIO

N 6. C

HILD

HE

ALTH

AN

D N

UTR

ITION

NE

XT-TO-LA

ST B

IRTH

LAS

T BIR

TH

NA

ME

612PU

BLIC

SECTO

RPU

BLIC

SECTO

RG

OV

ER

NM

EN

T HO

SP

ITAL

. . A

GO

VE

RN

ME

NT H

OS

PITA

L. .

AG

OV

ER

NM

EN

T HE

ALTH

GO

VE

RN

ME

NT H

EA

LTHC

EN

TER

. . . . . . . . . . . . . B

CE

NTE

R. . . . . . . . . . . . .

BG

OV

ER

NM

EN

T HE

ALTH

GO

VE

RN

ME

NT H

EA

LTHP

OS

T. . . . . . . . . . . . .

CP

OS

T. . . . . . . . . . . . .

CO

THE

R P

UB

LIC S

EC

TOR

OTH

ER

PU

BLIC

SE

CTO

R

DD

NG

ON

GO

HE

ALTH

FAC

ILITY. . . . . . .

EH

EA

LTH FA

CILITY

. . . . . . . E

OTH

ER

NG

OO

THE

R N

GO

HE

ALTH

FAC

ILITYH

EA

LTH FA

CILITY

FF

PRIVA

TE MED

ICA

L SECTO

RPR

IVATE M

EDIC

AL SEC

TOR

PR

IVA

TE H

OS

PITA

L . . . . . . . G

PR

IVA

TE H

OS

PITA

L . . . . . . . G

PR

IVA

TE C

LINI C

. . . . . . . . . . H

PR

IVA

TE C

LINI C

. . . . . . . . . . H

OTH

ER

PR

IVA

TEO

THE

R P

RIV

ATE

ME

DIC

AL S

EC

TOR

ME

DIC

AL S

EC

TOR

II

OTH

ER SO

UR

CE

OTH

ER SO

UR

CE

SH

OP

/DR

UG

VE

ND

OR

. . . . . J

SH

OP

/DR

UG

VE

ND

OR

. . . . . J

TRA

DITIO

NA

LTR

AD

ITION

AL

PR

AC

TITION

ER

. . . . . . . K

PR

AC

TITION

ER

. . . . . . . K

MA

RK

ET

. . . . . . . . . . . . . . . . L

MA

RK

ET

. . . . . . . . . . . . . . . . L

OTH

ER

XO

THE

RX

613TW

O O

RO

NLY

TWO

OR

ON

LYM

OR

EO

NE

MO

RE

ON

EC

OD

ES

CO

DE

CO

DE

SC

OD

EC

IRC

LED

CIR

CLE

DC

IRC

LED

CIR

CLE

D

(SK

IP TO

615)(S

KIP

TO 615)

614

FIRS

T PLA

CE

. . . . . . . . . . FIR

ST P

LAC

E. . . . . . . . . .

US

E LE

TTER

CO

DE

FRO

M 612.

Where did you first seek advice or

treatment?

CH

EC

K 612:

Where did you seek advice or treatm

ent?

Anyw

here else?

(SP

EC

IFY)

(SP

EC

IFY)

(SP

EC

IFY)

(SP

EC

IFY)

(SP

EC

IFY)

(SP

EC

IFY)

(SP

EC

IFY)

(SP

EC

IFY)

PR

OB

E TO

IDE

NTIFY

THE

TYP

E O

F S

OU

RC

E.

IF UN

AB

LE TO

DE

TER

MIN

E IF P

UB

LIC

OR

PR

IVA

TE S

EC

TOR

, WR

ITE TH

E

NA

ME

OF TH

E P

LAC

E(S

).

(NA

ME

OF P

LAC

E(S

))

W-40

430 •Appendix E

NO

.N

AM

EQ

UE

STIO

NS

AN

D FILTE

RS

SE

CTIO

N 6. C

HILD

HE

ALTH

AN

D N

UTR

ITION

NE

XT-TO-LA

ST B

IRTH

LAS

T BIR

TH

NA

ME

615

YE

SN

OD

KY

ES

NO

DK

a)a)

FLUID

FRO

Ma)

FLUID

FRO

MO

RS

OR

SP

AC

KE

T. .

12

8P

AC

KE

T. .

12

8b)

b)H

OM

EM

AD

Eb)

HO

ME

MA

DE

FLUID

. . . . . 1

28

FLUID

. . . . . 1

28

c)c)

ZINC

. . . . . . . 1

28

c)ZIN

C. . . . . . .

12

8

616

AN

Y 'Y

ES

'A

LL 'NO

'O

R 'D

K'

a)b)

YE

S. . . . . . . . . . . . . . . . . . . . .

1Y

ES

. . . . . . . . . . . . . . . . . . . . . 1

NO

. . . . . . . . . . . . . . . . . . . . .

2N

O

. . . . . . . . . . . . . . . . . . . . . 2

(SK

IP TO

618)(S

KIP

TO 618)

DO

N'T K

NO

W. . . . . . . . . . . . .

8D

ON

'T KN

OW

. . . . . . . . . . . . . 8

617PILL O

R SYR

UP

PILL OR

SYRU

PA

NTIB

IOTIC

. . . . . . . . . . . . . A

AN

TIBIO

TIC. . . . . . . . . . . . .

AA

NY

'YE

S'

ALL 'N

O'

AN

TIMO

TILITY. . . . . . . . . .

BA

NTIM

OTILITY

. . . . . . . . . . B

OR

'DK

'O

THE

R (N

OT A

NTIB

IOTIC

OTH

ER

(NO

T AN

TIBIO

TICa)

b)O

R A

NTIM

OTILITY

). . . . .

CO

R A

NTIM

OTILITY

). . . . .

CU

NK

NO

WN

PILL

UN

KN

OW

N P

ILLO

R S

YR

UP

. . . . . . . . . . D

OR

SY

RU

P. . . . . . . . . .

D

INJEC

TION

INJEC

TION

AN

TIBIO

TIC. . . . . . . . . . . . .

EA

NTIB

IOTIC

. . . . . . . . . . . . . E

NO

N-A

NTIB

IOTIC

. . . . . . . F

NO

N-A

NTIB

IOTIC

. . . . . . . F

UN

KN

OW

NU

NK

NO

WN

INJE

CTIO

N. . . . . . . . . .

GIN

JEC

TION

. . . . . . . . . . G

(IV) IN

TRA

VE

NO

US

. . . . . . . . . . H

(IV) IN

TRA

VE

NO

US

. . . . . . . . . . H

HO

ME

RE

ME

DY

/H

OM

E R

EM

ED

Y/

HE

RB

AL M

ED

ICIN

E. . . . . . .

IH

ER

BA

L ME

DIC

INE

. . . . . . . I

OTH

ER

XO

THE

RX

618Y

ES

. . . . . . . . . . . . . . . . . . . . . 1

YE

S. . . . . . . . . . . . . . . . . . . . .

1N

O

. . . . . . . . . . . . . . . . . . . . . 2

NO

. . . . . . . . . . . . . . . . . . . . .

2D

ON

'T KN

OW

. . . . . . . . . . . . . 8

DO

N'T K

NO

W. . . . . . . . . . . . .

8

620Y

ES

. . . . . . . . . . . . . . . . . . . . . 1

YE

S. . . . . . . . . . . . . . . . . . . . .

1N

O

. . . . . . . . . . . . . . . . . . . . . 2

NO

. . . . . . . . . . . . . . . . . . . . .

2D

ON

'T KN

OW

. . . . . . . . . . . . . 8

DO

N'T K

NO

W. . . . . . . . . . . . .

8

621Y

ES

. . . . . . . . . . . . . . . . . . . . . 1

YE

S. . . . . . . . . . . . . . . . . . . . .

1N

O

. . . . . . . . . . . . . . . . . . . . . 2

NO

. . . . . . . . . . . . . . . . . . . . .

2(S

KIP

TO 623)

(SK

IP TO

623)D

ON

'T KN

OW

. . . . . . . . . . . . . 8

DO

N'T K

NO

W. . . . . . . . . . . . .

8

Was anything

given to treat the diarrhea?

Zinc tablets or syrup?

Has (N

AM

E) been ill w

ith a fever at any tim

e in the last 2 weeks?

A governm

ent-recomm

ended hom

emade fluid?

RE

CO

RD

ALL TR

EA

TME

NTS

GIV

EN

.

What w

as given to treat the diarrhea?

Anything else?

What else w

as given to treat the diarrhea?

Anything else?

(SP

EC

IFY)

(SP

EC

IFY)

Was anything

else given to treat the diarrhea?

CH

EC

K 615:

CH

EC

K 615:

Was (N

AM

E) given any of the follow

ing at any tim

e since (NA

ME

) started having the diarrhea:

A fluid m

ade from a special packet

called LEM

LEM

?

Has (N

AM

E) had an illness w

ith a cough at any tim

e in the last 2 weeks?

Has (N

AM

E) had fast, short, rapid

breaths or difficulty breathing at any time

in the last 2 weeks?

W-41

• 431Appendix E

NO

.N

AM

EQ

UE

STIO

NS

AN

D FILTE

RS

SE

CTIO

N 6. C

HILD

HE

ALTH

AN

D N

UTR

ITION

NE

XT-TO-LA

ST B

IRTH

LAS

T BIR

TH

NA

ME

622C

HE

ST O

NLY

. . . . . . . . . . . . .1

CH

ES

T ON

LY . . . . . . . . . . . . .

1N

OS

E O

NLY

. . . . . . . . . . . . . . . .2

NO

SE

ON

LY . . . . . . . . . . . . . . . .

2B

OTH

. . . . . . . . . . . . . . . . . . . 3

BO

TH. . . . . . . . . . . . . . . . . . .

3

OTH

ER

6O

THE

R6

DO

N'T K

NO

W. . . . . . . . . . . . .

8D

ON

'T KN

OW

. . . . . . . . . . . . . 8

(SK

IP TO

624)(S

KIP

TO 624)

623Y

ES

NO

OR

DK

YE

SN

O O

R D

K

(SK

IP TO

646)(S

KIP

TO 646)

624Y

ES

. . . . . . . . . . . . . . . . . . . . . 1

YE

S. . . . . . . . . . . . . . . . . . . . .

1N

O

. . . . . . . . . . . . . . . . . . . . . 2

NO

. . . . . . . . . . . . . . . . . . . . .

2(S

KIP

TO 629)

(SK

IP TO

629)

625PU

BLIC

SECTO

RPU

BLIC

SECTO

RG

OV

ER

NM

EN

T HO

SP

ITAL

. . A

GO

VE

RN

ME

NT H

OS

PITA

L. .

AG

OV

ER

NM

EN

T HE

ALTH

GO

VE

RN

ME

NT H

EA

LTHC

EN

TER

. . . . . . . . . . . . . B

CE

NTE

R. . . . . . . . . . . . .

BG

OV

ER

NM

EN

T HE

ALTH

GO

VE

RN

ME

NT H

EA

LTHP

OS

T. . . . . . . . . . . . .

CP

OS

T. . . . . . . . . . . . .

CO

THE

R P

UB

LIC S

EC

TOR

OTH

ER

PU

BLIC

SE

CTO

R

DD

NG

ON

GO

HE

ALTH

FAC

ILITY. .

EH

EA

LTH FA

CILITY

. . E

OTH

ER

NG

OO

THE

R N

GO

HE

ALTH

FAC

ILITYH

EA

LTH FA

CILITY

FF

PRIVA

TE MED

ICA

L SECTO

RPR

IVATE M

EDIC

AL SEC

TOR

PR

IVA

TE H

OS

PITA

LG

PR

IVA

TE H

OS

PITA

LG

PR

IVA

TE C

LINIC

HP

RIV

ATE

CLIN

ICH

OTH

ER

PR

IVA

TEO

THE

R P

RIV

ATE

ME

DIC

AL S

EC

TOR

ME

DIC

AL S

EC

TOR

II

OTH

ER SO

UR

CE

OTH

ER SO

UR

CE

SH

OP

/DR

UG

VE

ND

OR

. . . . . J

SH

OP

/DR

UG

VE

ND

OR

. . . . . J

TRA

DITIO

NA

LTR

AD

ITION

AL

PR

AC

TITION

ER

. . . . . . . K

PR

AC

TITION

ER

. . . . . . . K

MA

RK

ET

. . . . . . . . . . . . . . . . L

MA

RK

ET

. . . . . . . . . . . . . . . . L

OTH

ER

XO

THE

RX

626TW

O O

RO

NLY

TWO

OR

ON

LYM

OR

EO

NE

MO

RE

ON

EC

OD

ES

CO

DE

CO

DE

SC

OD

EC

IRC

LED

CIR

CLE

DC

IRC

LED

CIR

CLE

D

(SK

IP TO

628)(S

KIP

TO 628)

IF UN

AB

LE TO

DE

TER

MIN

E IF P

UB

LIC

OR

PR

IVA

TE S

EC

TOR

, WR

ITE TH

E

NA

ME

OF TH

E P

LAC

E(S

).

Where did you seek advice or treatm

ent?

Anyw

here else?

PR

OB

E TO

IDE

NTIFY

THE

TYP

E O

F S

OU

RC

E.

Was the fast or difficult breathing due to a

problem in the chest or to a blocked or

runny nose?

CH

EC

K 618: H

AD

FEV

ER

?

(SP

EC

IFY)

(SP

EC

IFY)

(SP

EC

IFY)

(SP

EC

IFY)

(SP

EC

IFY)

(SP

EC

IFY)

(SP

EC

IFY)

(SP

EC

IFY)

(SP

EC

IFY)

(SP

EC

IFY)

Did you seek advice or treatm

ent for the illness from

any source?

(NA

ME

OF P

LAC

E(S

))

CH

EC

K 625:

W-42

432 •Appendix E

NO

.N

AM

EQ

UE

STIO

NS

AN

D FILTE

RS

SE

CTIO

N 6. C

HILD

HE

ALTH

AN

D N

UTR

ITION

NE

XT-TO-LA

ST B

IRTH

LAS

T BIR

TH

NA

ME

627

FIRS

T PLA

CE

. . . . . . . . . . FIR

ST P

LAC

E. . . . . . . . . .

628

DA

YS

. . . . . . . . . . D

AY

S. . . . . . . . . .

629Y

ES

. . . . . . . . . . . . . . . . . . . . . 1

YE

S. . . . . . . . . . . . . . . . . . . . .

1N

O

. . . . . . . . . . . . . . . . . . . . . 2

NO

. . . . . . . . . . . . . . . . . . . . .

2(S

KIP

TO 646)

(SK

IP TO

646)D

ON

'T KN

OW

. . . . . . . . . . . . . 8

DO

N'T K

NO

W. . . . . . . . . . . . .

8

630A

NTIM

ALA

RIA

L DR

UG

SA

NTIM

ALA

RIA

L DR

UG

SA

RTE

MIS

ININ

AR

TEM

ISIN

INC

OM

BIN

ATIO

NC

OM

BIN

ATIO

NTH

ER

AP

Y (A

CT)

. . . . . A

THE

RA

PY

(AC

T). . . . .

AS

P/FA

NS

IDA

R. . . . . . . . . .

BS

P/FA

NS

IDA

R. . . . . . . . . .

BC

HLO

RO

QU

INE

. . . . . . . . . . C

CH

LOR

OQ

UIN

E. . . . . . . . . .

CA

MO

DIA

QU

INE

. . . . . . . . . . D

AM

OD

IAQ

UIN

E. . . . . . . . . .

DQ

UIN

INE

QU

ININ

EP

ILLS. . . . . . . . . . . . . . . .

EP

ILLS. . . . . . . . . . . . . . . .

EIN

JEC

TION

/IV. . . . . . .

FIN

JEC

TION

/IV. . . . . . .

FA

RTE

SU

NA

TEA

RTE

SU

NA

TER

EC

TAL

. . . . . . . . . . . . . G

RE

CTA

L. . . . . . . . . . . . .

GIN

JEC

TION

/IV. . . . . . .

HIN

JEC

TION

/IV. . . . . . .

H

OTH

ER

AN

TIMA

LAR

IAL

OTH

ER

AN

TIMA

LAR

IAL

II

AN

TIBIO

TIC D

RU

GS

AN

TIBIO

TIC D

RU

GS

PILL/S

YR

UP

. . . . . . . . . . . . . J

PILL/S

YR

UP

. . . . . . . . . . . . . J

INJE

CTIO

N/IV

. . . . . . . . . . K

INJE

CTIO

N/IV

. . . . . . . . . . K

OTH

ER D

RU

GS

OTH

ER D

RU

GS

AS

PIR

IN. . . . . . . . . . . . . . . .

LA

SP

IRIN

. . . . . . . . . . . . . . . . L

AC

ETA

MIN

OP

HE

N. . . . . . .

MA

CE

TAM

INO

PH

EN

. . . . . . . M

IBU

PR

OFE

N. . . . . . . . . . . . .

NIB

UP

RO

FEN

. . . . . . . . . . . . . N

OTH

ER

XO

THE

RX

DO

N'T K

NO

W. . . . . . . . . . . . .

ZD

ON

'T KN

OW

. . . . . . . . . . . . . Z

646G

O TO

604 IN N

EXT-TO

-LAS

T C

OLU

MN

OF N

EW

Q

UE

STIO

NN

AIR

E; O

R, IF N

O M

OR

E

BIR

THS

, GO

TO 647.

(SP

EC

IFY)

(SP

EC

IFY)

(SP

EC

IFY)

(SP

EC

IFY)

GO

BA

CK

TO 604 IN

NE

XT C

OLU

MN

; OR

, IF NO

MO

RE

B

IRTH

S, G

O TO

647.

Where did you first seek advice or

treatment?

RE

CO

RD

ALL M

EN

TION

ED

.

What drugs did (N

AM

E) take?

Any other drugs?

IF THE

SA

ME

DA

Y R

EC

OR

D ‘00’.

How

many days after the illness began

did you first seek advice or treatment for

(NA

ME

)?

At any tim

e during the illness, did (NA

ME

) take any drugs for the illness?

US

E LE

TTER

CO

DE

FRO

M 625.

W-43

• 433Appendix E

NO

.

647

NO

CH

ILDA

NY

CH

ILDR

EC

EIV

ED

FLUID

RE

CE

IVE

D FLU

ID649

FRO

M O

RS

PA

CK

ET

FRO

M O

RS

PA

CK

ET

648Y

ES

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1

NO

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2

649

ON

E O

R M

OR

EN

ON

E

CH

EC

K 215 A

ND

218, ALL R

OW

S: N

UM

BE

R O

F CH

ILDR

EN

BO

RN

IN 2006-2008 LIV

ING

WITH

THE

R

ES

PO

ND

EN

T

SE

CTIO

N 6. C

HILD

HE

ALTH

AN

D N

UTR

ITION

Have you ever heard of a special product called

LEM

LEM

OR

PR

E-P

AC

KA

GE

D O

RS

LIQU

ID] you can

get for the treatment of diarrhea?

CH

EC

K 615(a), A

LL CO

LUM

NS

:

QU

ES

TION

S A

ND

FILTER

SS

KIP

CO

DIN

G C

ATE

GO

RIE

S

(NA

ME

OF Y

OU

NG

ES

T CH

ILD LIV

ING

WITH

HE

R)

701

W-44

434 •Appendix E

NO

.

SE

CTIO

N 6. C

HILD

HE

ALTH

AN

D N

UTR

ITION

QU

ES

TION

S A

ND

FILTER

SS

KIP

CO

DIN

G C

ATE

GO

RIE

S

650

YE

SN

OD

K

a)a)

. . . . . . . . . . . . . 1

28

b)b)

. . . . . . . . . . . . . 1

28

c)c)

. . . . . . . . . . . . . 1

28

d)d)

. . . . . . . . . . . . . 1

28

e)e)

. . . . . . . . . . . . . 1

28

f)f)

. . . . . . . . . . . . . 1

28

g)g)

. . . . . . . . . . . . . 1

28

h)h)

. . . . . . . . . . . . . 1

28

i)i)

. . . . . . . . . . . . . 1

28

j)j)

. . . . . . . . . . . . . 1

28

k)k)

. . . . . . . . . . . . . 1

28

l)l)

. . . . . . . . . . . . . 1

28

m)

m)

. . . . . . . . . . . . . 1

28

n)n)

. . . . . . . . . . . . . 1

28

o)o)

. . . . . . . . . . . . . 1

28

p)p)

. . . . . . . . . . . . . 1

28

q)q)

. . . . . . . . . . . . . 1

28

r)r)

. . . . . . . . . . . . . 1

28

s)s)

. . . . . . . . . . . . . 1

28

t)t)

. . . . . . . . . . . . . 1

28

u)u)

. . . . . . . . . . . . . 1

28

651

NO

T A S

ING

LE 'Y

ES

'A

T LEA

ST O

NE

'YE

S'

653

Any foods m

ade from beans, peas, lentils, or nuts?

Cheese or other food m

ade from m

ilk?

Any other solid, sem

i-solid, or soft food?

Now

I would like to ask you about liquids or foods that

(NA

ME

FRO

M 649) had yesterday during the day or at

night. I am interested in w

hether your child had the item

I mention even if it w

as combined w

ith other foods.D

id (NA

ME

FRO

M 649) drink or eat:

Plain w

ater?

Juice or juice drinks?

Clear broth?

Any com

mercially fortified baby food like Fafa,

Hilina, C

erilak, Cerifam

, Mother C

hoice?

Injera, bread, rice, noodles, porridge, or other foods m

ade from grains such as tef, oats, m

aize, barley,

Infant formula such as P

lan, S-26?

IF YE

S: H

ow m

any times did (N

AM

E) drink infant

formula?

Milk such as tinned, pow

dered, or fresh animal m

ilk?IF Y

ES

: How

many tim

es did (NA

ME

) drink milk?

IF 7 OR

MO

RE

TIME

S, R

EC

OR

D '7'.

Any m

eat, such as beef, pork, lamb, goat, chicken,

or duck?

NU

MB

ER

OF

TIME

S D

RA

NK

NU

MB

ER

OF

TIME

S D

RA

NK

NU

MB

ER

OF

TIME

S A

TE

CH

EC

K 650 (C

ATE

GO

RIE

S 'g' TH

RO

UG

H 'u'):

Ripe m

angoes, papayas?

Any other fruits or vegetables?

Any dark green, leafy vegetables like kale, spinach,

Pum

pkin, carrots, squash, or sweet potatoes that

are yellow or orange inside?

IF 7 OR

MO

RE

TIME

S, R

EC

OR

D '7'.

Any other liquids?

Fresh or dried fish or shellfish?

White potatoes, w

hite yams, bulla, kocho, m

anioc, cassava, or any other foods m

ade from roots?

Yogurt?

IF YE

S: H

ow m

any times did (N

AM

E) eat yogurt?

IF 7 OR

MO

RE

TIME

S, R

EC

OR

D '7'.

Liver, kidney, heart, or other organ meats?

Eggs?

W-45

• 435Appendix E

NO

.

SE

CTIO

N 6. C

HILD

HE

ALTH

AN

D N

UTR

ITION

QU

ES

TION

S A

ND

FILTER

SS

KIP

CO

DIN

G C

ATE

GO

RIE

S

652Y

ES

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1

(THE

N C

ON

TINU

E TO

653)

NO

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2

654

653N

UM

BE

R O

F TIME

S. . . . . . . . . . . . . . . . . . .

DO

N'T K

NO

W. . . . . . . . . . . . . . . . . . . . . . . . . . .

8

654C

HILD

US

ED

TOILE

T OR

LATR

INE

. . . . . . . . . . 01

PU

T/RIN

SE

DIN

TO TO

ILET O

R LA

TRIN

E. . . . . . . . . . . . . . . .

02P

UT/R

INS

ED

INTO

DR

AIN

OR

DITC

H. . . . . . . . . . . . . . . .

03TH

RO

WN

INTO

GA

RB

AG

E. . . . . . . . . . . . . . . . . . . 04

BU

RIE

D. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

05LE

FT IN TH

E O

PE

N. . . . . . . . . . . . . . . . . . . . . . . .

06

OTH

ER

96(S

PE

CIFY

)

The last time (N

AM

E FR

OM

649) passed stools, what

was done to dispose of the stools?

IF 7 OR

MO

RE

TIME

S, R

EC

OR

D ‘7'.

How

many tim

es did (NA

ME

FRO

M 649) eat solid, sem

i-solid, or soft foods yesterday during the day or at night?

Did (N

AM

E FR

OM

649) eat any solid, semi-solid, or soft

foods yesterday during the day or at night?

IF ‘YE

S’ P

RO

BE

: What kind of solid, sem

i-solid or soft foods did (N

AM

E) eat?

(GO

BA

CK

TO 650 TO

RE

CO

RD

FO

OD

EA

TEN

YE

STE

RD

AY

)

W-46

436 •Appendix E

NO

.

701YES, C

UR

REN

TLY MA

RR

IED

. . . . . . . . . . . . . . . . 1

YE

S, LIV

ING

WITH

A M

AN

. . . . . . . . . . . . . . . . . . . 2

NO

, NO

T IN U

NIO

N. . . . . . . . . . . . . . . . . . . . . . . .

3

702Y

ES

, FOR

ME

RLY

MA

RR

IED

. . . . . . . . . . . . . . . . 1

YE

S, LIV

ED

WITH

A M

AN

. . . . . . . . . . . . . . . . . . . 2

NO

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 3

712

703W

IDO

WE

D. . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

1D

IVO

RC

ED

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2

709S

EP

AR

ATE

D. . . . . . . . . . . . . . . . . . . . . . . . . . .

3

704LIV

ING

WITH

HE

R. . . . . . . . . . . . . . . . . . . . . . . .

1S

TAY

ING

ELS

EW

HE

RE

. . . . . . . . . . . . . . . . . . . 2

705N

AM

E

LINE

NO

.. . . . . . . . . . . . . . . . . . . . . . . .

706Y

ES

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1

NO

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2

DO

N'T K

NO

W. . . . . . . . . . . . . . . . . . . . . . . . . . .

8

707TO

TAL N

UM

BE

R O

F WIV

ES

A

ND

LIVE

-IN P

AR

TNE

RS

. . . . . . .

DO

N'T K

NO

W. . . . . . . . . . . . . . . . . . . . . . . . . . .

98

708R

AN

K. . . . . . . . . . . . . . . . . . . . . . . .

709O

NLY

ON

CE

. . . . . . . . . . . . . . . . . . . . . . . . . . . 1

MO

RE

THA

N O

NC

E. . . . . . . . . . . . . . . . . . . . .

2

710

MA

RR

IED

/M

AR

RIE

D/

LIVE

D W

ITH A

LIVE

D W

ITH A

MA

NM

AN

MO

RE

MO

NTH

. . . . . . . . . . . . . . . . . . . . . . . . O

NLY

ON

CE

THA

N O

NC

E

a)b)

DO

N'T K

NO

W M

ON

TH. . . . . . . . . . . . . . . . . . . 98

YE

AR

. . . . . . . . . . . . .

DO

N'T K

NO

W Y

EA

R. . . . . . . . . . . . . . . . . . .

9998

711A

GE

. . . . . . . . . . . . . . . . . . . . . . . . . . .

711AM

YS

ELF

. . . .

. . . .

. . . .

. . . .

. . . .

. . . .

1P

AR

EN

TS. .

. . . .

. . . .

. . . .

. . . .

. . . .

2O

THE

R FA

MILY

/RE

LATIV

ES

. . . .

. . . .

. . . .

3

OTH

ER

6

711BY

ES

. . . . . . . . . . . . . . . . . . . . . . . . . . . 1

NO

. . . . . . . . . . . . . . . . . . . . . 2

712

711A

How

old were you w

hen you first started living with him

?

Were you attending school before your m

arriage?

The first time you got m

arried who decide on your

marriage?

(SP

EC

IFY)

Including yourself, in total, how m

any wives or live-in

partners does he have?

Are you the first, second, …

wife?

Have you been m

arried or lived with a m

an only once or m

ore than once?

CH

EC

K 709:

In what m

onth and year did you start living w

ith your (husband/partner)?

Now

I would like to ask

about your first (husband/partner). In w

hat month and year

did you start living with

him?

709

SE

CTIO

N 7. M

AR

RIA

GE

AN

D S

EXU

AL A

CTIV

ITY

QU

ES

TION

S A

ND

FILTER

SC

OD

ING

CA

TEG

OR

IES

SK

IP

Are you currently m

arried or living together with a m

an as if m

arried?704

Have you ever been m

arried or lived together with a

man as if m

arried?

What is your m

arital status now: are you w

idowed,

divorced, or separated?

Is your (husband/partner) living with you now

or is he staying elsew

here?

RE

CO

RD

THE

HU

SB

AN

D'S

/PA

RTN

ER

'S N

AM

E A

ND

LIN

E N

UM

BE

R FR

OM

THE

HO

US

EH

OLD

Q

UE

STIO

NN

AIR

E. IF H

E IS

NO

T LISTE

D IN

THE

H

OU

SE

HO

LD, R

EC

OR

D '00'.

Does your (husband/partner) have other w

ives or does he live w

ith other wom

en as if married?

W-47

• 437Appendix E

NO

.

SE

CTIO

N 7. M

AR

RIA

GE

AN

D S

EXU

AL A

CTIV

ITY

QU

ES

TION

S A

ND

FILTER

SC

OD

ING

CA

TEG

OR

IES

SK

IP

711CY

ES

. . . . . . . . . . . . . . . . . . . . . . . . . . . 1

712N

O. . . . . . . . . . . . . . . . . . . . .

2

711DG

RA

DU

ATE

D FR

OM

SC

HO

OL

. . . . . . . . . . . . . . . . 1

TOO

BU

SY

WITH

FAM

ILY LIF E. . . . . . . . . . . . . . . .

2H

US

BA

ND

DID

NO

T WA

NT M

E TO

GO. .

. . . .

. . 3

OTH

ER

6

712

713

NE

VE

R H

AD

SE

XUA

LIN

TER

CO

UR

SE

. . . . . . . . . . . . . . . . . . . . . . . .00

731

AG

E IN

YE

AR

S. . . . . . . . . . . . . . . . . . .

714D

AY

S A

GO

. . . . . . . . . . . . . 1

WE

EK

S A

GO

. . . . . . . . . . . . . 2

MO

NTH

S A

GO

. . . . . . . . . . . . . 3

YE

AR

S A

GO

. . . . . . . . . . . . . 4

IF LES

S TH

AN

13 MO

NTH

S, A

NS

WE

R M

US

T BE

R

EC

OR

DE

D IN

DA

YS

, WE

EK

S O

R M

ON

THS

. IF 13 M

ON

THS

(ON

E Y

EA

R) O

R M

OR

E, A

NS

WE

R M

US

T B

E R

EC

OR

DE

D IN

YE

AR

S.

727

CH

ECK

FOR

PRESEN

CE O

F OTH

ERS. B

EFOR

E CO

NTIN

UIN

G, M

AK

E EVERY EFFO

RT TO

ENSU

RE PR

IVAC

Y.

Now


e questions about sexual activity in order to gain a better understanding of som

e im

portant life issues. Let me assure you again that your

answers are com

pletely confidential and will not be told

to anyone. If we should com

e to any question that you don't w

ant to answer, just let m

e know and w

e will go to

the next question. How

old were you w

hen you had sexual intercourse for the very first tim

e?

I would like to ask you about your recent sexual activity.

When w

as the last time you had sexual intercourse?

716

Did you continue to attend school after your m

arriage?

Why did you stop attending school after your m

arriage?

(SP

EC

IFY)

W-48

438 •Appendix E

715D

AYS

DA

YSA

GO

. . 1

AG

O. .

1W

EE

KS

WE

EK

SA

GO

. . 2

AG

O. .

2M

ON

THS

MO

NTH

SA

GO

. . 3

AG

O. .

3

716YE

S. . . . . . . . . . . . . . . .

1YE

S. . . . . . . . . . . . . . . .

1YE

S. . . . . . . . . . . . . . . .

1N

O. . . . . . . . . . . . . . . .

2N

O. . . . . . . . . . . . . . . .

2N

O. . . . . . . . . . . . . . . .

2(S

KIP

TO 718)

(SK

IP TO

718)(S

KIP

TO 718)

717YE

S. . . . . . . . . . . . . . . .

1YE

S. . . . . . . . . . . . . . . .

1YE

S. . . . . . . . . . . . . . . .

1N

O. . . . . . . . . . . . . . . .

2N

O. . . . . . . . . . . . . . . .

2N

O. . . . . . . . . . . . . . . .

2

718H

US

BA

ND

. . . . . . . . . . 1

HU

SB

AN

D. . . . . . . . . .

1H

US

BA

ND

. . . . . . . . . . 1

LIVE

-IN P

AR

TNE

R. . . . .

2LIV

E-IN

PA

RTN

ER

. . . . . 2

LIVE

-IN P

AR

TNE

R. . . . .

2B

OYFR

IEN

D N

OT

BO

YFRIE

ND

NO

TB

OYFR

IEN

D N

OT

LIVIN

G W

ITHLIV

ING

WITH

LIVIN

G W

ITHR

ES

PO

ND

EN

T. . . . .

3R

ES

PO

ND

EN

T. . . . .

3R

ES

PO

ND

EN

T. . . . .

3C

AS

UA

LC

AS

UA

LC

AS

UA

LA

CQ

UA

INTA

NC

E. .

4A

CQ

UA

INTA

NC

E. .

4A

CQ

UA

INTA

NC

E. .

4C

LIEN

T/SE

X WO

RK

ER

. . 5

CLIE

NT/S

EX W

OR

KE

R. .

5C

LIEN

T/SE

X WO

RK

ER

. . 5

OTH

ER

6O

THE

R6

OTH

ER

6

719D

AYS

DA

YSD

AYS

AG

O. .

1A

GO

. . 1

AG

O. .

1W

EE

KS

WE

EK

SW

EE

KS

AG

O. .

2A

GO

. . 2

AG

O. .

2M

ON

THS

MO

NTH

SM

ON

THS

AG

O. .

3A

GO

. . 3

AG

O. .

3YE

AR

SYE

AR

SYE

AR

SA

GO

. . 4

AG

O. .

4A

GO

. . 4

720

NU

MB

ER

OF

NU

MB

ER

OF

NU

MB

ER

OF

TIME

S. . . . .

TIME

S. . . . .

TIME

S. . . . .

721A

GE

OF

AG

E O

FA

GE

OF

PA

RTN

ER

PA

RTN

ER

PA

RTN

ER

DO

N'T K

NO

W. . . . . . . .

98D

ON

'T KN

OW

. . . . . . . . 98

DO

N'T K

NO

W. . . . . . . .

98

722YE

S. . . . . . . . . . . . . . . .

1YE

S. . . . . . . . . . . . . . . .

1

NO

. . . . . . . . . . . . . . . . 2

NO

. . . . . . . . . . . . . . . . 2

(SK

IP TO

724)(S

KIP

TO 724)

723

NU

MB

ER

OF

PA

RTN

ER

SLA

ST 12

MO

NTH

S. .

DO

N'T K

NO

W. . . . . . . . 98

In total, with how

many

different people have you had sexual intercourse in the last 13 m

onths? IF N

ON

-NU

ME

RIC

AN

SW

ER

, P

RO

BE

TO G

ET A

N

ES

TIMA

TE. IF N

UM

BE

R O

F P

AR

TNE

RS

IS 95 O

R M

OR

E,

RE

CO

RD

'95'.

How

many tim

es during the last 13 m

onths did you have sexual intercourse w

ith this person?IF N

ON

-NU

ME

RIC

AN

SW

ER

, P

RO

BE

TO G

ET A

N

ES

TIMA

TE. IF N

UM

BE

R O

F TIM

ES

IS 95 O

R M

OR

E,

RE

CO

RD

'95'.

How

old is this person?

Apart from

this person, have you had sexual intercourse w

ith any other person in the last 13 m

onths?

(GO

BA

CK

TO 715

IN N

EXT C

OLU

MN

)(G

O B

AC

K TO

715 IN

NE

XT CO

LUM

N)

Was a condom

used every tim

e you had sexual intercourse w

ith this person in the last 13 m

onths?

What w

as your relationship to this person w

ith whom

you had sexual intercourse?

IF BO

YFRIE

ND

: Were you

living together as if married?

IF YES

, RE

CO

RD

'2'.IF N

O, R

EC

OR

D '3'.

(SP

EC

IFY)(S

PE

CIFY)

(SP

EC

IFY)

How

long ago did you first have sexual intercourse w

ith this person?

SE

CTIO

N 7. M

AR

RIA

GE

AN

D S

EXU

AL A

CTIV

ITY

LAS

T SE

XUA

L PA

RTN

ER

SE

CO

ND

-TO-LA

ST S

EXU

AL

PA

RTN

ER

THIR

D-TO

-LAS

T SE

XUA

L P

AR

TNE

R

When w

as the last time you

had sexual intercourse with

this person?

The last time you had sexual

intercourse with this person,

was a condom

used?

W-49

• 439Appendix E

NO

.

724

AG

E 15-24

AG

E 25-49

725

NO

TC

UR

RE

NTLY

MA

RR

IED

/IN

A U

NIO

NLIV

ING

WITH

A M

AN

726Y

ES

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1

NO

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2

727N

UM

BE

R O

F PA

RTN

ER

SIN

LIFETIM

E. . . . . . . . . . . . . . . . . . .

DO

N'T K

NO

W. . . . . . . . . . . . . . . . . . . . . . . . . . .

98

728

NO

,Y

ES

,C

ON

DO

MC

ON

DO

M U

SE

DN

OT U

SE

DN

OT

AS

KE

D731

729S

EN

SA

TION

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 01

HIW

OT TR

US

T. . . . . . . . . . . . . . . . . . . . . . . . . . .

02M

EM

BE

RS

ON

L Y. . . . . . . . . . . . . . . . . . . . . . . . . . . 03

GO

LD. . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

04G

EA

NS

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 05

DU

RE

X. . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

06M

OO

DS

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 07

OTH

ER

96

DO

N'T K

NO

W. . . . . . . . . . . . . . . . . . . . . . . . . . .

98

731

IF BR

AN

D N

OT K

NO

WN

, AS

K TO

SE

E TH

E

PA

CK

AG

E.

(SP

EC

IFY)

You told m

e that a condom w

as used the last time you

had sex. What is the brand nam

e of the condom used

at that time?

CH

EC

K 716, M

OS

T RE

CE

NT P

AR

TNE

R (FIR

ST C

OLU

MN

):

SE

CTIO

N 7. M

AR

RIA

GE

AN

D S

EXU

AL A

CTIV

ITY

QU

ES

TION

S A

ND

FILTER

SC

OD

ING

CA

TEG

OR

IES

SK

IP

CH

EC

K 106:

727

CH

EC

K 701:

727

In the past 13 months have you had sex or been

sexually involved with anyone because he gave you or

told you he would give you gifts, cash, or anything else?

In total, with how

many different people have you had

sexual intercourse in your lifetime?

IF NO

N-N

UM

ER

IC A

NS

WE

R, P

RO

BE

TO G

ET A

N

ES

TIMA

TE. IF N

UM

BE

R O

F PA

RTN

ER

S IS

95 OR

M

OR

E, R

EC

OR

D '95'.

W-50

440 •Appendix E

NO

.

SE

CTIO

N 7. M

AR

RIA

GE

AN

D S

EXU

AL A

CTIV

ITY

QU

ES

TION

S A

ND

FILTER

SC

OD

ING

CA

TEG

OR

IES

SK

IP

730PU

BLIC

SECTO

RG

OV

T. HO

SP

ITAL

. . . . . . . . . . . . . . . . . . . . . 11

GO

V .H

EA

LTH C

EN

TER

. . . . . . . . . . . . . . . . . . . 12G

OV

. HE

ALTH

PO

ST. . . . . . . . . . . . . . . . . . . . .

13P

UB

LIC P

HA

RM

AC

Y. . . . . . . . . . . . . . . . . . . . . 14

OTH

ER

PU

BLIC

SE

CTO

R

16

NG

OHE

ALTH

FAC

ILITY. . . . . . . . . . . . . . . . . . . . .

21O

THE

R N

GO

ME

DIC

AL S

EC

TOR

26

PRIVA

TE MED

ICA

L SECTO

RP

RIV

ATE

HO

SP

ITA L. . . . . . . . . . . . . . . . . . . . . 31

PR

IVA

TE C

LINI C

. . . . . . . . . . . . . . . . . . . . . . . . 32

PR

IVA

TE P

HA

RM

AC

Y

. . . . . . . . . . . . . . . . . . . 33O

THE

R P

RIV

ATE

ME

DIC

AL S

EC

TOR

. . . .

. . . .

. . . .

. . 36

OTH

ER SO

UR

CE

SH

OP

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 41

BA

R/H

OTE

L/GR

OC

ER

Y. . . . . . . . . . . . . . . . . . . 42

FRIE

ND

/RE

LATIV

E. . . . . . . . . . . . . . . . . . . . .

43

OTH

ER

96

DO

N'T K

NO

W. . . . . . . . . . . . . . . . . . . . . . . . . . .

98

731Y

ES

NO

CH

ILDR

EN

<10. . . . . . . . . . . . . . . . . . .

12

MA

LE A

DU

LTS. . . . . . . . . . . . . . . . . . .

12

FEM

ALE

AD

ULTS

. . . . . . . . . . . . . . . . 1

2

PR

ES

EN

CE

OF O

THE

RS

DU

RIN

G TH

IS S

EC

TION

.

(SP

EC

IFY)

(NA

ME

OF P

LAC

E)

(SP

EC

IFY)

From w

here did you obtain the condom the last tim

e?

PRO

BE TO ID

ENTIFY TYPE O

F SOU

RC

E.

IF UN

AB

LE TO

DE

TER

MIN

E IF P

UB

LIC O

R P

RIV

ATE

S

EC

TOR

, WR

ITE TH

E N

AM

E O

F THE

PLA

CE

.

(SP

EC

IFY)

(SP

EC

IFY)

W-51

• 441Appendix E

NO

.

801

NE

ITHE

RH

E O

R S

HE

STE

RILIZE

DS

TER

ILIZED

802

PR

EG

NA

NT

NO

T PR

EG

NA

NT

OR

UN

SU

RE

803H

AV

E A

NO

THE

R C

HILD

. . . . . . . . . . . . . . . . . . . 1

805N

O M

OR

E. . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

2U

ND

EC

IDE

D/D

ON

'T KN

OW

. . . . . . . . . . . . . . . . 8

804H

AV

E (A

/AN

OTH

ER

) CH

ILD. . . . . . . . . . . . . . . .

1N

O M

OR

E/N

ON

E. . . . . . . . . . . . . . . . . . . . . . . .

2807

SA

YS

SH

E C

AN

'T GE

T PR

EG

NA

NT

. . . . . . . . . . 3

813U

ND

EC

IDE

D/D

ON

'T KN

OW

. . . . . . . . . . . . . . . . 8

811

805M

ON

THS

. . . . . . . . . . . . . . . . 1

NO

T PR

EG

NA

NT

PR

EG

NA

NT

OR

UN

SU

RE

YE

AR

S. . . . . . . . . . . . . . . . . . .

2

a)b)

SO

ON

/NO

W. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 993

811S

AY

S S

HE

CA

N'T G

ET P

RE

GN

AN

T. . . . . . . . . . 994

813A

FTER

MA

RR

IAG

E. . . . . . . . . . . . . . . . . . . . . . . . 995

OTH

ER

996811

DO

N'T K

NO

W. . . . . . . . . . . . . . . . . . . . . . . . . . . 998

806

NO

T PR

EG

NA

NT

PR

EG

NA

NT

OR

UN

SU

RE

807

NO

TC

UR

RE

NTLY

CU

RR

EN

TLYU

SIN

G813

US

ING

808

'24' OR

MO

RE

MO

NTH

SN

OT

'00-23' MO

NTH

SO

R '02' O

R M

OR

E Y

EA

RS

AS

KE

DO

R '00-01' Y

EA

R812

809

YE

AR

SD

AY

S, W

EE

KS

OR

AG

OM

ON

THS

AG

ON

OT

AS

KE

D811

CH

EC

K 226:

Now

I have some questions about the future. W

ould you like to have (a/another) child, or w

ould you prefer not to have any (m

ore) children?

After the birth of the

child you are expecting now

, how long w

ould you like to w

ait before the birth of another child?

How

long would you like

to wait from

now before

the birth of (a/another) child?

804

812

Now

I have some questions about the future. A

fter the child you are expecting now

, would you like to have

another child, or would you prefer not to have any m

ore children?

CH

EC

K 304:

CH

EC

K 226:

SE

CTIO

N 8. FE

RTILITY

PR

EFE

RE

NC

ES

QU

ES

TION

S A

ND

FILTER

SC

OD

ING

CA

TEG

OR

IES

SK

IP

813

CH

EC

K 303: U

SIN

G A

CO

NTR

AC

EP

TIVE

ME

THO

D?

CH

EC

K 226:

CH

EC

K 714:

812

(SP

EC

IFY)

CH

EC

K 805:

811

W-52

442 •Appendix E

NO

.

SE

CTIO

N 8. FE

RTILITY

PR

EFE

RE

NC

ES

QU

ES

TION

S A

ND

FILTER

SC

OD

ING

CA

TEG

OR

IES

SK

IP

810C

HE

CK

804:N

OT M

AR

RIE

D. . . . . . . . . . . . . . . . . . . . . . . . . . .

A

WA

NTS

TO H

AV

EW

AN

TS N

O M

OR

E/

FERTILITY-R

ELATED

REA

SON

SA

/AN

OTH

ER

CH

ILDN

ON

EN

OT H

AV

ING

SE

X. . . . . . . . . . . . . . . . . . . . .

BIN

FRE

QU

EN

T SE

X. . . . . . . . . . . . . . . . . . . . .

Ca)

b)M

EN

OP

AU

SA

L/HY

STE

RE

CTO

MY

. . . . . . . . . . D

CA

N'T G

ET P

RE

GN

AN

T. . . . . . . . . . . . . . . .

EN

OT M

EN

STR

UA

TED

SIN

CE

LAS

T BIR

TH. . . . . . . . . . . . . . . . . . . . . . . .

FB

RE

AS

TFEE

DIN

G. . . . . . . . . . . . . . . . . . . . .

GU

P TO

GO

D/FA

TALIS

TIC. . . . . . . . . . . . . . . .

H

OPPO

SITION

TO U

SER

ES

PO

ND

EN

T OP

PO

SE

D. . . . . . . . . . . . . . . .

IH

US

BA

ND

/PA

RTN

ER

OP

PO

SE

D. . . . . . . . . .

JO

THE

RS

OP

PO

SE

D. . . . . . . . . . . . . . . . . . .

KR

ELIG

IOU

S P

RO

HIB

ITION

. . . . . . . . . . . . . . . . L

LAC

K O

F KN

OW

LEDG

EK

NO

WS

NO

ME

THO

D. . . . . . . . . . . . . . . . . . .

MK

NO

WS

NO

SO

UR

CE

. . . . . . . . . . . . . . . . . . . N

METH

OD

-RELA

TED R

EASO

NS

SID

E E

FFEC

TS/H

EA

LTHC

ON

CE

RN

S. . . . . . . . . . . . . . . . . . . . . . . .

OLA

CK

OF A

CC

ES

S/TO

O FA

R. . . . . . . . . . . . .

PC

OS

TS TO

O M

UC

H. . . . . . . . . . . . . . . . . . .

QP

RE

FER

RE

D M

ETH

OD

NO

T AV

AILA

BLE

. . . . . . . . . . . . . . . . . . . R

NO

ME

THO

D A

VA

ILAB

LE. . . . . . . . . . . . . . . .

SIN

CO

NV

EN

IEN

T TO U

SE

. . . . . . . . . . . . . . . . T

INTE

RFE

RE

S W

ITH B

OD

Y'S

NO

RM

AL P

RO

CE

SS

ES

. . . . . . . . . . . . . . . . U

OTH

ER

X

DO

N'T K

NO

W. . . . . . . . . . . . . . . . . . . . . . . . . . .

Z

811

NO

TN

O, N

OT

YE

S,

ASKEDC

UR

REN

TLY USIN

GC

UR

RE

NTLY U

SING

812Y

ES

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1

NO

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2

DO

N'T K

NO

W. . . . . . . . . . . . . . . . . . . . . . . . . . .

8

813

HA

S LIV

ING

NO

LIVIN

GC

HILD

RE

NC

HILD

RE

NN

ON

E. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

00815

a)b)

NU

MB

ER

. . . . . . . . . . . . . . . . . . . . . . . .

OTH

ER

96815

814

NU

MB

ER

. .

OTH

ER

96

How

many of these children w

ould you like to be boys, how

many w

ould you like to be girls and for how m

any w

ould it not matter if it’s a boy or a girl?

RE

CO

RD

ALL R

EA

SO

NS

ME

NTIO

NE

D.

CH

EC

K 303: U

SIN

G A

CO

NTR

AC

EP

TIVE

ME

THO

D?

Do you think you w

ill use a contraceptive method to

delay or avoid pregnancy at any time in the future?

PR

OB

E FO

R A

NU

ME

RIC

RE

SP

ON

SE

.

You have said that you

do not want (a/another)

child soon. Can you tell

me w

hy you are not using a m

ethod to prevent pregnancy?

Any other reason?

You have said that you

do not want any (m

ore) children. C

an you tell m

e why you are not

using a method to

prevent pregnancy?

Any other reason?

If you could go back to the tim

e you did not have any children and could choose exactly the num

ber of children to have in your w

hole life, how

many w

ould that be?

If you could choose exactly the num

ber of children to have in your w

hole life, how m

any w

ould that be?

CH

EC

K 216:

(SP

EC

IFY)

813

(SP

EC

IFY)

EITH

ER

GIR

LSB

OY

S

(SP

EC

IFY)

W-53

• 443Appendix E

NO

.

SE

CTIO

N 8. FE

RTILITY

PR

EFE

RE

NC

ES

QU

ES

TION

S A

ND

FILTER

SC

OD

ING

CA

TEG

OR

IES

SK

IP

815Y

ES

NO

a)a)

RA

DIO

. . . . . . . . . . . . . . . . . . . . . . . . 1

2

b)b)

TELE

VIS

ION

. . . . . . . . . . . . . . . . . . . 1

2

c)c)

NE

WS

PA

PE

R O

R M

AG

AZIN

E. . . . . . .

12

d)d)

PA

MP

HLE

T/PO

STE

RS

/LEA

FLET S

. . . . . 1

2

e)e)

CO

MM

UN

ITY E

VE

NT/C

ON

V. . . . . . . . . . 1

2

f)f)

MO

BILE

PH

ON

E. . . . . . . . . . . . . . . . . . .

12

g)g)

INTE

RN

ET

. . . . . . . . . . . . . . . . . . . 1

2

817

YE

S,

YE

S,

NO

,C

UR

RE

NTLY

LIVIN

GN

OT IN

A U

NIO

NM

AR

RIE

DW

ITH A

MA

N

818

NO

TC

UR

RE

NTLY

CU

RR

EN

TLYU

SIN

GU

SIN

GN

OT

AS

KE

D822

819M

AIN

LY R

ES

PO

ND

EN

T. . . . . . . . . . . . . . . . . . .

1M

AIN

LY H

US

BA

ND

/PA

RTN

ER

. . . . . . . . . . . . . . . . 2

JOIN

T DE

CIS

ION

. . . . . . . . . . . . . . . . . . . . . . . . 3

821

OTH

ER

6

820M

AIN

LY R

ES

PO

ND

EN

T. . . . . . . . . . . . . . . . . . .

1M

AIN

LY H

US

BA

ND

/PA

RTN

ER

. . . . . . . . . . . . . . . . 2

JOIN

T DE

CIS

ION

. . . . . . . . . . . . . . . . . . . . . . . . 3

OTH

ER

6

821

NE

ITHE

R A

RE

HE

OR

SH

E A

RE

STE

RILIZE

DS

TER

ILIZED

822S

AM

E N

UM

BE

R. . . . . . . . . . . . . . . . . . . . . . . . . . .

1M

OR

E C

HILD

RE

N. . . . . . . . . . . . . . . . . . . . . . . .

2FE

WE

R C

HILD

RE

N. . . . . . . . . . . . . . . . . . . . . . . .

3D

ON

'T KN

OW

. . . . . . . . . . . . . . . . . . . . . . . . . . . 8

Does your (husband/partner) w

ant the same num

ber of children that you w

ant, or does he want m

ore or fewer

than you want?

Would you say that not using contraception is m

ainly your decision, m

ainly your (husband's/partner's) decision, or did you both decide together?

CH

EC

K 701:

CH

EC

K 303: U

SIN

G A

CO

NTR

AC

EP

TIVE

ME

THO

D?

Would you say that using contraception is m

ainly your decision, m

ainly your (husband's/partner's) decision, or did you both decide together?

CH

EC

K 304:

In the last few m

onths have you:

Read about fam

ily planning in a pam

phlet/posters/leaflets?

Read about fam

ily planning in a newspaper or

magazine?

Seen anything about fam

ily planning on the television?

Heard about fam

ily planning on the radio?

Heard about fam

ily planning at comm

unity even/conversation?R

eceived a voice or text message about fam

ily planning on a m

obile phone?S

een anything about family planning on the internet?

901

(SP

EC

IFY)

(SP

EC

IFY)

901

820

W-54

444 •Appendix E

NO

.

901

CU

RR

EN

TLY M

AR

RIE

D/

NO

T INLIV

ING

WITH

A M

AN

UN

ION

902A

GE

IN C

OM

PLE

TED

YE

AR

S. . . . . . .

903Y

ES

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1

NO

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2

906

904P

RIM

AR

Y. . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

1S

EC

ON

DA

RY

. . . . . . . . . . . . . . . . . . . . . . . . . . . 2

TEC

HN

ICA

L/VO

CA

TION

AL

3H

IGH

ER

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 4

DO

N'T K

NO

W. . . . . . . . . . . . . . . . . . . . . . . . . . .

8

905[G

RA

DE

/YE

AR

S]

. . . . . . . . . . . . .

DO

N'T K

NO

W. . . . . . . . . . . . . . . . . . . . . . . . . . .

98

906Y

ES

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1

908N

O. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

2D

ON

'T KN

OW

. . . . . . . . . . . . . . . . . . . . . . . . . . . 8

907Y

ES

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1

NO

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2

DO

N'T K

NO

W. . . . . . . . . . . . . . . . . . . . . . . . . . .

8

908

909Y

ES

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1

913N

O. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

2

910

YE

S. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

1913

NO

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2

911Y

ES

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1

913N

O. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

2

912Y

ES

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1

NO

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2

917

913

909

Has your (husband/partner) done any w

ork in the last 13 m

onths?

Although you did not w

ork in the last seven days, do you have any job or business from

which you w

ere absent for leave, illness, vacation, m

aternity leave, or any other such reason?

SE

CTIO

N 9. H

US

BA

ND

'S B

AC

KG

RO

UN

D A

ND

WO

MA

N'S

WO

RK

AN

D D

EC

ISIO

N M

AK

ING

CH

EC

K 701:

How

old was your (husband/partner) on his last

birthday?

Did your (husband/partner) ever attend school?

What w

as the highest level of school he attended: prim

ary, secondary, technical/vocational or higher?

SK

IPC

OD

ING

CA

TEG

OR

IES

QU

ES

TION

S A

ND

FILTER

S

909

What w

as the highest [GR

AD

E/Y

EA

RS

] he completed

at that level?IF C

OM

PLE

TED

LES

S TH

AN

ON

E Y

EA

R A

T THA

T LE

VE

L, RE

CO

RD

'00'.

What is your occupation? That is, w

hat kind of work do

you mainly do?

As you know

, some w

omen take up jobs for w

hich they are paid in cash or kind. O

thers sell things, have a small

business or work on the fam

ily farm or in the fam

ily business. In the last seven days, have you done any of these things or any other w

ork?

Have you done any w

ork in the last 13 months?

What is your (husband's/partner's) occupation? That is,

what kind of w

ork does he mainly do?

Aside from

your own housew

ork, have you done any w

ork in the last seven days?

Has your (husband/partner) done any w

ork in the last 7 days?

W-55

• 445Appendix E

NO

.

SE

CTIO

N 9. H

US

BA

ND

'S B

AC

KG

RO

UN

D A

ND

WO

MA

N'S

WO

RK

AN

D D

EC

ISIO

N M

AK

ING

SK

IPC

OD

ING

CA

TEG

OR

IES

QU

ES

TION

S A

ND

FILTER

S

914FO

R FA

MILY

ME

MB

ER

. . . . . . . . . . . . . . . . . . . . . 1

FOR

SO

ME

ON

E E

LSE

. . . . . . . . . . . . . . . . . . . . . 2

SE

LF-EM

PLO

YE

D. . . . . . . . . . . . . . . . . . . . . . . .

3

915TH

RO

UG

HO

UT TH

E Y

EA

R. . . . . . . . . . . . . . . .

1S

EA

SO

NA

LLY/P

AR

T OF TH

E Y

EA

R. . . . . . . . . .

2O

NC

E IN

A W

HILE

. . . . . . . . . . . . . . . . . . . . . . . . 3

916C

AS

H O

NLY

. . . . . . . . . . . . . . . . . . . . . . . . . . . 1

CA

SH

AN

D K

IND

. . . . . . . . . . . . . . . . . . . . . . . . 2

IN K

IND

ON

LY. . . . . . . . . . . . . . . . . . . . . . . . . . .

3N

OT P

AID

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 4

917

CU

RR

EN

TLYM

AR

RIE

D/LIV

ING

NO

T IN U

NIO

N925

WITH

A M

AN

918

CO

DE

'1' OR

'2'O

THE

RC

IRC

LED

919R

ES

PO

ND

EN

T. . . . . . . . . . . . . . . . . . . . . . . . . . .

1H

US

BA

ND

/PA

RTN

ER

. . . . . . . . . . . . . . . . . . . . . 2

RE

SP

ON

DE

NT A

ND

HU

SB

AN

D/P

AR

TNE

R JO

INTLY

. . . . . . . . . . 3

OTH

ER

6

920M

OR

E TH

AN

HIM

. . . . . . . . . . . . . . . . . . . . . . . . 1

LES

S TH

AN

HIM

. . . . . . . . . . . . . . . . . . . . . . . . 2

AB

OU

T THE

SA

ME

. . . . . . . . . . . . . . . . . . . . . . . . 3

HU

SB

AN

D/P

AR

TNE

R H

AS

NO

EA

RN

ING

S. . . . . . . . . . . . . . . . . . . . . . . .

4922

DO

N'T K

NO

W. . . . . . . . . . . . . . . . . . . . . . . . . . .

8

921R

ES

PO

ND

EN

T. . . . . . . . . . . . . . . . . . . . . . . . . . .

1H

US

BA

ND

/PA

RTN

ER

. . . . . . . . . . . . . . . . . . . . . 2

RE

SP

ON

DE

NT A

ND

HU

SB

AN

D/P

AR

TNE

R JO

INTLY

. . . . . . . . . . 3

HU

SB

AN

D/P

AR

TNE

R H

AS

N

O E

AR

NIN

GS

. . . . . . . . . . . . . . . . . . . . . . . . 4

OTH

ER

6

922R

ES

PO

ND

EN

T. . . . . . . . . . . . . . . . . . . . . . . . . . .

1H

US

BA

ND

/PA

RTN

ER

. . . . . . . . . . . . . . . . . . . . . 2

RE

SP

ON

DE

NT A

ND

HU

SB

AN

D/P

AR

TNE

R JO

INTLY

. . . . . . . . . . 3

SO

ME

ON

E E

LSE

. . . . . . . . . . . . . . . . . . . . . . . . 4

OTH

ER

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 6

923R

ES

PO

ND

EN

T. . . . . . . . . . . . . . . . . . . . . . . . . . .

1H

US

BA

ND

/PA

RTN

ER

. . . . . . . . . . . . . . . . . . . . . 2

RE

SP

ON

DE

NT A

ND

HU

SB

AN

D/P

AR

TNE

R JO

INTLY

. . . . . . . . . . 3

SO

ME

ON

E E

LSE

. . . . . . . . . . . . . . . . . . . . . . . . 4

OTH

ER

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 6

Who usually m

akes decisions about making m

ajor household purchases?

Who usually m

akes decisions about health care for yourself: you, your (husband/partner), you and your (husband/partner) jointly, or som

eone else?

Who usually decides how

your (husband's/partner's) earnings w

ill be used: you, your (husband/partner), or you and your (husband/partner) jointly?

Who usually decides how

the money you earn w

ill be used: you, your (husband/partner), or you and your (husband/partner) jointly?

(SP

EC

IFY)

(SP

EC

IFY)

921

Would you say that the m

oney that you earn is more

than what your (husband/partner) earns, less than w

hat he earns, or about the sam

e?

Are you paid in cash or kind for this w

ork or are you not paid at all?

CH

EC

K 701:

CH

EC

K 916:

Do you usually w

ork throughout the year, or do you work

seasonally, or only once in a while?

Do you do this w

ork for a mem

ber of your family, for

someone else, or are you self-em

ployed?

W-56

446 •Appendix E

NO

.

SE

CTIO

N 9. H

US

BA

ND

'S B

AC

KG

RO

UN

D A

ND

WO

MA

N'S

WO

RK

AN

D D

EC

ISIO

N M

AK

ING

SK

IPC

OD

ING

CA

TEG

OR

IES

QU

ES

TION

S A

ND

FILTER

S

924R

ES

PO

ND

EN

T. . . . . . . . . . . . . . . . . . . . . . . . . . .

1H

US

BA

ND

/PA

RTN

ER

. . . . . . . . . . . . . . . . . . . . . 2

RE

SP

ON

DE

NT A

ND

HU

SB

AN

D/P

AR

TNE

R JO

INTLY

. . . . . . . . . . 3

SO

ME

ON

E E

LSE

. . . . . . . . . . . . . . . . . . . . . . . . 4

OTH

ER

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 6

924AY

ES

. . . . . . . . . . . . . . . . . . . . . . . . . . . 1

NO

. . . . . . . . . . . . . . . . . . . . . 2

925N

OT LIV

ING

HU

SB

AN

D/P

AR

TNE

R3

924BA

LMO

ST E

VE

RY

. . . . . . . . . . . . . . . . . . . . . . . . . . . 1

ATLE

AS

T ON

CE

A W

EE

K. . . . . . . . . . . . . . . .

2R

AR

ELY

. . . . . . . . . . . . . . . . . . . . . 3

925A

LON

E O

NLY

. . . . . . . . . . . . . . . . . . . . . . . . . . . 1

JOIN

TLY O

NLY

. . . . . . . . . . . . . . . . . . . . . . . . . . . 2

BO

TH A

LON

E A

ND

JOIN

TLY. . . . . . . . . . . . . . . .

3D

OE

S N

OT O

WN

. . . . . . . . . . . . . . . . . . . . . . . . 4

928

926Y

ES

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1

NO

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2

DO

N'T K

NO

W. . . . . . . . . . . . . . . . . . . . . . . . . . .

8

927Y

ES

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1

NO

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2

DO

N'T K

NO

W. . . . . . . . . . . . . . . . . . . . . . . . . . .

8

928A

LON

E O

NLY

. . . . . . . . . . . . . . . . . . . . . . . . . . . 1

JOIN

TLY O

NLY

. . . . . . . . . . . . . . . . . . . . . . . . . . . 2

BO

TH A

LON

E A

ND

JOIN

TLY. . . . . . . . . . . . . . . .

3D

OE

S N

OT O

WN

. . . . . . . . . . . . . . . . . . . . . . . . 4

931

929Y

ES

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1

NO

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2

DO

N'T K

NO

W. . . . . . . . . . . . . . . . . . . . . . . . . . .

8

930Y

ES

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1

NO

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2

DO

N'T K

NO

W. . . . . . . . . . . . . . . . . . . . . . . . . . .

8

931P

RE

S./

PR

ES

./N

OT

NO

TLIS

TEN

.LIS

TEN

.P

RE

S.

CH

ILDR

EN

< 10. . . . . . . . . .

12

3H

US

BA

ND

. . . . . . . . . . . . . 1

23

OTH

ER

MA

LES

. . . . . . . . . . 1

23

OTH

ER

FEM

ALE

S. . . . . . .

12

3

932Y

ES

NO

DK

a)a)

GO

ES

OU

T. . . . . . . . . .

12

8b)

b)N

EG

LEC

TS C

HILD

RE

N. .

12

8c)

c)A

RG

UE

S. . . . . . . . . . . . .

12

8d)

d)R

EFU

SE

S S

EX

. . . . . . . 1

28

e)e)

BU

RN

S FO

OD

. . . . . . . 1

28

Do you ow

n this or any other house either alone or jointly w

ith someone else?

Who usually m

akes decisions about visits to your family

or relatives?

Do you ow

n any agricultural or non-agricultural land either alone or jointly w

ith someone else?

If she burns the food?If she refuses to have sex w

ith him?

If she argues with him

?If she neglects the children?

928

Is your name on the title deed?

Do you have a title deed for any house you ow

n?

Is your name on the title deed?

Do you have a title deed for any land you ow

n?

931

If she goes out without telling him

?

In your opinion, is a husband justified in hitting or beating his w

ife in the following situations:

PR

ES

EN

CE

OF O

THE

RS

AT TH

IS P

OIN

T (PR

ES

EN

T A

ND

LISTE

NIN

G, P

RE

SE

NT B

UT N

OT LIS

TEN

ING

, O

R N

OT P

RE

SE

NT)

Does your huband help you w

ith household chores like looking after children,cooking,cleaning the house and doing other w

ork around the house?

Does he help you alm

ost every day, at least once a w

eek or rarely?

W-57

• 447Appendix E

NO

.

1001Y

ES

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1

NO

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2

1042

1002Y

ES

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1

NO

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2

DO

N'T K

NO

W. . . . . . . . . . . . . . . . . . . . . . . . . . .

8

1003Y

ES

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1

NO

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2

DO

N'T K

NO

W. . . . . . . . . . . . . . . . . . . . . . . . . . .

8

1004Y

ES

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1

NO

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2

DO

N'T K

NO

W. . . . . . . . . . . . . . . . . . . . . . . . . . .

8

1005Y

ES

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1

NO

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2

DO

N'T K

NO

W. . . . . . . . . . . . . . . . . . . . . . . . . . .

8

1006Y

ES

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1

NO

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2

DO

N'T K

NO

W. . . . . . . . . . . . . . . . . . . . . . . . . . .

8

1007Y

ES

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1

NO

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2

DO

N'T K

NO

W. . . . . . . . . . . . . . . . . . . . . . . . . . .

8

1008Y

ES

NO

DK

a)a)

DU

RIN

G P

RE

GN

AN

CY

. . 1

28

b)b)

DU

RIN

G D

ELIV

ER

Y. .

12

8c)

c)B

RE

AS

TFEE

DIN

G. . . . .

12

8

1009

AT LE

AS

TO

THE

RO

NE

'YE

S'

1010Y

ES

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1

NO

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2

DO

N'T K

NO

W. . . . . . . . . . . . . . . . . . . . . . . . . . .

8

1011

NO

BIR

THS

1027

1012

HA

DN

OA

NTE

NA

TAL

AN

TEN

ATA

L1020

CA

RE

CA

RE

1013

1014Y

ES

NO

DK

a)a)

HIV

FRO

M M

OTH

ER

. . 1

28

b)b)

THIN

GS

TO D

O. . . . . . .

12

8c)

c)TE

STE

D FO

R H

IV. . . . .

12

8

1027

Is it possible for a healthy-looking person to have HIV

?

Can people get H

IV because of w

itchcraft or other supernatural m

eans?

Can people get H

IV by sharing food w

ith a person who

has HIV

?

By breastfeeding?

During delivery?

During pregnancy?

Can H

IV be transm

itted from a m

other to her baby:

SE

CTIO

N 10. H

IV/A

IDS

SK

IPC

OD

ING

CA

TEG

OR

IES

QU

ES

TION

S A

ND

FILTER

S

Can people reduce their chance of getting H

IV by using

a condom every tim

e they have sex?

Can people get H

IV from

mosquito bites?

HIV

is the virus that can lead to AID

S. C

an people reduce their chance of getting H

IV by having just one

uninfected sex partner who has no other sex partners?

Now

I would like to talk about som

ething else. Have you

ever heard of HIV

or AID

S?

Things that you can do to prevent getting HIV

?B

abies getting HIV

from their m

other?

During any of the antenatal visits for your last birth w

ere you given any inform

ation about:

1011

Getting tested for H

IV?

CH

EC

K 1008:

CH

EC

K 208 A

ND

215:

Are there any special drugs that a doctor or a nurse can

give to a wom

an infected with H

IV to reduce the risk of

transmission to the baby?

CH

EC

K 408 FO

R LA

ST B

IRTH

:

CH

ECK

FOR

PRESEN

CE O

F OTH

ERS. B

EFOR

E CO

NTIN

UIN

G, M

AK

E EVERY EFFO

RT TO

ENSU

RE PR

IVAC

Y.

LAS

T BIR

TH IN

2005 O

R E

AR

LIER

LAS

T BIR

TH IN

2006-2008

W-58

448 •Appendix E

NO

.

SE

CTIO

N 10. H

IV/A

IDS

SK

IPC

OD

ING

CA

TEG

OR

IES

QU

ES

TION

S A

ND

FILTER

S

1015Y

ES

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1

NO

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2

1016Y

ES

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1

NO

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2

1020

1017PU

BLIC

SECTO

RG

OV

T. HO

SP

ITAL

. . . . . . . . . . . . . . . . . . . . . 11

GO

V .H

EA

LTH C

EN

TER

. . . . . . . . . . . . . 12

GO

V. H

EA

LTH P

OS

T. . . . . . . . . . . . . . . . . . . . .13

OTH

ER

PU

BLIC

SE

CTO

R

16

NG

OHE

ALTH

FAC

ILITY. .

. . . .

. . . .

. . . .

. . 21

OTH

ER

NG

O M

ED

ICA

L SE

CTO

R26

PRIVA

TE MED

ICA

L SECTO

RP

RIV

ATE

HO

SP

ITAL

. . . .

. . . .

. . . .

. . 31

PR

IVA

TE C

LINIC

. . . .

. . . .

. . . .

. . . .

32O

THE

R P

RIV

ATE

ME

DIC

AL S

EC

TOR

. . . .

. . . .

. . . .

. . 36

OTH

ER SO

UR

CE

WO

RK

PLA

CE

. . . . . . . . . . . . . . . . . . . . . . . . 41

CO

RR

EC

TION

AL FA

CILITY

. . . . . . . . . . . . . 42

OTH

ER

96

1018Y

ES

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1

NO

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2

1020

1019Y

ES

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1

NO

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2

DO

N'T K

NO

W. . . . . . . . . . . . . . . . . . . . . . . . . . .

8

1020

AN

Y C

OD

E

OTH

ER

'21-36' CIR

CLE

D

1021Y

ES

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1

NO

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2

1022Y

ES

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1

NO

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2

1024

1023Y

ES

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1

NO

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2

1024

YE

SN

O O

RN

OT A

SK

ED

1025Y

ES

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1

1028N

O. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

2

1026M

ON

THS

AG

O. . . . . . . . . . . . . . . . . . .

TWO

OR

MO

RE

YE

AR

S. . . . . . . . . . . . . . . . . . . 95

I don't want to know

the results, but were you tested for

HIV

at that time?

(SP

EC

IFY)

(SP

EC

IFY)

(SP

EC

IFY)(SP

EC

IFY)

1024

1035

1025

1027


the results, but did you get the results of the test?

CH

EC

K 1016:

(NA

ME

OF P

LAC

E)

CH

EC

K 430 FO

R LA

ST B

IRTH

:

All w

omen are supposed to receive counseling after

being tested. After you w

ere tested, did you receive counseling?



How

many m

onths ago was your m

ost recent HIV

test?

Have you been tested for H

IV since that tim

e you were

tested during your pregnancy?

Betw

een the time you w

ent for delivery but before the baby w

as born, were you offered an H

IV test?

PRO

BE TO ID

ENTIFY TH

E TYPE OF SO

UR

CE.

IF UN

AB

LE TO

DE

TER

MIN

E IF P

UB

LIC O

R P

RIV

ATE

S

EC

TOR

, WR

ITE TH

E N

AM

E O

F THE

PLA

CE

.

Where w

as the test done?


the results, but were you tested for

HIV

as part of your antenatal care?

Were you offered a test for H

IV as part of your antenatal

care?

W-59

• 449Appendix E

NO

.

SE

CTIO

N 10. H

IV/A

IDS

SK

IPC

OD

ING

CA

TEG

OR

IES

QU

ES

TION

S A

ND

FILTER

S

1027Y

ES

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1

NO

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2

1031

1028M

ON

THS

AG

O. . . . . . . . . . . . . . . . . . .

TWO

OR

MO

RE

YE

AR

S. . . . . . . . . . . . . . . . . . . 95

1029Y

ES

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1

NO

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2

1030PU

BLIC

SECTO

RG

OV

T. HO

SP

ITAL

. . . . . . . . . . . . . . . . . . . . . 11

GO

V .H

EA

LTH C

EN

TER

. . . . . . . . . . . . . . . . 12

GO

V. H

EA

LTH P

OS

T. . . . . . . . . . . . . . . . . . . . .13

OTH

ER

PU

BLIC

SE

CTO

R

16

NG

OHE

ALTH

FAC

ILITY. .

. . . .

. . . .

. . . .

. . 21

OTH

ER

NG

O M

ED

ICA

L SE

CTO

R. .

. . . .

26

1035PR

IVATE M

EDIC

AL SEC

TOR

PR

IVA

TE H

OS

PITA

L. .

. . . .

. . . .

. . . .

31P

RIV

ATE

CLIN

IC. .

. . . .

. . . .

. . . .

. . 32

OTH

ER

PR

IVA

TEM

ED

ICA

L SE

CTO

R. . . . . . . . . . . . . . . . . . . 36

OTH

ER SO

UR

CE

HO

ME

. . . .

. . . .

. . . .

. . . .

. . . .

. . . .

41W

OR

KP

LAC

E. . . . . . . . . . . . . . . . . . . . . . . .

42C

OR

RE

CTIO

NA

L FAC

ILITY. . . . . . . . . . . . .

43

OTH

ER

96

1031Y

ES

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1

NO

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2

1035

1032PU

BLIC

SECTO

RG

OV

T. HO

SP

ITAL

. . . . . . . . . . . . . . . . . . . . . A

GO

V .H

EA

LTH C

EN

TER

. . . . . . . . . . . . . . . . B

GO

V. H

EA

LTH P

OS

T. . . . . . . . . . . . . . . . . . . . .C

OTH

ER

PU

BLIC

SE

CTO

RD

NG

OHE

ALTH

FAC

ILITY. . . . . . . . . . . . . . . . . . . . .

EO

THE

R N

GO

ME

DIC

AL S

EC

TOR

F

PRIVA

TE MED

ICA

L SECTO

RP

RIV

ATE

HO

SP

ITAL

. . . . . . . . . . . . . . . . . . . G

PR

IVA

TE C

LINIC

. . . . . . . . . . . . . . . . . . . . . H

OTH

ER

PR

IVA

TEM

ED

ICA

L SE

CTO

RI

OTH

ER

X

1035Y

ES

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1

NO

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2

DO

N'T K

NO

W/N

OT S

UR

E/D

EP

EN

DS

. . . . . . . 8

PRO

BE TO ID

ENTIFY TH

E TYPE OF SO

UR

CE.

IF UN

AB

LE TO

DE

TER

MIN

E IF P

UB

LIC O

R P

RIV

ATE

S

EC

TOR

, WR

ITE TH

E N

AM

E O

F THE

PLA

CE

.

(SP

EC

IFY)

(SP

EC

IFY)

(SP

EC

IFY)

(SP

EC

IFY)(SP

EC

IFY)

(SP

EC

IFY)

(SP

EC

IFY)



How

many m

onths ago was your m

ost recent HIV

test?

(SP

EC

IFY)

Would you buy fresh vegetables from

a shopkeeper or vendor if you knew

that this person had HIV

?

(NA

ME

OF P

LAC

E)


the results, but have you ever been tested for H

IV?

Where is that?

Any other place?

Do you know

of a place where people can go to get an

HIV

test?

PRO

BE TO ID

ENTIFY TH

E TYPE OF SO

UR

CE.

IF UN

AB

LE TO

DE

TER

MIN

E IF P

UB

LIC O

R P

RIV

ATE

S

EC

TOR

, WR

ITE TH

E N

AM

E O

F THE

PLA

CE

.

(NA

ME

OF P

LAC

E)

Where w

as the test done?

W-60

450 •Appendix E

NO

.

SE

CTIO

N 10. H

IV/A

IDS

SK

IPC

OD

ING

CA

TEG

OR

IES

QU

ES

TION

S A

ND

FILTER

S

1036Y

ES

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1

NO

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2

DO

N'T K

NO

W/N

OT S

UR

E/D

EP

EN

DS

. . . . . . . 8

1037Y

ES

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1

NO

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2

DO

N'T K

NO

W/N

OT S

UR

E/D

EP

EN

DS

. . . . . . . 8

1038Y

ES

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1

NO

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2

DO

N'T K

NO

W/N

OT S

UR

E/D

EP

EN

DS

. . . . . . . 8

1039Y

ES

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1

NO

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2

DO

N'T K

NO

W/N

OT S

UR

E/D

EP

EN

DS

. . . . . . . 8

1040A

GR

EE

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1

DIS

AG

RE

E. . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

2D

ON

'T KN

OW

/NO

T SU

RE

/DE

PE

ND

S. . . . . . .

8

1041Y

ES

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1

NO

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2

SA

YS

SH

E H

AS

HIV

. . . . . . . . . . . . . . . . . . . . . 3

DO

N'T K

NO

W/N

OT S

UR

E/D

EP

EN

DS

. . . . . . . 8

1042

HE

AR

D A

BO

UT

NO

T HE

AR

D A

BO

UT

HIV

OR

AID

SH

IV O

R A

IDS

a)b)

YE

S. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

1N

O. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

2

1043

HA

S H

AD

SE

XUA

LN

EV

ER

HA

D S

EXU

AL

INTE

RC

OU

RS

EIN

TER

CO

UR

SE

1044

YE

SN

O

1051

1046

CH

EC

K 1042: H

EA

RD

AB

OU

T OTH

ER

SE

XUA

LLY TR

AN

SM

ITTED

INFE

CTIO

NS

?

CH

EC

K 713:

Have you heard about

infections that can be transm

itted through sexual contact?

Apart from

HIV

, have you heard about other infections that can be transm

itted through sexual contact?

Do people talk badly about people living w

ith HIV

, or w

ho are thought to be living with H

IV?

Do you think people hesitate to take an H

IV test

because they are afraid of how other people w

ill react if the test result is positive for H

IV?

Do you think children living w

ith HIV

should be allowed

to attend school with children w

ho do not have HIV

?

CH

EC

K 1001:

Do you fear that you could get H

IV if you com

e into contact w

ith the saliva of a person living with H

IV?

Do you agree or disagree w

ith the following statem

ent: I w

ould be ashamed if som

eone in my fam

ily had HIV

.

Do people living w

ith HIV

, or thought to be living with

HIV

, lose the respect of other people?

W-61

• 451Appendix E

NO

.

SE

CTIO

N 10. H

IV/A

IDS

SK

IPC

OD

ING

CA

TEG

OR

IES

QU

ES

TION

S A

ND

FILTER

S

1045Y

ES

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1

NO

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2

DO

N'T K

NO

W. . . . . . . . . . . . . . . . . . . . . . . . . . .

8

1046Y

ES

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1

NO

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2

DO

N'T K

NO

W. . . . . . . . . . . . . . . . . . . . . . . . . . .

8

1047Y

ES

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1

NO

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2

DO

N'T K

NO

W. . . . . . . . . . . . . . . . . . . . . . . . . . .

8

1048

HA

S H

AD

AN

HA

S N

OT H

AD

AN

INFE

CTIO

NIN

FEC

TION

OR

(AN

Y 'Y

ES

')D

OE

S N

OT K

NO

W

1049Y

ES

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1

NO

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2

1051

1050PU

BLIC

SECTO

RG

OV

T. HO

SP

ITAL

. . . . . . . . . . . . . . . . . . . . . A

GO

V .H

EA

LTH C

EN

TER

. . . . . . . . . . . . . . . . B

GO

V. H

EA

LTH P

OS

T. . . . . . . . . . . . . . . . . . . . .C

PU

BLIC

PH

AR

MA

CY

. . . . . . . . . . . . . . . . . . . D

OTH

ER

PU

BLIC

SE

CTO

R

E

NG

OHE

ALTH

FAC

ILITY. . . . . . . . . . . . . . . . . . . . .

FO

THE

R N

GO

ME

DIC

AL S

EC

TOR

. . . .

. . G

PRIVA

TE MED

ICA

L SECTO

RP

RIV

ATE

HO

SP

ITAL

. . . . . . . . . . . . . . . . . . . H

PR

IVA

TE C

LINIC

. . . . . . . . . . . . . . . . . . . . . I

PR

IVA

TE P

HA

RM

AC

Y. . . . . . . . . . . . . . . . . . .

JO

THE

R P

RIV

ATE

ME

DIC

AL S

EC

TOR

. . . .

. . . .

. . K

OTH

ER SO

UR

CE

SH

OP

/MA

RK

ET

. . . . . . . . . . . . . . . . . . . . . . . . L

TRA

DITIO

NA

L PR

AC

TITION

ER

. . . . . . . . . . . . . M

OTH

ER

X

1051Y

ES

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1

NO

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2

DO

N'T K

NO

W. . . . . . . . . . . . . . . . . . . . . . . . . . .

8

1052Y

ES

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1

NO

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2

DO

N'T K

NO

W. . . . . . . . . . . . . . . . . . . . . . . . . . .

8

1051

Now


e questions about your health in the last 13 m

onths. During the last 13 m

onths, have you had a disease w

hich you got through sexual contact?

Som

etimes w

omen experience a bad-sm

elling abnormal

genital discharge. During the last 13 m

onths, have you had a bad-sm

elling abnormal genital discharge?

Som

etimes w

omen have a genital sore or ulcer. D

uring the last 13 m

onths, have you had a genital sore or ulcer?

CH

EC

K 1045, 1046, A

ND

1047:

The last time you had (P

RO

BLE

M FR

OM

1045/1046/1047), did you seek any kind of advice or treatm

ent?

PRO

BE TO ID

ENTIFY TH

E TYPE OF SO

UR

CE.

IF UN

AB

LE TO

DE

TER

MIN

E IF P

UB

LIC O

R P

RIV

ATE

S

EC

TOR

, WR

ITE TH

E N

AM

E O

F THE

PLA

CE

.

(NA

ME

OF P

LAC

E)

Where did you go?

Any other place?

Is a wife justified in refusing to have sex w

ith her husband w

hen she knows he has sex w

ith other w

omen?

If a wife know

s her husband has a disease that she can get during sexual intercourse, is she justified in asking that they use a condom

when they have sex?

(SP

EC

IFY)

(SP

EC

IFY)

(SP

EC

IFY)(SP

EC

IFY)

W-62

452 •Appendix E

NO

.

SE

CTIO

N 10. H

IV/A

IDS

SK

IPC

OD

ING

CA

TEG

OR

IES

QU

ES

TION

S A

ND

FILTER

S

1053

CU

RR

EN

TLY M

AR

RIE

D/

NO

T IN U

NIO

NLIV

ING

WITH

A M

AN

1054Y

ES

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1

NO

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2

DE

PE

ND

S/N

OT S

UR

E. . . . . . . . . . . . . . . . . . . . .

8

1055Y

ES

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1

NO

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2

DE

PE

ND

S/N

OT S

UR

E. . . . . . . . . . . . . . . . . . . . .

8

1056Y

ES

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1

NO

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2

1057

CH

ILDR

EN

UN

DE

RN

O C

HILD

UN

DE

R15 Y

EA

RS

OLD

15 YE

AR

S O

LD

1058N

UM

BE

R O

F CH

ILDR

EN

TES

TED

. . . . .

DO

N'T K

NO

W. . . . . . . . . . . . . . . . . . . . . . . . . . .

8

CH

EC

K 701:

Could you ask your (husband/partner) to use a condom

if you w

anted him to?

Can you say no to your (husband/partner) if you do not

want to have sexual intercourse?

Have you had a pre-m

arital HIV

testing as a couple or individual, before you w

ere married or started living w

ith your husband/partner to prevent H

IV infection betw

een partners?

CH

EC

K 217:

1101

How

many of your children under 15 years old have

been tested for HIV

?

1101

W-63

• 453Appendix E

NO

.

1101

NU

MB

ER

OF IN

JEC

TION

S. . . . . . .

NO

NE

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 00

1104

1102

NU

MB

ER

OF IN

JEC

TION

S. . . . . . .

NO

NE

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 00

1104

1103Y

ES

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1

NO

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2

DO

N'T K

NO

W. . . . . . . . . . . . . . . . . . . . . . . . . . .

8

1104E

VE

RY

DA

Y. . . . . . . . . . . . . . . . . . . . . . . . . . .

1S

OM

E D

AY

S. . . . . . . . . . . . . . . . . . . . . . . . . . .

2N

OT A

T ALL

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 3

1105N

UM

BE

R O

F CIG

AR

ETTE

S. . . . . . .

1106E

VE

RY

DA

Y. . . . . . . . . . . . . . . . . . . . . . . . . . .

1S

OM

E D

AY

S. . . . . . . . . . . . . . . . . . . . . . . . . . .

2N

OT A

T ALL

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 3

1107A

1107P

IPE

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . A

CH

EW

ING

TOB

AC

CO

. . . . . . . . . . . . . . . . B

SN

UFF/S

UR

ET

. . . . . . . . . . . . . . . . . . . . . . . . C

SH

ISH

A. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . D

GA

YA

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . E

OTH

ER

X

1107AY

ES

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1

NO

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2

1107C

1107BN

UM

BE

R O

F DA

YS

. . . . . . . . . . . . . . . .

NO

NE

IN TH

E LA

ST 30 D

AY

S. . . . . . . . . . . . . . . .

00

1107CY

ES

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1

NO

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2

1108

1107DN

UM

BE

R O

F DA

YS

. . . . . . . . . . . . . . . .

NO

NE

IN TH

E LA

ST 30 D

AY

S. . . . . . . . . . . . . . . .

00

1107EA

LMO

ST E

VE

RY

DA

Y. . . . . . . . . . . . . . . . . . . . . . . .

1A

T LEA

ST O

NC

E A

WE

EK

. . . . . . . . . . . . . . . . . . . . . 2

LES

S TH

AN

ON

CE

A W

EE

K. . . . . . . . . . . . . . . . . . . . . 3

NO

NE

IN TH

E LA

ST 13 M

ON

THS

. . . . . . . . . . . . . . . . 4

What other type of tobacco do you currently sm

oke or use?

(SP

EC

IFY)

During the last 30 days how

many days did you chew

C

hat?

During the last 13 m

onths, how often did you take a

drink that contains alcohol?

Have you ever chew

ed Chat?

Have you ever taken a drink that contains alcohol

(Tella/Tegi/Areke/B

eer/Wine, etc...)?

During the last 30 days, how

many days did you have a

drink that contains alcohol?

SE

CTIO

N 11. O

THE

R H

EA

LTH IS

SU

ES

Now


e other questions relating to health m

atters. Have you had an injection for

any reason in the last 13 months?

IF YE

S: H

ow m

any injections have you had?

IF NU

MB

ER

OF IN

JEC

TION

S IS

90 OR

MO

RE

, OR

D

AILY

FOR

3 MO

NTH

S O

R M

OR

E, R

EC

OR

D '90'. IF

NO

N-N

UM

ER

IC A

NS

WE

R, P

RO

BE

TO G

ET A

N

ES

TIMA

TE.

Am

ong these injections, how m

any were adm

inistered by a doctor, a nurse, a pharm

acist, a dentist, or any other health w

orker?

IF NU

MB

ER

OF IN

JEC

TION

S IS

90 OR

MO

RE

, OR

D

AILY

FOR

3 MO

NTH

S O

R M

OR

E, R

EC

OR

D '90'. IF

NO

N-N

UM

ER

IC A

NS

WE

R, P

RO

BE

TO G

ET A

N

ES

TIMA

TE.

The last time you got an injection from

a health worker,

did he/she take the syringe and needle from a new

, unopened package?

Do you currently sm

oke cigarettes every day, some

days, or not at all?

On average, how

many cigarettes do you currently

smoke each day?

Do you currently sm

oke or use any other type of tobacco every day, som

e days, or not at all?

SK

IPC

OD

ING

CA

TEG

OR

IES

QU

ES

TION

S A

ND

FILTER

S

1106

RE

CO

RD

ALL M

EN

TION

ED

.

W-64

454 •Appendix E

NO

.

SE

CTIO

N 11. O

THE

R H

EA

LTH IS

SU

ES

SK

IPC

OD

ING

CA

TEG

OR

IES

QU

ES

TION

S A

ND

FILTER

S

1108

BIG

NO

T A B

IGP

RO

BLE

MP

RO

BLE

M

a)a)

PE

RM

ISS

ION

TO G

O. . . . .

12

b)b)

GE

TTING

MO

NE

Y. . . . . . .

12

c)c)

DIS

TAN

CE

. . . . . . . . . . . . . 1

2

d)d)

GO

ALO

NE

. . . . . . . . . . . . . 1

2

1109Y

ES

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1

NO

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2

1201

1110M

UTU

AL H

EA

LTH O

RG

AN

IZATIO

N/

CO

MM

UN

ITY-B

AS

ED

HE

ALTH

INS

UR

AN

CE

. . . . . . . . . . . . . . . . . . . . . . . .A

HE

ALTH

INS

UR

AN

CE

THR

OU

GH

EM

PLO

YE

R . . . . . . . . . . . . . . . . . . . . . . . . . . .

BS

OC

IAL S

EC

UR

ITY . . . . . . . . . . . . . . . . . . . . .

CO

THER

PRIVATELY PU

RC

HASED

CO

MM

ER

CIA

L HE

ALTH

INS

UR

AN

CE

. . . . . D

OTH

ER

X

RE

CO

RD

ALL M

EN

TION

ED

.

What type of health insurance are you covered by?

Are you covered by any health insurance?

Many different factors can prevent w

omen from

getting m

edical advice or treatment for them

selves. When you

are sick and want to get m

edical advice or treatment, is

each of the following a big problem

or not a big problem:

The distance to the health facility?

Getting m

oney needed for advice or treatment?

Getting perm

ission to go to the doctor?

Not w

anting to go alone?

(SP

EC

IFY)

W-65

• 455Appendix E

NO

.C

OD

ING

CA

TEG

OR

IES

SK

IP

1201N

UM

BE

R O

F BIR

THS

TON

ATU

RA

L MO

THE

R. . . . . . . . .

1202C

HE

CK

1201:TW

O O

R M

OR

E B

IRTH

SO

NLY

ON

E B

IRTH

NE

XT(R

ES

PO

ND

EN

T ON

LY)

1203N

UM

BE

R O

F P

RE

CE

DIN

G B

IRTH

S. . . . . . . . .

1204(1)

(2)(3)

(4)(5)

(6)

1205M

ALE

1M

ALE

1M

ALE

1M

ALE

1M

ALE

1M

ALE

1FE

MA

LE2

FEM

ALE

2FE

MA

LE2

FEM

ALE

2FE

MA

LE2

FEM

ALE

2

1206Y

ES

. . . 1

YE

S. . .

1Y

ES

. . . 1

YE

S. . .

1Y

ES

. . . 1

YE

S. . .

1N

O. . .

2N

O. . .

2N

O. . .

2N

O. . .

2N

O. . .

2N

O. . .

2G

O TO

1208G

O TO

1208G

O TO

1208G

O TO

1208G

O TO

1208G

O TO

1208D

K. . .

8D

K. . .

8D

K. . .

8D

K. . .

8D

K. . .

8D

K. . .

8G

O TO

(2)G

O TO

(3)G

O TO

(4)G

O TO

(5)G

O TO

(6)G

O TO

(7)

1207

GO

TO (2)

GO

TO (3)

GO

TO (4)

GO

TO (5)

GO

TO (6)

GO

TO (7)

1208

1209

IF MA

LE O

RIF M

ALE

OR

IF MA

LE O

RIF M

ALE

OR

IF MA

LE O

RIF M

ALE

OR

DIE

D B

EFO

RE

DIE

D B

EFO

RE

DIE

D B

EFO

RE

DIE

D B

EFO

RE

DIE

D B

EFO

RE

DIE

D B

EFO

RE

12 YE

AR

S12 Y

EA

RS

12 YE

AR

S12 Y

EA

RS

12 YE

AR

S12 Y

EA

RS

OF A

GE

OF A

GE

OF A

GE

OF A

GE

OF A

GE

OF A

GE

GO

TO (2)

GO

TO (3)

GO

TO (4)

GO

TO (5)

GO

TO (6)

GO

TO (7)

1210Y

ES

. . . 1

YE

S. . .

1Y

ES

. . . 1

YE

S. . .

1Y

ES

. . . 1

YE

S. . .

1G

O TO

1213G

O TO

1213G

O TO

1213G

O TO

1213G

O TO

1213G

O TO

1213N

O. . .

2N

O. . .

2N

O. . .

2N

O. . .

2N

O. . .

2N

O. . .

2

1211Y

ES

. . . 1

YE

S. . .

1Y

ES

. . . 1

YE

S. . .

1Y

ES

. . . 1

YE

S. . .

1G

O TO

1213G

O TO

1213G

O TO

1213G

O TO

1213G

O TO

1213G

O TO

1213N

O. . .

2N

O. . .

2N

O. . .

2N

O. . .

2N

O. . .

2N

O. . .

2

1212Y

ES

. . . 1

YE

S. . .

1Y

ES

. . . 1

YE

S. . .

1Y

ES

. . . 1

YE

S. . .

1N

O. . .

2N

O. . .

2N

O. . .

2N

O. . .

2N

O. . .

2N

O. . .

2

1213

IF NO

MO

RE

BR

OTH

ER

S O

R S

ISTE

RS

, GO

TO N

EXT S

EC

TION

.

How

many live

born children did (N

AM

E) give

birth to during her lifetim

e?

How

old is (N

AM

E)?

How

many years

ago did (NA

ME

) die?

How

old was

(NA

ME

) when

(he/she) died?

Was (N

AM

E)

pregnant when

she died?

Did (N

AM

E) die

during childbirth?

Did (N

AM

E) die

within tw

o m

onths after the end of a pregnancy or childbirth?

Is (NA

ME

) still alive?

SE

CTIO

N 12. M

ATE

RN

AL M

OR

TALITY

Now


e questions about your brothers and sisters, that is, all of the children born to your natural m

other, including those who are living w

ith you, those living elsew

here and those who have died.

How

many children did your m

other give birth to, including you?

How

many births did your m

other have before you were born?

What w

as the nam

e given to your (oldest/ next oldest) brother or sister?

Is (NA

ME

) male

or female?

1301

W-66

456 •Appendix E

1204(7)

(8)(9)

(10)(11)

(12)

1205M

ALE

1M

ALE

1M

ALE

1M

ALE

1M

ALE

1M

ALE

1FE

MA

LE2

FEM

ALE

2FE

MA

LE2

FEM

ALE

2FE

MA

LE2

FEM

ALE

2

1206Y

ES

. . . 1

YE

S. . .

1Y

ES

. . . 1

YE

S. . .

1Y

ES

. . . 1

YE

S. . .

1N

O. . .

2N

O. . .

2N

O. . .

2N

O. . .

2N

O. . .

2N

O. . .

2G

O TO

1208G

O TO

1208G

O TO

1208G

O TO

1208G

O TO

1208G

O TO

1208D

K. . .

8D

K. . .

8D

K. . .

8D

K. . .

8D

K. . .

8D

K. . .

8G

O TO

(8)G

O TO

(9)G

O TO

(10)G

O TO

(11)G

O TO

(12)G

O TO

(13)

1207

GO

TO (8)

GO

TO (9)

GO

TO (10)

GO

TO (11)

GO

TO (12)

GO

TO (13)

1208

1209

IF MA

LE O

RIF M

ALE

OR

IF MA

LE O

RIF M

ALE

OR

IF MA

LE O

RIF M

ALE

OR

DIE

D B

EFO

RE

DIE

D B

EFO

RE

DIE

D B

EFO

RE

DIE

D B

EFO

RE

DIE

D B

EFO

RE

DIE

D B

EFO

RE

12 YE

AR

S12 Y

EA

RS

12 YE

AR

S12 Y

EA

RS

12 YE

AR

S12 Y

EA

RS

OF A

GE

OF A

GE

OF A

GE

OF A

GE

OF A

GE

OF A

GE

GO

TO (8)

GO

TO (9)

GO

TO (10)

GO

TO (11)

GO

TO (12)

GO

TO (13)

1210Y

ES

. . . 1

YE

S. . .

1Y

ES

. . . 1

YE

S. . .

1Y

ES

. . . 1

YE

S. . .

1G

O TO

1213G

O TO

1213G

O TO

1213G

O TO

1213G

O TO

1213G

O TO

1213N

O. . .

2N

O. . .

2N

O. . .

2N

O. . .

2N

O. . .

2N

O. . .

2

1211Y

ES

. . . 1

YE

S. . .

1Y

ES

. . . 1

YE

S. . .

1Y

ES

. . . 1

YE

S. . .

1G

O TO

1213G

O TO

1213G

O TO

1213G

O TO

1213G

O TO

1213G

O TO

1213N

O. . .

2N

O. . .

2N

O. . .

2N

O. . .

2N

O. . .

2N

O. . .

2

1212Y

ES

. . . 1

YE

S. . .

1Y

ES

. . . 1

YE

S. . .

1Y

ES

. . . 1

YE

S. . .

1N

O. . .

2N

O. . .

2N

O. . .

2N

O. . .

2N

O. . .

2N

O. . .

2

1213

IF NO

MO

RE

BR

OTH

ER

S O

R S

ISTE

RS

, GO

TO N

EXT S

EC

TION

.

Was (N

AM

E)

pregnant when

she died?

Did (N

AM

E) die

during childbirth?

Did (N

AM

E) die

within tw

o m

onths after the end of a pregnancy or childbirth?

How

many live

born children did (N

AM

E) give

birth to during her lifetim

e?

What w

as the nam

e given to your (oldest/ next oldest) brother or sister?

Is (NA

ME

) male

or female?

Is (NA

ME

) still alive?

How

old is (N

AM

E)?

How

many years

ago did (NA

ME

) die?

How

old was

(NA

ME

) when

(he/she) died?

W-67

• 457Appendix E

SE

CTIO

N 13. FE

MA

LE G

EN

ITAL M

UTILA

TION

NO

.Q

UE

STIO

NS

AN

D FILTE

RS

CO

DIN

G C

ATE

GO

RIE

SS

KIP

1300

1301Y

ES

. . . . . . . . . . . . . . . . . . . . . . . . . . 1

1303N

O. . . . . . . . . . . . . . . . . . . . . . . . . .

2

1302Y

ES

. . . . . . . . . . . . . . . . . . . . . . . . . . 1

NO

. . . . . . . . . . . . . . . . . . . . . . . . . . 2

1400

1303Y

ES

. . . . . . . . . . . . . . . . . . . . . . . . . . 1

NO

. . . . . . . . . . . . . . . . . . . . . . . . . . 2

1309

1304Y

ES

. . . . . . . . . . . . . . . . . . . . . . . . . . 1

1306N

O. . . . . . . . . . . . . . . . . . . . . . . . . .

2D

ON

'T KN

OW

. . . . . . . . . . . . . . . . . . 8

1305Y

ES

. . . . . . . . . . . . . . . . . . . . . . . . . . 1

NO

. . . . . . . . . . . . . . . . . . . . . . . . . . 2

DO

N'T K

NO

W. . . . . . . . . . . . . . . . . .

8

1306Y

ES

. . . . . . . . . . . . . . . . . . . . . . . . . . 1

NO

. . . . . . . . . . . . . . . . . . . . . . . . . . 2

DO

N'T K

NO

W. . . . . . . . . . . . . . . . . .

8

1307A

GE

IN C

OM

PLE

TED

YE

AR

SIF TH

E R

ES

PO

ND

EN

T DO

ES

NO

T KN

OW

THE

EXA

CT A

GE

, PR

OBE TO

GET AN

ESTIMATE.

AS A BABY/DU

RIN

G IN

FANC

Y. . . . . 95

DO

N'T K

NO

W. . . . . . . . . . . . . . . . . .

98

1308TR

AD

ITION

AL

TRA

D. C

IRC

UM

CIS

ER

. . . . . . . . . 11TR

AD

. BIR

TH A

TTEN

DA

NT

. . . . . 12

OTH

ER

TRA

D.

16(S

PE

CIFY

)

HE

ALTH

PR

OFE

SS

ION

AL

DO

CTO

R. . . . . . . . . . . . . . . . . . . . 21

NU

RS

E/M

IDW

IFE. . . . . . . . . . . . 22

OTH

ER

HE

ALTH

PR

OFE

SS

ION

AL

26(S

PE

CIFY

)D

ON

'T KN

OW

. . . . . . . . . . . . . . . . . . 98

1309C

HE

CK

213, 215 AN

D 216:

HA

S O

NE

OR

MO

RE

HA

S N

O LIV

ING

LIV

ING

DA

UG

HTE

RS

DA

UG

HTE

RS

1317B

OR

N IN

1992B

OR

N IN

1992O

R LA

TER

OR

LATE

R

1500

CH

EC

K C

OV

ER

PA

GE

OF Q

UE

STIO

NN

AIR

E: H

OU

SE

HO

LD S

ELE

CTE

D FO

R FE

MA

LE G

EN

ITAL

MU

TILATIO

N M

OD

ULE

(FGM

) AN

D D

OM

ES

TIC V

IOLE

NC

E (D

V)?

YE

S N

O

How

old were you w

hen you were circum

cised?

Who perform

ed the circumcision?

Now


e questions about a practice known

as female circum

cision. Have you ever heard of fem

ale circum

cision?

Have you yourself ever been circum

cised?

Now

I would like to ask you w

hat was done to you at that tim

e. W

as any flesh removed from

the genital area?

Was the genital area just nicked w

ithout removing any flesh?

Was your genital area sew

n closed?

In some countries, there is a practice in w

hich a girl may have

part of her genitals cut. Have you ever heard about this

practice?

W-68

458 •Appendix E

CH

EC

K 213, 215 A

ND

216: EN

TER

IN TH

E TA

BLE

THE

BIR

TH H

ISTO

RY

NU

MB

ER

AN

D N

AM

E O

F EA

CH

LIVIN

G

DA

UG

HTE

R B

OR

N IN

1992 OR

LATE

R. A

SK

THE

QU

ES

TION

S A

BO

UT A

LL OF TH

ES

E D

AU

GH

TER

S. B

EG

IN W

ITH

THE

YO

UN

GE

ST D

AU

GH

TER

. (IF THE

RE

AR

E M

OR

E TH

AN

3 DA

UG

HTE

RS

, US

E A

DD

ITION

AL Q

UE

STIO

NN

AIR

ES

).

1310

1311B

IRTH

HIS

TOR

Y N

UM

BE

RY

OU

NG

ES

T LIVIN

GN

EXT-TO

-YO

UN

GE

ST

SE

CO

ND

-TO-Y

OU

NG

ES

TA

ND

NA

ME

DA

UG

HTE

RLIV

ING

DA

UG

HTE

RLIV

ING

DA

UG

HTE

RO

F EA

CH

LIVIN

G D

AU

GH

TER

BIR

THB

IRTH

BIR

THB

OR

N IN

1992 OR

LATE

RH

ISTO

RY

HIS

TOR

YH

ISTO

RY

NU

MB

ER

NU

MB

ER

NU

MB

ER

NA

ME

_____________N

AM

E_____________

NA

ME

_____________

1312Y

ES

. . . . . . . . . . . 1

YE

S. . . . . . . . . . .

1Y

ES

. . . . . . . . . . . 1

NO

. . . . . . . . . . . . . 2

NO

. . . . . . . . . . . . . 2

NO

. . . . . . . . . . . . . 2

(GO

TO 1311

(GO

TO 1311

(GO

TO 1311

IN N

EXT C

OLU

MN

;IN

NE

XT CO

LUM

N;

IN FIR

ST C

OLU

MN

OR

IF NO

MO

RE

OR

IF NO

MO

RE

OF N

EW

DA

UG

HTE

RS

,D

AU

GH

TER

S,

QU

ES

TION

NA

IRE

; OR

IFG

O TO

1316)G

O TO

1316)N

O M

OR

E D

AU

GH

TER

S,

GO

TO 1316)

1313A

GE

INA

GE

INA

GE

INC

OM

PLE

TED

CO

MP

LETE

DC

OM

PLE

TED

YE

AR

S. . .

YE

AR

S. . .

YE

AR

S. . .

IF THE

RE

SP

ON

DE

NT D

OE

S N

OT

DO

N'T K

NO

W. . . . .

98D

ON

'T KN

OW

. . . . . 98

DO

N'T K

NO

W. . . . .

98K

NO

W TH

E A

GE

, PR

OB

E TO

G

ET A

N E

STIM

ATE

.

1314Y

ES

. . . . . . . . . . . . . 1

YE

S. . . . . . . . . . . . .

1Y

ES

. . . . . . . . . . . . . 1

NO

. . . . . . . . . . . . . 2

NO

. . . . . . . . . . . . . 2

NO

. . . . . . . . . . . . . 2

DO

N'T K

NO

W. . . . .

8D

ON

'T KN

OW

. . . . . 8

DO

N'T K

NO

W. . . . .

8

1315TR

AD

ITION

AL

TRA

DITIO

NA

LTR

AD

ITION

AL

TRA

DITIO

NA

LTR

AD

ITION

AL

TRA

DITIO

NA

LC

IRC

UM

CIS

ER

11C

IRC

UM

CIS

ER

11C

IRC

UM

CIS

ER

11TR

AD

. BIR

THTR

AD

. BIR

THTR

AD

. BIR

THA

TTEN

DA

NT

12A

TTEN

DA

NT

12A

TTEN

DA

NT

12O

THE

R TR

AD

.O

THE

R TR

AD

.O

THE

R TR

AD

.16

1616

(SP

EC

IFY)

(SP

EC

IFY)

(SP

EC

IFY)

HE

ALTH

PR

OFE

SS

ION

AL

HE

ALTH

PR

OFE

SS

ION

AL

HE

ALTH

PR

OFE

SS

ION

AL

DO

CTO

R. . . . . . .

21D

OC

TOR

. . . . . . . 21

DO

CTO

R. . . . .

21N

UR

SE

/MID

WIFE

22N

UR

SE

/MID

WIFE

22N

UR

SE

/MID

WIFE

22O

THE

R H

EA

LTHO

THE

R H

EA

LTHO

THE

R H

EA

LTHP

RO

FES

SIO

NA

LP

RO

FES

SIO

NA

LP

RO

FES

SIO

NA

L26

2626

(SP

EC

IFY)

(SP

EC

IFY)

(SP

EC

IFY)

DO

N'T K

NO

W. . . . .

98D

ON

'T KN

OW

. . . . . 98

DO

N'T K

NO

W. . . . .

98

1316G

O B

AC

K TO

1311 ING

O B

AC

K TO

1311 ING

O TO

1311 INN

EXT C

OLU

MN

; OR

, IFN

EXT C

OLU

MN

; OR

, IFFIR

ST C

OLU

MN

OF N

EW

NO

MO

RE

DA

UG

HTE

RS

,N

O M

OR

E D

AU

GH

TER

S,

QU

ES

TION

NA

IRE

; OR

IFG

O TO

1317.G

O TO

1317.N

O M

OR

E D

AU

GH

TER

S,

GO

TO 1317.

1317Y

ES

. . . . . . . . . . . . . . . . . . . . . . . . . . 1

NO

. . . . . . . . . . . . . . . . . . . . . . . . . . 2

NO

RE

LIGIO

N. . . . . . . . . . . . . . . . .

3D

ON

'T KN

OW

. . . . . . . . . . . . . . . . . . . 8

1318C

ON

TINU

ED

. . . . . . . . . . . . . . . . . . . 1

STO

PP

ED

. . . . . . . . . . . . . . . . . . . . 2

DE

PE

ND

S. . . . . . . . . . . . . . . . . . . .

3D

ON

'T KN

OW

. . . . . . . . . . . . . . . . . . . 8

Do you believe that fem

ale circumcision is required by your

religion?

Do you think that fem

ale circumcision should be continued, or

should it be stopped?

Now


e questions about your (daughter/daughters).

Is (NA

ME

OF D

AU

GH

TER

) circum

cised?

How

old was (N

AM

E O

F D

AU

GH

TER

) when she w

as circum

cised?

Who perform

ed the circumcision?

Was her genital area sew

n closed?

W-69

• 459Appendix E

SE

CTIO

N 14. V

IOLE

NC

E A

GA

INS

T WO

ME

N M

OD

ULE

NO

.Q

UE

STIO

NS

AN

D FILTE

RS

CO

DIN

G C

ATE

GO

RIE

SS

KIP

1400

WO

MA

N S

ELE

CTE

DW

OM

AN

FOR

THIS

SE

CTIO

NN

OT S

ELE

CTE

D1500

1401C

HE

CK

FOR

PR

ES

EN

CE

OF O

THE

RS

:

DO

NO

T CO

NTIN

UE

UN

TIL PR

IVA

CY

IS E

NS

UR

ED

.

PR

IVA

CY

PR

IVA

CY

OB

TAIN

ED

. . . . . . . 1

NO

T PO

SS

IBLE

. . . . . . . 2

1432

1401A

1402C

HE

CK

701 AN

D 702:

FO

RM

ER

LYC

UR

REN

TLYM

AR

RIED

/N

EVER M

AR

RIED

/M

AR

RIE

D/

LIVE

D W

ITH A

MA

NN

EV

ER

LIVE

D W

ITHLIV

ING

(RE

AD

IN P

AS

T TEN

SE

A M

AN

WITH

A M

AN

AN

D U

SE

'LAS

T' WITH

1416H

US

BA

ND

/PA

RTN

ER

')

1403

YE

SN

OD

Ka)

JEA

LOU

S. . . . . . . . . . .

12

8b)

AC

CU

SE

S. . . . . . . . . . .

12

8c)

NO

T ME

ET FR

IEN

DS

. . . 1

28

d)N

O FA

MIL Y

. . . . . . . . . . . 1

28

e)W

HE

RE

YO

U A

RE

. . . . . 1

28

1404

A.

B.

SO

ME

-N

OT IN

LAS

TE

VE

RO

FTEN

TIME

S

13 MO

NTH

S

a)Y

ES

11

23

NO

2

b)Y

ES

11

23

NO

2

c)Y

ES

11

23

NO

2

CH

EC

K C

OV

ER

PA

GE

OF Q

UE

STIO

NN

AIR

E: H

OU

SE

HO

LD S

ELE

CTE

D FO

R FE

MA

LE G

EN

ITAL

MU

TILATIO

N M

OD

ULE

(FGM

) AN

D D

OM

ES

TIC V

IOLE

NC

E (D

V)?

Now

I need to ask some m

ore questions about your relationship w

ith your (last) (husband/partner).

Did your (last) (husband/partner) ever:

How

often did this happen during the last 13 m

onths: often, only sometim

es, or not at all?

say or do something to hum

iliate you in front of others?

RE

AD

TO TH

E R

ES

PO

ND

EN

T:N

ow I w

ould like to ask you questions about some other im

portant aspects of a wom

an's life. You m

ay find some

of these questions very personal. How

ever, your answers are crucial for helping to understand the condition of

wom

en in Ethiopia. Let m

e assure you that your answers are com

pletely confidential and will not be told to anyone

and no one else in your household will know

that you were asked these questions. If I ask you any question you

don't want to answ

er, just let me know

and I will go on to the next question.

First, I am going to ask you about som

e situations which

happen to some w

omen. P

lease tell me if these apply to your

relationship with your (last) (husband/partner)?

He (is/w

as) jealous or angry if you (talk/talked) to other men?

He frequently (accuses/accused) you of being unfaithful?

He (does/did) not perm

it you to meet your fem

ale friends?H

e (tries/tried) to limit your contact w

ith your family?

He (insists/insisted) on know

ing where you (are/w

ere) at all tim

es?threaten to hurt or harm you or som

eone you care about?

insult you or make you feel bad about

yourself?

W-70

460 •Appendix E

NO

.Q

UE

STIO

NS

AN

D FILTE

RS

CO

DIN

G C

ATE

GO

RIE

SS

KIP

1405A

.B

.

SO

ME

-N

OT IN

LAS

TE

VE

RO

FTEN

TIME

S

13 MO

NTH

S

a)Y

ES

11

23

NO

2

b)Y

ES

11

23

NO

2

c)Y

ES

11

23

NO

2

d)Y

ES

11

23

NO

2

e)Y

ES

11

23

NO

2

f)Y

ES

11

23

NO

2

g)Y

ES

11

23

NO

2

h)Y

ES

11

23

NO

2

i)Y

ES

11

23

NO

2

j)Y

ES

11

23

NO

2

1406C

HE

CK

1405A (a-j):

A

T LEA

ST O

NE

NO

T A S

ING

LE'Y

ES

''Y

ES

'1409

1407

NU

MB

ER

OF Y

EA

RS

. . . . . . .

BE

FOR

E M

AR

RIA

GE

/BE

FOR

EIF LE

SS

THA

N O

NE

YE

AR

, RE

CO

RD

'00'.LIV

ING

TOG

ETH

ER

. . . . . . . . . . . . . 95

1408

a)Y

ES

. . . . . . . . . . . . . . . . . . . . . . . . . . . . 1

NO

. . . . . . . . . . . . . . . . . . . . . . . . . . . . 2

b)Y

ES

. . . . . . . . . . . . . . . . . . . . . . . . . . . . 1

NO

. . . . . . . . . . . . . . . . . . . . . . . . . . . . 2

c)Y

ES

. . . . . . . . . . . . . . . . . . . . . . . . . . . . 1

NO

. . . . . . . . . . . . . . . . . . . . . . . . . . . . 2

How

often did this happen during the last 13 m

onths: often, only sometim

es, or not at all?

push you, shake you, or throw som

ething at you?

You had cuts, bruises, or aches?

You had eye injuries, sprains, dislocations, or burns?

twist your arm

or pull your hair?

Did your (last) (husband/partner) ever do

any of the following things to you:

slap you?

You had deep w

ounds, broken bones, broken teeth, or any other serious injury?

punch you with his fist or w

ith something

that could hurt you?

kick you, drag you, or beat you up?

try to choke you or burn you on purpose?

threaten or attack you with a knife, gun,

or other weapon?

physically force you to have sexual intercourse w

ith him w

hen you did not w

ant to?

physically force you to perform any other

sexual acts you did not want to?

force you with threats or in any other w

ay to perform

sexual acts you did not want

to?

How

long after you first (got married/started living together) w

ith your (last) (husband/partner) did (this/any of these things) first happen?

Did the follow

ing ever happen as a result of what your (last)

(husband/partner) did to you:

W-71

• 461Appendix E

NO

.Q

UE

STIO

NS

AN

D FILTE

RS

CO

DIN

G C

ATE

GO

RIE

SS

KIP

1409Y

ES

. . . . . . . . . . . . . . . . . . . . . . . . . . . . 1

N

O. . . . . . . . . . . . . . . . . . . . . . . . . . . .

21411

1410O

FTEN

. . . . . . . . . . . . . . . . . . . . . . . . 1

S

OM

ETIM

ES

. . . . . . . . . . . . . . . . . . . . 2

NO

T AT A

LL. . . . . . . . . . . . . . . . . . . .

3

1411Y

ES

. . . . . . . . . . . . . . . . . . . . . . . . . . . . 1

N

O. . . . . . . . . . . . . . . . . . . . . . . . . . . .

21413

1412O

FTEN

. . . . . . . . . . . . . . . . . . . . . . . . 1

S

OM

ETIM

ES

. . . . . . . . . . . . . . . . . . . . 2

NE

VE

R. . . . . . . . . . . . . . . . . . . . . . . .

3

1413M

OS

T OF TH

E TIM

E A

FRA

ID. . . . . . .

1

SO

ME

TIME

S A

FRA

ID. . . . . . . . . . . . .

2

N

EV

ER

AFR

AID

. . . . . . . . . . . . . . . . . 3

1414C

HE

CK

709:

MA

RR

IED

MO

RE

M

AR

RIE

D O

NLY

TH

AN

ON

CE

ON

CE

1416

1415A

.B

.

0 - 11 12+

DO

N'T

EV

ER

MO

NTH

SM

ON

THS

RE

ME

MB

ER

AG

OA

GO

a)Y

ES

11

23

NO

2

b)Y

ES

11

23

NO

2

How

long ago did this last happen?

Did any previous (husband/partner) ever hit,

slap, kick, or do anything else to hurt you physically?

Did any previous (husband/partner)

physically force you to have intercourse or perform

any other sexual acts against your w

ill?

Does (did) your (last) (husband/partner) drink alcohol?

How

often does (did) he get drunk: often, only sometim

es, or never?

Have you ever hit, slapped, kicked, or done anything else to

physically hurt your (last) (husband/partner) at times w

hen he w

as not already beating or physically hurting you?

In the last 13 months, how

often have you done this to your (last) (husband/partner): often, only som

etimes, or not at all?

Are (W

ere) you afraid of your (last) (husband/partner): most of

the time, som

etimes, or never?

So far w

e have been talking about the behavior of your (current/last) (husband/partner). N

ow I w

ant to ask you about the behavior of any previous (husband/partner).

W-72

462 •Appendix E

NO

.Q

UE

STIO

NS

AN

D FILTE

RS

CO

DIN

G C

ATE

GO

RIE

SS

KIP

1416C

HE

CK

701 AN

D 702:

E

VE

R M

AR

RIE

D/E

VE

R

NE

VE

R M

AR

RIE

D/N

EV

ER

LIVE

D W

ITH A

MA

NLIV

ED

WITH

A M

AN

a)b)

YE

S. . . . . . . . . . . . . . . . . . . . . . . . . . . .

1N

O. . . . . . . . . . . . . . . . . . . . . . . . . . . .

2

RE

FUS

ED

TO A

NS

WE

R/

NO

AN

SW

ER

. . . . . . . . . . . . . . . . . . . 3

1419

1417M

OTH

ER

/STE

P-M

OTH

ER

. . . . . . . . . . . A

FATH

ER

/STE

P-FA

THE

R. . . . . . . . . . . . .

B

SIS

TER

/BR

OTH

ER

. . . . . . . . . . . . . . . . . CD

AU

GH

TER

/SO

N. . . . . . . . . . . . . . . . . D

OTH

ER

RE

LATIV

E. . . . . . . . . . . . . . . . . E

CU

RR

EN

T BO

YFR

IEN

D. . . . . . . . . . . . .

FR

EC

OR

D A

LL ME

NTIO

NE

D.

FOR

ME

R B

OY

FRIE

ND

. . . . . . . . . . . . . GM

OTH

ER

-IN-LA

W. . . . . . . . . . . . . . . . . H

FATH

ER

-IN-LA W

. . . . . . . . . . . . . . . . . . . I

OTH

ER

IN-LA

W. . . . . . . . . . . . . . . . . . .

JTE

AC

HE

R. . . . . . . . . . . . . . . . . . . . . .

KE

MP

LOY

ER

/SO

ME

ON

E A

T WO

R. . . . .

LP

OLIC

E/S

OLD

IER

. . . . . . . . . . . . . . . . . M

OTH

ER

X

1418O

FTEN

. . . . . . . . . . . . . . . . . . . . . . . . 1

SO

ME

TIME

S. . . . . . . . . . . . . . . . . . . .

2

NO

T AT A

L L. . . . . . . . . . . . . . . . . . . . . . 3

1419C

HE

CK

201, 226, AN

D 230:

E

VE

R B

EE

N

NE

VE

R B

EE

NP

RE

GN

AN

TP

RE

GN

AN

T1422

(YE

S O

N 201

OR

226 OR

230)

1420Y

ES

. . . . . . . . . . . . . . . . . . . . . . . . . . . . 1

N

O. . . . . . . . . . . . . . . . . . . . . . . . . . . .

21422

1420BY

ES

. . . . . . . . . . . . . . . . . . . . . . . . . . . . 1

N

O. . . . . . . . . . . . . . . . . . . . . . . . . . . .

2

1421C

UR

REN

T HU

SBAND

/PARTN

ER. . .

A

MO

THE

R/S

TEP

-MO

THE

R. . . . . . . . .

BFA

THE

R/S

TEP

-FATH

ER

. . . . . . . . . . . C

SIS

TER

/BR

OTH

ER

. . . . . . . . . . . . . . . DD

AU

GH

TER

/SO

N. . . . . . . . . . . . . . . . . E

OTH

ER

RE

LATIV

E. . . . . . . . . . . . . . .

FFO

RM

ER

HU

SB

AN

D/P

AR

TNE

R. . . . .

GR

EC

OR

D A

LL ME

NTIO

NE

D.

CU

RR

EN

T BO

YFR

IEN

D. . . . . . . . . . .

HFO

RM

ER

BO

YFR

IEN

D. . . . . . . . . . .

IM

OTH

ER

-IN-LA

W. . . . . . . . . . . . . . . . .

JFA

THE

R-IN

-LAW

. . . . . . . . . . . . . . . . . KO

THE

R IN

-LAW

. . . . . . . . . . . . . . . . . L

TEA

CH

ER

. . . . . . . . . . . . . . . . . . . . . . M

EM

PLO

YE

R/S

OM

EO

NE

AT W

OR

K.

NP

OLIC

E/S

OLD

IER

. . . . . . . . . . . . . . . O

OTH

ER

X

(SP

EC

IFY)

(SP

EC

IFY)

In the last 13 months, how

often has (this person/have these persons) physically hurt you: often, only som

etimes, or not at

all?

Has any one ever hit, slapped, kicked, or done anything else to

hurt you physically while you w

ere pregnant?

Did you m

iscarry as a result of the violence?

Who has done any of these things to physically hurt you w

hile you w

ere pregnant?

Anyone else?

From the tim

e you were 15

years old has anyone other than (your/any) (husband/partner) hit you, slapped you, kicked you, or done anything else to hurt you physically?

From the tim

e you were 15

years old has anyone hit you, slapped you, kicked you, or done anything else to hurt you physically?

Who has hurt you in this w

ay?

Anyone else?

W-73

• 463Appendix E

NO

.Q

UE

STIO

NS

AN

D FILTE

RS

CO

DIN

G C

ATE

GO

RIE

SS

KIP

1422C

HE

CK

701 AN

D 702:

EV

ER

MA

RR

IED

/EV

ER

NE

VE

R M

AR

RIE

D/N

EV

ER

LIVE

D W

ITH A

MA

NLIV

ED

WITH

A M

AN

1422B

1422A

YE

S. . . . . . . . . . . . . . . . . . . . . . . . . . . .

11423

NO

. . . . . . . . . . . . . . . . . . . . . . . . . . . . 2

R

EFU

SE

D TO

AN

SW

ER

/

NO

AN

SW

ER

. . . . . . . . . . . . . . . . . . . 3

1424A

1422BY

ES

. . . . . . . . . . . . . . . . . . . . . . . . . . . . 1

NO

. . . . . . . . . . . . . . . . . . . . . . . . . . . . 2

RE

FUS

ED

TO A

NS

WE

R/

NO

AN

SW

ER

. . . . . . . . . . . . . . . . . . . 3

1426

1423C

UR

REN

T HU

SBAND

/PARTN

ER. . . 01

FOR

ME

R H

US

BA

ND

/PA

RTN

ER

. . . . . 02C

UR

RE

NT/FO

RM

ER

BO

YFR

IEN

D. . . 03

FATH

ER

/STE

P-FA

THE

R. . . . . . . . . . . 04

BR

OTH

ER

/STE

P-B

RO

THE

R. . . . . . . 05

OTH

ER

RE

LATIV

E. . . . . . . . . . . . . . . 06

IN-LA

W. . . . . . . . . . . . . . . . . . . . . . . . 07

OW

N FR

IEN

D/A

CQ

UA

INTA

NC

E. . . 08

FAM

ILY FR

IEN

D. . . . . . . . . . . . . . . . . 09

TEA

CH

ER

. . . . . . . . . . . . . . . . . . . . . . 10E

MP

LOY

ER

/SO

ME

ON

E A

T WO

RK

11P

OLIC

E/S

OLD

IER

. . . . . . . . . . . . . . . 12P

RIE

ST/R

ELIG

IOU

S LE

AD

ER

. . . . . 13S

TRA

NG

ER

. . . . . . . . . . . . . . . . . . . . 14

OTH

ER

96

1424C

HE

CK

701 AN

D 702:

E

VE

R M

AR

RIE

D/E

VE

RN

EV

ER

MA

RR

IED

/NE

VE

RLIV

ED

WITH

A M

AN

LIVE

D W

ITH A

MA

N

a)b)

YE

S. . . . . . . . . . . . . . . . . . . . . . . . . . . .

1N

O. . . . . . . . . . . . . . . . . . . . . . . . . . . .

21425

1424AC

HE

CK

1405A (h-j) and 1415A

(b)

AT LE

AS

T ON

EN

OT A

'Y

ES

'S

ING

LE 'Y

ES

'1426

1425C

HE

CK

701 AN

D 702:

EV

ER

MA

RR

IED

/EV

ER

NE

VE

R M

AR

RIE

D/N

EV

ER

LIVE

D W

ITH A

MA

NLIV

ED

WITH

A M

AN

a)b)

AG

E IN

CO

MP

LETE

D Y

EA

RS

DO

N'T K

NO

W. . . . . . . . . . . . . . . . . . . .

98

(SP

EC

IFY)

In the last 13 months, has

anyone other than (your/any) (husband/partner) physically forced you to have sexual intercourse w

hen you did not w

ant to?

In the last 13 months has

anyone physically forced you to have sexual intercourse w

hen you did not w

ant to?

How

old were you the first

time you w

ere forced to have sexual intercourse or perform

any other sexual acts by anyone, including (your/any) husband/partner?

How

old were you the first

first time you w

ere forced to have sexual intercourse or perform

any other sexual acts?

At any tim

e in your life, as a child or as an adult, has anyone ever forced you in any w

ay to have sexual intercourse or perform

any other sexual acts when you did not w

ant to?

Who w

as the person who w

as forcing you the very first time this

happened?

Now

I want to ask you about things that m

ay have been done to you by som

eone other than (your/any) (husband/partner).

At any tim

e in your life, as a child or as an adult, has anyone ever forced you in any w

ay to have sexual intercourse or perform

any other sexual acts when you did not w

ant to?W-74

464 •Appendix E

NO

.Q

UE

STIO

NS

AN

D FILTE

RS

CO

DIN

G C

ATE

GO

RIE

SS

KIP

1426C

HE

CK

1405A (a-j), 1415A

(a,b), 1416, 1420, 1422A, A

ND

1422B:

A

T LEA

ST O

NE

NO

T A S

ING

LE'Y

ES

''Y

ES

'1430

1427Y

ES

. . . . . . . . . . . . . . . . . . . . . . . . . . . . 1

N

O. . . . . . . . . . . . . . . . . . . . . . . . . . . .

21429

1428O

WN

FAM

ILY. . . . . . . . . . . . . . . . . . . A

HU

SB

AN

D'S

/PA

RTN

ER

'S FA

MILY

. . . B

C

UR

RE

NT/FO

RM

ER

H

US

BA

ND

/PA

RTN

ER

. . . . . . . . . . . C

RE

CO

RD

ALL M

EN

TION

ED

.C

UR

RE

NT/FO

RM

ER

BO

YFR

IEN

D.

DFR

IEN

D. . . . . . . . . . . . . . . . . . . . . . . .

EN

EIG

HB

OR

. . . . . . . . . . . . . . . . . . . . F

RE

LIGIO

US

LEA

DE

R. . . . . . . . . . . . . G

DO

CTO

R/M

ED

ICA

L PE

RS

ON

NE

L. . .

H1429

PO

LICE

. . . . . . . . . . . . . . . . . . . . . . . . I

LAW

YE

R. . . . . . . . . . . . . . . . . . . . . .

JS

OC

IAL S

ER

VIC

E O

RG

AN

IZATIO

NK

CO

MM

UN

ITY B

AS

ED

OR

GA

NIZA

TION

LW

OM

EN

AN

D Y

OU

TH A

FFAIR

. . . . . M

OTH

ER

X

1428AE

MB

AR

AS

SE

D. . . . . . . . . . . . . . . . . . . A

DID

N'T K

NO

W W

HE

RE

TO G

O. . . . .

BD

IDN

'T KN

OW

WH

O TO

TELL

. . . . . C

NO

T NE

CE

SS

AR

Y. . . . . . . . . . . . . . . D

NO

T WA

NTIN

G TO

TELL

. . . . . . . . . E

AFR

AID

THE

Y M

AY

NO

T BE

LIEV

E M

EF

TH

INK

ING

I WILL N

OT G

ET S U

. . . . . . . G

OTH

ER

X

1429Y

ES

. . . . . . . . . . . . . . . . . . . . . . . . . . . . 1

N

O. . . . . . . . . . . . . . . . . . . . . . . . . . . .

2

1430Y

ES

. . . . . . . . . . . . . . . . . . . . . . . . . . . . 1

N

O. . . . . . . . . . . . . . . . . . . . . . . . . . . .

2D

ON

'T KN

OW

. . . . . . . . . . . . . . . . . . . 8

THA

NK

THE

RE

SP

ON

DE

NT FO

R H

ER

CO

OP

ER

ATIO

N A

ND

RE

AS

SU

RE

HE

R A

BO

UT TH

E C

ON

FIDE

NTIA

LITY O

F HE

RA

NS

WE

RS

. FILL OU

T THE

QU

ES

TION

S B

ELO

W W

ITH R

EFE

RE

NC

E TO

THE

DO

ME

STIC

VIO

LEN

CE

MO

DU

LE O

NLY

.

1431D

ID YO

U H

AVE TO IN

TERR

UPT TH

EY

ES

YE

S, M

OR

E

INTE

RV

IEW

BE

CA

US

E S

OM

E A

DU

LT WA

SO

NC

ETH

AN

ON

CE

NO

TRY

ING

TO LIS

TEN

, OR

CA

ME

INTO

THE

HU

SB

AN

D. . . . . . . . . . .

12

3R

OO

M, O

R IN

TER

FER

ED

IN A

NY

OTH

ER

O

THE

R M

ALE

AD

UL T. . .

12

3W

AY

?FE

MA

LE A

DU

L T. . . . . . .

12

3

1432IN

TER

VIE

WE

R'S

CO

MM

EN

TS / E

XPLA

NA

TION

FOR

NO

T CO

MP

LETIN

G TH

E D

OM

ES

TIC V

IOLE

NC

E M

OD

ULE

As far as you know

, did your father ever beat your mother?

Thinking about what you yourself have experienced am

ong the different things w

e have been talking about, have you ever tried to seek help?

(SP

EC

IFY)

Why didn't you seek help at that tim

e?

Have you ever told anyone about this?

(SP

EC

IFY)

From w

hom have you sought help?

Anyone else?

W-75

• 465Appendix E

NO

.

1500

1501Y

ES

. . . . . . . . . . . . . . . . . . . 1

NO

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2

DO

N'T K

NO

W. . . . . . . . . . . . . . . .

8

1502

1503

GR

AN

TED

1G

RA

NTE

D1

(SIG

N)

(SIG

N)

RE

FUS

ED

2R

EFU

SE

D2

(THE

N S

KIP

TO 1514)

(THE

N S

KIP

TO 1514)

1504B

IRTH

HIS

TOR

Y N

UM

BE

RO

F EA

CH

CH

ILD

BIR

THB

IRTH

BO

RN

IN 2005 O

R LA

TER

HIS

TOR

YH

ISTO

RY

FRO

M 212 IN

BIR

TH H

ISTO

RY

.N

UM

BE

R.............N

UM

BE

R...............

1505

DA

Y.......................

DA

Y..........................

MO

NTH

...................M

ON

TH.....................

YE

AR

YE

AR

1506A

GE

..................................

AG

E

................................

1507

1508

1509

1510

NO

CA

RD

AN

D N

O O

THE

R

DO

CU

ME

NT S

EE

NC

AR

D O

R O

THE

R

DO

CU

ME

NT S

EE

N1515

SE

CTIO

N 15. IN

FOR

MA

TION

AB

OU

T HE

ALTH

FAC

ILITY W

HE

RE

VA

CC

INA

TION

CA

RD

S A

RE

KE

PT

QU

ES

TION

S A

ND

FILTER

SC

OD

ING

CA

TEG

OR

IES

SK

IP

CH

EC

K 504A

, 507A, 504B

AN

D 507B

: VA

CC

INA

TION

CA

RD

SE

EN

?

Did any of your children born betw

een 2005-2008 ever receive any vaccination at a health faciltiy (including governem

ent hospitals, health centers/posts, NG

O

facilities, or private hospitals/clinics)?

1515

As part of this survey, w

e would like to visit the health facility in w

hich your children got vaccinated. With your perm

ission, our health facility team

will visit the health center and copy the vaccination records from

the health cards directly to the same questionnaire I

am using right now

for our interview. The inform

ation will be kept confidential and w

ill not be shared with anyone other than

mem

bers of our survey team. W

e hope you will allow

access to the health cards because information about your children's

vaccinations is very important. The inform

ation will com

plement the inform

ation that we obtained from

you in this interview. M

any dangerous childhood illnesses such as m

easles or tetanus can be prevented through timely and effective vaccination. The

information from

the cards will assist the governm

ent to develop programs to protect children from

vaccine preventable diseases and reduce childhood m

ortality and morbidity in E

thiopia.


Will you allow

(NA

ME

OF C

HILD

) to have his/her vaccination records copied from his/her health card kept at the health facility?

CIR

CLE

THE

CO

DE

AN

DS

IGN

YO

UR

NA

ME

.(LA

ST B

IRTH

)(N

EXT-TO

-LAS

T BIR

TH)

AS

K R

ES

PO

ND

EN

T FOR

CO

NS

EN

T TO C

OP

Y V

AC

CIN

ATIO

N D

ATE

S FR

OM

THE

CH

ILDR

EN

'S H

EA

LTH C

AR

DS

KE

PT IN

A

HE

ALTH

FAC

ILITY

RE

CO

RD

CH

ILD'S

FULL N

AM

E, M

OTH

ER

'S FU

LL NA

ME

, FATH

ER

'S FU

LL NA

ME

, CH

ILD'S

KE

BE

LE, TO

WN

, AN

D R

EG

ION

, AN

D N

AM

E O

F H

EALTH FAC

ILITY WH

ERE C

HILD

'S LAST VACC

INATIO

N W

AS ADM

INISTER

ED. BE SU

RE TO

TAKE ADD

RESS AN

D LO

CATIO

N

DE

SC

RIP

TION

OF H

EA

LTH FA

CILITY

.

What is the nam

e of the health facility w

here (NA

ME

's) last vaccination was

administered?

On w

hat day, month, and year w

as (N

AM

E) born?

How

old was (N

AM

E) at (N

AM

E's) last

birthday?

What is your first and last nam

e?

What is the first and last nam

e of (N

AM

E's) father?

NA

ME

OF H

EA

LTH FA

CILITY

NA

ME

OF H

EA

LTH FA

CILITY

What nam

e was used at the health facility

where (N

AM

E) w

as last vaccinated?

W-76

466 •Appendix E

NO

.

SE

CTIO

N 15. IN

FOR

MA

TION

AB

OU

T HE

ALTH

FAC

ILITY W

HE

RE

VA

CC

INA

TION

CA

RD

S A

RE

KE

PT

QU

ES

TION

S A

ND

FILTER

SC

OD

ING

CA

TEG

OR

IES

SK

IP

1511K

EB

ELE

KE

BE

LE

TOW

NTO

WN

WO

RE

DA

WO

RE

DA

1512

1513

1514

1515H

OU

RS

. . . . . . . . . . . . . . . . . . . . . . . .

MIN

UTE

S. . . . . . . . . . . . . . . . . . . . . . . .

What is the nam

e of the Doctor/health

officer that vaccinated (NA

ME

) at the health facility?

RE

CO

RD

THE

TIME

.

What is the location (K

ebele, Town,

Woreda), w

here (NA

ME

's) last vaccination w

as administered?

Can you describe the location of the

health facility?

AD

D TO

THE

DE

SC

RIP

TION

ALL

LAN

DM

AR

KS

(SU

CH

AS

A P

AR

K),

PU

BLIC

STR

UC

TUR

ES

(SU

CH

AS

S

CH

OO

L OR

CH

UR

CH

), AN

D S

TRE

ETS

O

R R

OA

DS

.

GO

BA

CK

TO 1504 IN

NE

XT C

OLU

MN

; OR

, IF NO

MO

RE

B

IRTH

S, G

O TO

1515.

GO

TO 1504 IN

NE

XT-TO-LA

ST

CO

LUM

N O

F NE

W

QU

ES

TION

NA

IRE

; OR

, IF NO

MO

RE

C

HILD

GO

TO 1515.

W-77

• 467Appendix E

CO

MM

EN

TS A

BO

UT IN

TER

VIE

W:

CO

MM

EN

TS O

N S

PE

CIFIC

QU

ES

TION

S:

AN

Y O

THE

R C

OM

ME

NTS

:

INTE

RV

IEW

ER

'S O

BS

ER

VA

TION

S

TO B

E FILLE

D IN

AFTE

R C

OM

PLE

TING

INTE

RV

IEW

SU

PE

RV

ISO

R'S

OB

SE

RV

ATIO

NS

ED

ITOR

'S O

BS

ER

VA

TION

S

W-78

468 •Appendix E

ETHIO

PIAC

ENTR

AL STA

TISTICA

L AG

ENC

Y (CSA

)

NA

ME

OF H

EA

LTH FA

CILITY

LOC

ALITY

OF TH

E H

EA

LTH FA

CILITY

NA

ME

OF C

HILD

CLU

STE

R N

UM

BE

R. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

HO

US

EH

OLD

NU

MB

ER

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

LINE

NU

MB

ER

OF W

OM

AN

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

BIR

TH H

ISTO

RY

NU

MB

ER

OF C

HILD

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

CH

ILD’S

DA

TE O

F BIR

TH (D

AY

, MO

NTH

, AN

D Y

EA

R)

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

MO

NTH

YE

AR

DA

TED

AY

MO

NTH

YE

AR

INTE

RV

IEW

ER

'SN

AM

EIN

T. NO

.

RE

SU

LT*R

ES

ULT*

NE

XT V

ISIT:

DA

TETO

TAL N

UM

BE

RTIM

EO

F VIS

ITS

*RE

SU

LT CO

DE

S:

1 CO

MP

LETE

D5 H

EA

LTH FA

CILITY

TEM

PO

RA

RILY

CLO

SE

D9 O

THE

R2 FA

CILITY

NO

T FOU

ND

6 HE

ALTH

FAC

ILITY P

ER

SO

NN

EL

3 HE

ALTH

FAC

ILITY

NO

T AV

AILA

BLE

PE

RM

AN

EN

TLY C

LOS

ED

7 A

CC

ES

S TO

RE

CO

RD

S D

EN

IED

4 TOO

FAR

TO B

E V

ISITE

D8 R

EC

OR

D N

OT FO

UN

D FO

R TH

IS C

HILD

SP

EC

IFY

DEM

OG

RA

PHIC

AN

D H

EALTH

SUR

VEYH

EALTH

FAC

ILITY QU

ESTION

NA

IRE

IDEN

TIFICA

TION

HEA

LTH FA

CILITY VISITS

12

3FIN

AL V

ISIT

HF-1

• 515Appendix E

SIGN

ATUR

E OF H

EALTH FAC

ILITY INTER

VIEWER

HEALTH

FACILITY

HEALTH

FACILITY PER

SON

NEL

GIVES AC

CES

. . 1

DEN

IES ACC

ES. .

2EN

D

NO

.

101H

OU

RS

. . . . . . . . . . . . . . . . . . . . . . . . .

MIN

UTES

. . . . . . . . . . . . . . . . . . . . . .

102YES C

HILD

'S INFO

RM

ATION

SEEN

................1

103YES VAC

CIN

ATION

REC

OR

DS LO

CATED

,BU

T NO

REC

OR

D O

F CH

ILD'S IN

FOR

MATIO

N2

NO

, VACC

INATIO

N R

ECO

RD

S NO

T FOU

ND

....3

OTH

ER96

(SPECIFY)

103D

AY........................................................

MO

NTH

................................................

YEAR.................................

104

105In w

hat type of facility did the visit take place?PU

BLIC SEC

TOR

. . . .

. . . .

. . . .

. . . .

. . 1

NG

O. .

. . . .

. . . .

. . . .

. . . .

. . . .

. . . .

2PR

IVATE SECTO

R. .

. . . .

. . . .

. . . .

. . 3

OTH

ER96

(SPECIFY)

HO

UR

S. . . . . . . . . . . . . . . . . . . . . . . . .

MIN

UTES

. . . . . . . . . . . . . . . . . . . . . .

RO

TAVIRU

S 1

REC

OR

D TH

E TIME.

OR

AL POLIO

VACC

INE (O

PV) 0 (BIRTH

DO

SE)

OR

AL POLIO

VACC

INE (O

PV) 1

OR

AL POLIO

VACC

INE (O

PV) 2

OR

AL POLIO

VACC

INE (O

PV) 3

CO

PY CH

ILD’S D

ATE OF BIR

TH (D

AY, MO

NTH

, AND

YEAR

) FRO

M H

EALTH FAC

ILITY REC

OR

D.

PNEU

MO

CO

CC

AL 3

DPT-H

EP.B-HIB (PEN

TAVALENT) 1

DPT-H

EP.B-HIB (PEN

TAVALENT) 2

DPT-H

EP.B-HIB (PEN

TAVALENT) 3

PNEU

MO

CO

CC

AL 1

PNEU

MO

CO

CC

AL 2

IF UN

ABLE TO D

ETERM

INE IF PU

BLIC O

R PR

IVATE SEC

TOR

, WR

ITE THE N

AME O

F THE PLAC

E.

106R

ECO

RD

THE TIM

E.

RO

TAVIRU

S 2

MEASLES

VITAMIN

A (MO

ST REC

ENT)

INTR

OD

UC

TION

AND

CO

NSEN

T

Hello. M

y name is _______________________________________. I am

working w

ith Central Statistical Agency (C

SA). We are conducting a

survey about health and other topics all over Ethiopia. As part of this survey, we w

ould like to visit health facilities in which children born in

January 2005 or later got vaccinated. We have already recieved consent from

the parent of the child, and with your your perm

ission, we

would like to copy the vaccination records from

the health cards to the questionnaire for the following child.

In case you need more inform

ation about the survey, you may contact the person listed on the letter that has already been show

n to you.


May I have access to the vaccination records of (C

HILD

'S NAM

E)?

DATE

SECTIO

N 1. H

EALTH FAC

ILITY FOR

M

BCG

QU

ESTION

S AND

FILTERS

CO

DIN

G C

ATEGO

RIES

SKIP

Have you located the vaccination records of (N

AME O

F C

HILD

'S NAM

E IN 1505) in the W

OM

AN'S

QU

ESTION

NAIR

E?

IMM

UN

IZATION

REC

OR

DS FR

OM

HEALTH

FACILITY

CO

PY DATA ABO

UT EAC

H VAC

CIN

E FRO

M IM

MU

NIZATIO

N R

ECO

RD

S W

RITE ‘44' IN

‘DAY' C

OLU

MN

IF CAR

D SH

OW

S THAT A D

OSE W

AS GIVEN

, BUT N

O D

ATE IS REC

OR

DED

.

DAY

MO

NTH

YEAR

105

HF-2

516 •Appendix E

Introduction of pneumococcal conjugate vaccination in Ethiopia

Documents

Transcript of Introduction of pneumococcal conjugate vaccination in Ethiopia